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Water treatment approaches for pharmaceutically active compounds (PhACs) are restricted by 
the chemically-variable nature of the PhACs themselves, each successful in treating only a 
small number; or the adaptability or expense of the treatment system.   Minimal study has 
taken place concerning novel, affordable, amendable treatment media that can be employed 
on numerous scales and water types, with the potential to treat a variety of PhACs and other 
water contaminants. This study evaluates the removal of a suite of environmentally relevant 
pharmaceuticals from water in response to contact with reactive media and/or natural organic 
matter. Experiments were conducted with batch samples containing a media of interest in 
simulated ground water spiked with carbamazepine, caffeine, naproxen, gemfibrozil, 
ibuprofen, sulfamethoxazole and clofibrate, each at an environmentally relevant concentration 
of 2-2.5 µg l-1.  Media investigated included: Stelco-BOF slag (STB), woodchips (WC), 
Borden sand (BDS), zero valent iron (ZVFe), and granular activated carbon (GAC). Water 
samples were analyzed for basic water quality parameters and pharmaceutical concentrations 
were calculated by internal and external calibration of HPLC-MS/MS results. Calculated 
pharmaceutical removal efficiencies were based upon percent changes in concentration 
between initial and final measurements. Pharmaceutical removal was observed for all 
investigated media, with success varying between media and pharmaceutical types. The 
greatest percent removal, of >99.88% was observed for all PhACs, with concentrations 
dropping below the limits of detection (LOD) of 3-189 ng l-1, in GAC and ZVFe-GAC 
mixtures; the smallest percentage removal when considering all media, of 0.0%, was 
exhibited by ibuprofen and naproxen in STB, BDS and WC samples.  The greatest removal 
was observed within the first 24 hours for the majority of the drugs that showed measurable 
removals. Results also indicated that the addition of activated carbon to zero valent iron may 
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1 INTRODUCTION:  
 
The body uses only a small portion of an administered pharmaceutical; the remaining 
portion is excreted.  Often this excreted portion is relatively unaltered or scarcely modified by 
metabolism, being reduced, oxidized, hydrolyzed, alkylated, or dealkylated through phase I 
metabolism, or conjugated to polar molecules such as glucuronides through phase II 
metabolism, to assist with drug clearance from the body (Cunningham, 2004). These 
metabolic changes are often undermined during sewage treatment; and thus oxidation-
reduction reactions as well as cleavage of conjugates can convert even metabolized 
compounds to the original active parent pharmaceutical, allowing its entrance into the aquatic 
environment (Herberer, 2001).   
However, parent pharmaceuticals are not the only compounds of concern. 
Pharmaceutical metabolites, conjugated or otherwise are suspected to be present at 
environmentally higher concentrations than their parent compounds; and given the potentially 
more toxic nature of some of these compounds, or their ability to chemically revert to an 
active form; these compounds deserve further research as well (Dorne et al., 2007; Brody et 
al., 2005). For example, studies by Miao and Metcalfe (2003) indicate that hydroxylated 
carbamazepine metabolites occur at higher concentrations in wastewater than the parent 
pharmaceutical.  Recent studies are thus investigating a broader scope, addressing not only 
parent pharmaceuticals but pharmaceutically active metabolites as well.  A number of studies 
have indicated that pharmaceutically active compounds (PhACs), including both 
pharmaceuticals and their active metabolites, are neither efficiently removed by wastewater 
treatment, nor biodegraded; and thus, the unchanged compounds are often discharged from 




Daughton and Ternes, 1999; Wilken et al., 2000). During recharge these receiving waters 
along with other contaminated surface water, landfill leachate, manufacturing residues, and 
leaking city sewer systems are pathways for PhAC-contaminated effluent to leach to 
underlying aquifers (Figure 1.0).  More than eighty micro-pollutants, including 
pharmaceutical compounds and drug metabolites, have been identified at concentrations up to 
10 μg l-1, in surface waters and municipal wastewaters (Jones et al., 2005; Castiligioni et al., 
2006; Skoumal et al., 2006). 
Recent studies have indicated the presence of a large number of pharmaceuticals and 
personal care products (PPCPs) in groundwater as well. Table 1.0 briefly outlines some 
recent studies documenting the occurrence of PhACs and PPCPs in groundwater.  An 
investigation of water supply systems found the occurrence of 26 PhACs; seven of which 
were present in drinking water, 16 in groundwater and post-treatment effluent, and three 
PhACs that were observed in both (Collier, 2007).   Studies conducted in Berlin, Germany, 
indicate that PhACs have entered a cycle originating and concluding with humans. PhACs 
travel from administration, to excretion, entering municipal sewage treatment plants, then 
surface and groundwater recharge, and returning back to humans via drinking water 
(Herberer, 2001).    
The concentrations of PhACs in groundwater have been observed in the μg l-1 level; 
and while this level of exposure may pose little risk to adult humans, the same may not be 
true for fetuses, infants or children and other organisms. Children have been shown to have up 
to an eight fold greater risk of adverse effects to PhAC exposure; and are potentially being 
exposed to several PhACs contraindicated, or not established as safe for pediatric use (Collier, 




from as little as 3.4 years to 34,000 years to ingest a single clinically used dose (Collier, 
2007).   Children, however, are not the only ones susceptible to low PhAC exposures, 
pregnant women are also at risk; or to be more precise, the developing infant.  Women over 
the course of a pregnancy are inadvertently exposed to a number of drugs that are teratogenic, 
ingesting up to almost 13% of a single dose over 36 weeks (Collier, 2007). Post-natal 
exposure to PhACs during breast-feeding is also grounds for concern (Collier, 2007).    
Whereas changes in physiological parameters are not immediately evident, sub-
clinical doses are known to cause effects at the cellular and organ system levels; and thus, 
developing fetuses and children subjected to chronic exposure may undergo long-term 
alterations in organ systems and/or structural function. Developmental patterns for life, as 
well as growth, are established during the fetal period, and subtle changes attributed to 
chronic PhAC exposure during this time may manifest into evident physiological, 
morphological or cognitive outcomes (Collier, 2007).   Therefore, whereas concentrations 
may appear low in ground and drinking water, chronic exposure to these low levels may harm 
the developing population, who is unable to process PhACs.   
 The potential risks of chronic low level PhAC release into the environment and the 
potential ecological effects are increasing researched and noted for their significance 
(Jørgensen and Halling-Sørensen, 2000; Stuer-Lauridsen et al., 2000; Kümmerer, 2004). The 
design of PhACs, to be persistent in the body and to cause a specific biological response, 
makes their release potentially harmful to aquatic flora and fauna.  Whereas information 
concerning chronic toxicity of human PhACs to biota is still limited, previous and current 
investigations have indicated chronic toxicity for algae, invertebrates and fish species 




PhACs have increased toxicity when present in a mixture with other PhACs, as they usually 
occur in the environment. Whereas the concentration of each component PhAC may be at a 
level independently confirmed to have little to no effect, the mixture itself may be toxic.  The 
toxicity of the mixture follows the concept of concentration addition, with compounds acting 
in an additive fashion (Triebskorn et al., 2007). Recent investigations by Cleuvers (2004) 
supported such findings, indicating that diclofenac, ibuprofen, acetylsalicylic acid and 
naproxen show greater toxicities as a mixture than as individual compounds. The effect of 
chronic PhAC exposure must include the sensitivity of specific organisms, such as those in 
early development. Accordingly, the complete exposure pathway must be considered when 
evaluating the environmental risk assessment for PhAC release. 
 With the unknown potential consequences of chronic PhAC exposure it is not 
surprising that treatment of pharmaceuticals in water has been and is currently a focus of 
investigation.  A great deal of data has been collected reflecting waste water and drinking 
water treatment for PhACs; Table 1.2 briefly outlines some of the recent studies. Little 
exploration has occurred, however, concerning new passive techniques comprised solely of 
affordable, amendable treatment media that can be employed on numerous scales and water 
varieties, from surface and wastewater to groundwater treatment. 
 Thus the objective of this study was to assess the removal of environmentally relevant 
pharmaceuticals from water in response to contact with reactive media and/or natural organic 
matter that are highly available, affordable, and offer the advantage of being low maintenance 
passive systems. The investigation explores the potential sorption and/or chemical 






















































































PhAC Use Reference for ground water detection 
Acetaminophen  Antipyretic  Hinkle et al., 2005; Heberer et al., 2002 
Benzafibrate Lipid regulator Clara et al., 2004 
Caffeine  Stimulant  Seiler et al., 1999; Buerge et al., 2003;  
Hinkle et al., 2005; Godfrey et al., 2007; 
Seiler et al., 1999 
Carbamazepine  Anticonvulsant,  
Anti-manic, antidepressant  
Seiler et al., 1999;  Drewes et al., 2003 ; 
Buerge et al., 2003; Clara et al., 2004;  
Godfrey et al., 2007; Snyder et al., 2004 ; 
Heberer et al., 2002; Heberer et al. 2004; 
Godfrey et al.;  Snyder et al., 2004 
Cimetidine  Antiasthmatic  Kolpin et al., 2002 
Codeine  Analgesic  Kolpin et al., 2002  
Cotinine  Nicotine metabolite  
 
Kolpin et al., 2002; Stackelberg, 2003;  
Godfrey el al., 2007;Barnes et al., 2004 
Clofibric Acid 
 
Lipid regulator Heberer et al., 2002; Sheytt et al.., 2007 ; 
Heberer et al., 2004 
Diclofenac Non-steroidal anti-inflammatory 
(NSAID) 
Heberer et al., 2002; Clara et al., 2004 ; 
Heberer et al., 2004 
Diazepam Anti-anxiety Heberer et al., 2002 
Diltiazem  Blood pressure control  Kolpin et al., 2002 
Erythromycin-18  Antibiotic  Kolpin et al., 2002; Snyder et al. 2004 
Fluoxetine  Antidepressant  Kolpin et al., 2002; Snyder et al, 2004 
Fenofibrate Lipid regulator Heberer et al., 2002 
Gemfibrozil Lipid-regulator Heberer et al., 2002 
Ibuprofen NSAID Heberer et al., 2002; Snyder et al., 2004 
Iopromide Contrast agent Herberer et al., 2002 ; Clara et al. 2004 
Lincomycin Antibiotic Barnes et al., 2004 
Metformin  Antihyperglycemic  Kolpin et al., 2002  
Naproxen Analgesic Drewes et al., 2003 
Nicotine  CNS stimulant; nicotinic agonist Albaiges et al., 1986; Rogers et al., 1986 
Paraxanthine   Caffeine metabolite  Kolpin et al., 2002, 2004 
Primidone Anti-convulsant Heberer et al., 2002; Scheytt et al., 2007; 
Drewes et al., 2003; Heberer et al., 2004 
Ranitidine  Histamine  Kolpin et al., 2002 
Salbutamol  Bronchodilator  Castiglioni et al., 2005 
Sulfamethoxazole  Antibiotic  Hartig et al., 1999; Huang et al.., 2002;   
Hinkle et al. 2005; Godfrey et al. 2007 ;  
Heberer et al., 2002; Godfrey et al., 2007 ; 
Snyder et al., 2004 
Trimethoprim  Antibiotic  Kolpin et al., 2002; Godfrey et al., 2007; 
Herberer et al., 2002; Snyder et al., 2004 ; 
Snyder et al., 2004 
Triclosan Anti-bacterial Snyder et al., 2004 ; Barnes et al., 2004 










Type Treatment Systems Source of study: 
Adsorptive and oxidative processes: Aluminum sulfate; ferric chloride 
coagulants,chemical lime softening, powder activated carbon, ozone and 
chlorination 
Westerhoff  et al., 2005  
Nanofiltration (NF) membranes: (Trisep) TS-80 and Desal HL, NF with 
subsequent GAC filtration 
Verliefde et al., 2007 
Ozone – oxidant 
 
Renato et al., 2007 ; 
Cornelissen et al., 2006 ; 
Wenyi et al., 2006 
Chlorine dioxide – oxidant 
 
Hubera et al., 2005 
AOPs: Advanced Oxidation Processes 
Photo-fenton reagent  
Pérez-Estrada et al., 2005 
*Clarification (chlorination):  FeCl3  /  Disinfection:  NaClO  /  Granular-
activated-carbon (GAC) filtration 
Gibbs et al., 2007 
Advanced Oxidation Processes:  Ultrasound (sonolysis) and  Thermal 
degradation (pyrolysis) 






Adsorption: micelles pre-adsorbed on montmorillonite  
*Micelles of benzyldimethylhexadecylammonium (BDMHDA)  
Groisman et al., 2006 
Anaerobic Biotransformation/Adsorption/Settling /Volatilization /Plant 
Uptake /Photolysis 
Conn et al., 2006 
Bagnati et al.,  2006 
Free Chlorine (chlorination/oxidation) Boyd et al., 2005 
Denitrifying biofilter;  Denitrifying/nitrifying Bacteria  and 
Denitrifying/nitrifying activated sludge, Activated sludge  
Vieno et al., 2007; Aga et al., 
2006 ; 
Lema et al., 2005;  Benito et al., 
2005; Hideshige et al., 2006; 
Kronberg et al., 2005 
Neutral and anion-exchange polymers: (adsorption) Polystyrene–
divinylbenzene Phenol–formaldehyde aliphatic acrylic, Aliphatic 
methacrylic  Polystyrene–divinylbenzene  Polystyrene–divinylbenzene 
aromatic acrylic   
Butler et al., 2006 
Chlorination: Hypochlorite  
 
Bedner and MacCrehan, 2006 
Irrigation: Soil aquifer treatment using  activated sludge 
 
Ternes et al., 2007 
*Activated Sludge treatment (AST)  and Membrane Bioreactor (MBR) – 
biodegradation  
Bernhard et al., 2006;  
Alder et al., 2005 
*Urine source-separation followed by… 
Treatment technologies: electrodialysis, bioreactor treatment, nanofiltration, 
struvite precipitation, ozonation 
Escher et al., 2006 
**Coagulation–flocculation technique / **Flotation technique 
 
Carballa et al., 2005 
WWT: 1)  primary settling process;  2) activated sludge – denitrification);  
3) phosphorous removal, gravity filtration, 4) disinfection  





**Up-flow anaerobic stage reactor (UASR) 
   Biomass = anaerobic digested sewage sludge – methanogenic bacteria 
Chelliapan et al., 2006 
Ferrate(VI) (FeVIO42-, Fe(VI)), - oxidants 
 
Mishra et al., 2006 
Advanced Oxidation processes:  
**O3 (ozonation)  and O3/H2O2 (perozonation) 






Membrane bioreactor (MBR) / Membrane filtration: Activated 
carbon/Reverse osmosis/Nanofiltration/Ultrafiltration 
GAC 




CHAPTER 2: REVIEW OF TREATMENT METHODS FOR THE REMOVAL OF 
PHACS FROM WASTEWATER AND DRINKING WATER 
 
As the pharmaceutical industry grows, advancements and new PhACs enter the 
marketplace everyday; and coinciding with this increasing variety of treatments is the increase 
in use of prescription and non-prescription pharmaceuticals. This greater use is equated with 
greater excretion of parent PhACs and metabolites to the envrionment because the body uses 
only a small portion of an administered dose. Thus, with each administered dose, we are not 
only treating ourselves, but also releasing PhACs to the environment (Cunningham, 2004).   
Both pharmaceutical compounds and pharmaceutical metabolites are a concern in the 
aquatic envrionment.  Changes to parent pharmaceuticals by metabolism, such as reduction, 
oxidation, hydrolysis, alkylation, dealkylation or conjugation assist in drug clearance from the 
body (Cunningham, 2004).  However, these changes can be reversed by sewage treatment or 
environmental reactions, or they can result in more toxic compounds; leaving parent or 
potentially more pharmaceutically active compounds to enter the aquatic environment 
(Heberer, 2001).  Recent studies are thus investigating a broader scope, addressing not only 
parent pharmaceuticals but pharmaceutically active metabolites as well; all of these 
compounds are addressed under the umbrella term of pharmaceutically active compounds or 
PhACs. 
Recent studies have indicated the presence of a large number of pharmaceuticals and 
personal care products in surface water, wastewater, drinking water and groundwater. Greater 
than eighty micropollutants, including PhACs have been identified at concentrations up to 10 
μg l-1 in municipal wastewater and surface waters (Heberer, 2002; Jones et al., 2005; 




widespread groundwater occurrence (Table 1.1). Numerous studies have indicated that 
PhACs are neither efficiently removed by wastewater treatment, nor biodegraded; and thus, 
the primarily unchanged compounds are often discharged from sewage treatment plants into 
receiving waters (Herberer, 2002;; Halling-Sørensen et al., 1998; Daughton and Ternes, 1999; 
Wilken et al., 2000). During recharge these receiving waters along with other contaminated 
surface water, landfill leachate, manufacturing residues, and leaking city sewer systems offer 
avenues for PhAC-contaminated effluent to enter nearby aquifers (Figure 1).  
The uncertain end results of chronic PhAC exposure to humans and the ecosystem 
have made investigations into PhAC treatment to reduce exposure increasingly popular.  An 
abundant mass of data has been compiled regarding primarily wastewater and drinking water 
treatment for PhACs.  An appraisal of this large body of research resulted in the formation of 
the following review. This review involves selected tables explicating distinct details of the 
overall review, including the frequency of investigation, the collective success of particular 
treatments and PhACs, and the mode of studies employed in the investigations; as well as a 
final inclusive table providing detailed description of recently investigated media and 
treatment systems, the PhACs and water type involved, procedural particulars and results of 
each study..  
 Forty-one journal articles were reviewed and summarized in a comparison chart.  
Investigations ranged from small laboratory-scale batch experiments to field scale analyses of 
full functioning waste- and drinking water treatment plants; a number of studies had both a 











Figure 2.1 Distribution of investigation type amoung reviewed articles.  Laboratory and field 
investigations were conducted in the reviewed studies; pie sections indicate the percentage of 
all investigations that were conducted at a laboratory-scale (black) or a field-scale (grey).  
Pilot-sized operations were considered laboratory-scale unless operated along side a full-scale 
operation.   
 
  
Whether conducted in the laboratory or in the field, the basis for most investigations 
was the increasing ability to detect and quantify PhACs at environmentally relevant 
concentrations, as low as ng l-1.  Advances in technology and increased knowledge concerning 
appropriate handling, extraction and analysis of such compounds have greatly contributed to 
the increasing body of information concerning not only the occurrence of PhACs in the 
environment, but also the treatment of such compounds.   For example, improvements from 
single quadrapole detectors and traditional ion trap systems to vastly improved ion trap 
systems and high sensitivity triple quadrapole detectors have provided improved assurance in 
the identification of trace concentrations of unknown compounds. Extraction procedures, such 




certain analytical devices such as high performance liquid chromatography (HPLC) and liquid 
chromatography tandem mass spectrometry (LC/MS/MS) and gas chromatography-mass 
spectrometry (GC/MS) systems. As depicted in Figure 2.2 these analytical devices dominated 
the research; however, colourimetric methods, biological testing, IR and NMR analyses were 
















Figure 2.2. Distribution of analysis type among reviewed articles.  LC, GC and HPLC 
represent liquid, gas and high performance liquid chromatography, respectively.  MS/MS 
indicates tandem mass spectrometry.  CLM and SPC denote colourimetric methods with 
spectrophotometry; and finally, MS, IR and NMR represent Mass Spectrometry (specific 
method not distinguished), Infrared Spectrometry and Nuclear Magnetic Resonance imaging, 
respectively.  Biological tests (biotest) included the algal chlorophyll fluorescence test, the 
yeast estrogen screen (YES) and the umu test; biotests can be used to detect PhACs using the 
known toxilogical natures of the pharmaceuticals examined and the elimination of a test 
species or introduced toxicity. 
 
  
An expanded variety of media and treatment systems, as well as, target PhACs and 
PPCPs were examined in the 41 studies.  Treatment media and treatment systems ranged from 
full-scale functioning wastewater and drinking water facilities to lone compounds such as 
granular activated carbon (GAC) or filtration membranes.  Oxidation techniques were the 
most commonly investigated treatments, including ozone, ferrate, chlorination media such as 





































chlorine dioxide, and advanced oxidation processes (AOPs) including photo-fenton reagents 
and ozone-peroxide mixtures.  Of the 68 treatments evaluated, 32% of them were oxidative 
treatments.  While oxidative techniques are described more distinctly in Figure 2.3, 
increasingly broad designations are used to describe less commonly explored media and 
system classifications.  Coagulant and precipitants included ferric chloride, aluminum sulfate, 
aluminum polychloride, ferric sulfate, calcium oxide and chemical lime softening; 
disinfection media included chlorine dixoide, hypochlorite, free chlorine and NaClO; waste 
water treatments included tank-, biofilter- and wetland-based facilities; activated sludge 
encompassed a number of forms including denitrifying and nitrifying sludge; filtration 
techniques include nanofiltration (NO), ultrafiltration(UF) and reverse osmosis (RO); and 
finally, exchange polymers of  various compositions, such as polystyrene and acrylic were 








Figure.2.3. Distribution of treatment media and systems explored in the reviewed 
investigations.   UASR =Up-flow anaerobic stage reactor; MBR = Membrane Bioreactor; 
FBR = Feedbed Bioreactor; GAC = granular activated carbon; PAC = powdered activated 
carbon; NF = nanofiltration; RO = reverse osmosis; UF = ultrafiltration; UV = ultraviolet 
radiation; WWTx = waste water treatment process.  
 
  
The variety of treatment media and systems explored was surpassed by the collection 
of analytes investigated.  Some studies were extremely focussed, studying one specific PhAC, 
Distribution of Treatment Media and Systems 
Amoung Reviewed Articles
Number of Studies





















while other studies explored the treatment success of greater than 60 different PhACs and 
PPCPs.  A total of 107 different PhACs and PPCPS were explored (Fig. 2.4).  A number of 
PhACs were reoccurring between studies as a consequence of their environmental relevancy; 
these included: carbamazepine, ibuprofen, gemfibrozil, naproxen, benzafibrate, ketoprofen, 
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Figure 2.4. Occurrence of PhACs and PPCPs in reviewed studies. The figure shows the 
number of studies in which each PhAC or PPCP was investigated.  Certain PhACs, such as 
sulfonamide antibiotics and estrogenic compounds were grouped together due to the sheer 
number of compounds in these categories.  
 
 
The success of the investigated treatment media and systems was extremely variable.  
The variation occurred both within and amidst treatment types ranging from no removal to 
complete removal of the target analytes.  The varying success of treatment media and systems 
was usually compound specific; underlying the fact that few techniques were efficient at 
removing analytes of varying chemical composition.  Differing success between larger 
systems, such as WWTx plants, was dependent not only on the analytes, but also on 
characteristics of the plants themselves, such as solid retention time (SRT), hydraulic 
retention time (HRT), composition and seasonality.   Figure 2.5 depicts the removal success 
of the different treatment media/systems explored in the reviewed studies, illustrating through 






Figure 2.5. Percent removal range for a variety of PhACs and PPCPs with respect to 
treatment media or system. The range of % removals for each treatment type are displayed in 
a box plot which indicates the minimum, low quartile, median, upper quartile, and maximum 
% removal for each treatment type. Data points indicate outliers in the removal ranges. Note: 
Not all studies described removal success in terms of % removal and thus only comparative 
data is included in this figure. UASR = upflow anaerobic reactor; BNR = biological nutrient 
removal; GAC = granualr activated carbon; PAC  = powdered activated carbon; WWTx = 
waste water treatment. 
  
Common to all investigations concerning multiple target analytes was the observation 
that treatment success was highly variable between PhAC and PPCPs.  Differences in 
chemical properties made each compound a unique removal challenge, showing varying 
levels of successful removal with different treatment approaches.  Certain PhACs were 
Percent Removal Range with respect to 
Treatment Media and Systems 




































































































observed to be highly persistent, resistent to most treatment approaches, such as clofibric acid, 
whereas others, such as caffeine, showed consistently high removals.  For the most part, both 
negligible and almost complete removals were seen for nearly all drugs, with variation 
occurring as a result of the type of treatment approach. Percent removals depicted in Figure 
2.6 indicate the average percent removal seen for each PhAC/PPCP considering all possible 
treatments.  Error bars indicate the standard deviation within the removal success.  
When considering the percent removals with respect to PhAC/PCCP type depicted in 
Figure 2.6, one should note that some PhAC and PPCPs are more extensively researched than 
others.  Thus, while a PhAC such as Tylosin may indicate 95% removal success, as compared 
to ibuprofen, with a removal range of 0 to 100%, the latter PhAC was evaluated many more 
times with a multitude of different treatment media.  Figure 2.6 portrays the extensive 
variation in removal success for compounds, given their differences in chemical nature, with 
different treatments, as well as an overall indication of compounds that are particularly 
difficult to treat. Treatment success, or percent removals with respect to PhAC or treatment 
type as depicted in Figures 2.5 and 2.6 should be considered in conjunction with Figures 2.3 
and 2.4 which indicate how extensively each PhAC/PPCP or treatment type has been 
explored. The following Table 2.1 has been included in this review to further allow 
appropriate weighting to be applied to the described removal data; the table shows the number 














Table 2.1 Number of PhAC/PPCPs investigated with respect to each type of treatment.  Some 
investigations used a group of compounds not indicating exact numbers, and thus the > sign 
indicates that more PhAC/PPCPs may have been investigated with that specific treatment 
media or system.  The number indicated in the table is thus the minimun number of 
PhAC/PPCPs explored.  
 
Treatment Type Number of PhAC/PPCPs 
Ozone 183 
WWTx >9 
Chlorination/Disinfection  111 




Exchange Polymers >1 
Filtration/Membranes >48 
Photo-Fenton oxidation  >2 







Biological Nutrient Removal 67 
UV radiation  34 
 
 
The final table, Table 2.2 the PhAC/PPCP treatment chart, briefly describes all 41 
reviewed journal articles.  The descriptions provide information pertaining to the investigated 
media and treatment systems, the PhACs and water types involved, as well as, procedural 







Figure 2.6. Percent removals, in literature pharmaceutical removal studies, with respect to 
PhAC/PPCP type.  Bars represent the mean percent removal while error bars represent the 
standard deviation within the removal data set from this mean.  
Percent Removal with Respect to PhAC type
Percent Removal
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DWT plant  
 























































Chlorine dioxide  
 
**Oxidant used for the 
disinfection.  
 
**Chlorite is the major 
reduction product; it is 
considered to be a 
blood poison (Condie, 
1986). 
 
* ClO2 is also used in 
waste water treatment 
disinfection  
 




and Giardia) than 
chlorine and the 
halogenated 
disinfection byproducts 





** ClO2 is a stable free 
radical; reacts via an 
electron transfer rxn 




** Highly selective 
oxidant for specific 
functional groups like 
phenolic moieties or 
tertiary amino groups 
(common to PhACs). 
 
Thus it is likely to 
oxidize many PhACs 
despite its lower 






** Samples were spiked with 
acidic and neutral PhACs up 1mg l-1 
 
**Lab experiments: Room 
temperature in batch reactors with 
ClO2 doses 0.95 and 11.5 mg l-1 and 
rxn time of 30 min. 
 
**Groundwater was spiked with 4 
sulfonamide (1 mg l-1 each), 4 
macrolide antibiotics (100 ng l-1 
each) & 3 estrogens (1 mg l-1 each); 
then treated with 0.1 mg l-1 ClO2 
 
**ClO2 concentrations were 
determined using 3 different 
methods: 
 (1) The direct spectrophotometrical 
determination at 359nm (Hoigne´ 
and Bader, 1994), 
(2) ABTS method –a colorimetric 
method adapted from Pinkernell et 
al.(2000) 
 (3) LGB method, a colorimetric 
methodusing lissamine green B 
(Chiswell and O’Halloran, 1991). 
 
** sulfamethoxazole and diclofenac 
concentrations were measured with 
a Hewlett-Packard 1050 series 
HPLC equipped with an Ultra 




** 4 of the 9 compounds showed an appreciable 
reactivity with ClO2 : (2nd order rate constants) 
       sulfamethoxazole          (6.7 X 103 mol-1s-1) 
        roxithromycin              (2.2 X 102  mol-1s-1) 
       17a-ethinylestradiol       (2.0 X 105  mol-1s-1) 
       diclofenac                     (1.05 X 104 mol-1s-1) 
 
Comparison to Ozone and Chlorine: 
** ClO2 reacted more slowly and with fewer 
compounds than ozone and faster than chlorine. It 
is effective to oxidize only certain compound 
classes such as the investigated classes of 
sulfonamide and macrolide antibiotics, and 
estrogens. 
 
** EE2, roxithromycin, and SMX all indicate pH-
dependent rate constants, with high reactivity at pH 
7. This is due to their protonation state.  
 
**ClO2 reacts very selectively with functional 
groups with high electron densities such as 
phenoxide ions and neutral tertiary amines, and 
thus non-protonated forms tend to be more 
reactive. 
 
** The relatively high rate constant of the aniline 
derivative diclofenac indicates that the aniline group 
is also reactive to ClO2.  
 
**Drinking Water treated for 30min with ClO2: 
bezafibrate, carbamazepine, diazepam, and 
ibuprofen showed no reactivity, whereas diclofenac 
was readily oxidized. 
 
**Surface water can have a substantial ClO2 
demand, causing PhACs and water matrix to 
compete for ClO2; in which case even highly 




-Oxidized more than 95% after 30 min of contact 
time.  
-Reactivity between sulfonamides varied more than 
expected and may be explained by differences in 
speciation. Reactivity seems strongly influenced by 
the protonation state of the acidic nitrogen  
 
**Macrolides: 
-Oxidized more slowly than the sulfonamides and 
only ~48% after 180 min.  
-Reactivity between macrolides was similar 




-Estrogens reacted too fast to be detected after 5 
min contact time. 
 
**Full mineralization is generally not achievable 
with oxidant doses commonly used in water 
treatment, thush it can only deactivate PhACs by 
selectively oxidizing functional groups crucial to 
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Environ. Sci. Technol. 2006, 40, 7358-7366 
 
Occurrence and Fate of Organic Contaminants during Onsite 
Wastewater Treatment 









































  - Anaerobic      
    Biotransformation 
  - Adsorption  






- Adsorption  
- Volatilization  
 
Wetland-based Tx 
  - Biotransformation  
  - Plant Uptake 
  - Adsorption  
  - Photolysis 
 
The 30 onsite treatment systems 
were sampled twice: August to 
October 2003 and March to May 
2004. At each site, grab samples of 
wastewater were collected 
 
**specific conductance, ammonia, 
carbonaceous biochemical oxygen 
demand (cBOD), and total 






** Efficiencies <1% to >99% depending on 
treatment type and physicochemical properties of 
the compound. 
 
**10 of 12 OWCs systems with additional aerobic 
treatment had lower median concentrations than 
anaerobic tank treatments. 
 
**Recirculation through aerobic textile-media 
biofilters, at 7of the sites increased sorption, 
volatilization, and aerobic biotransformation. 
 
**Biofilter-based systems had greater removal 
efficiencies than tank-based systems; resulting in 
96% reduction in 1,4-dichlorobenzene compared to 
22% removal in tank-based treatment (Figure 4).  
  -Volatilization in Biofilter Tx may effectively 
remove compounds with large Henry’s Law 
constants (KH) due to increased air-water exchange 
and turbulence. 
 
**Nonvolatile OWCs removal during Confined unit 
Tx can occur by biotransformation and sorption.  
  -Sorption to solids with subsequent removal by 
sedimentation or filtration was effective removal 
mechanisms in tank- and biofilter-based systems for 
compounds with large Kow’s.  
 
**Surface water/groundwater interactions may be 
notable when onsite treatment systems are situated 
near streams. Shallow groundwater can discharge to 
streams within 5 years of recharge, a time  period 
often deficient for degradation of recalcitrant 
compounds. Some compounds can volatilize and 
biodegrade in the unsaturated zone, but once in the 
saturated zone, low oxygen and nutrient conditions 
lead to long-term (>30 years) persistence and 
transport. 
 























Chlorine dosages:1, 5, and 10 mg l-1  
yielding naproxen:chlorine molar 
ratios of 30:1, 6:1, and 
3:1, respectively 
 
Bioreactor : 1-l glass feed jar, 2 
peristaltic pumps and 30.5m of 
polypropylene tubing, covered with 
aluminum foil to minimize light 
exposure.  
  -Feed bacteria for stimulating 
biofilm growth was collected from 




All samples were prepared in 
triplicate and residual naproxen 




**Formation of naproxen products was dependent 
on pH, chlorine dosage and contact time.  
 
**Naproxen readily reacted with free chlorine and 
formed disinfection products.   
 
**Formation of specific reaction products varied 
depending on water/wastewater characteristics and 
treatment operating conditions. 
 
**Bioreactor Results: Naproxen was not degraded 
biologically for the conditions of this study. 
 
**The naproxen solution containing chlorination 
products caused an adverse response by discharging 
biomass from the bioreactor. Thus naproxen 
chlorination products can potentially impact the 
performance of biofilm processes in natural and 
engineered aquatic environments. 
 
**The amount of biomass in the bioreactor 
decreased for 20 days following the addition of the 
chlorine–naproxen solution. 
 
**After 6 min.the original chromatographic peak 
for naproxen disappeared and new peaks appeared 
indicating the formation of intermediate products, 
which were further transformed/degraded until two 
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**End product, observable by HPLC at 254 nm, 
suggests that the naproxen is transformed, but not 
mineralized. 
 
** ~30 min of contact time with free chlorine 
typically used for microbial inactivation in WWT 
systems may be too short for complete oxidation of 
PPCP contaminants such as naproxen. More time 
maybe needed for chemical reactions to reach 
completion at lower concentrations at treatment 
plants (1–100 mg l-1 or lower for naproxen, 0.5–1 
mg l-1 for chlorine) or in the presence of natural 
organic matter. 
 
** PhACs that occur in natural waters and sewage 
systems may not be completely oxidized by  
chlorination treatment processes, but instead only  
transformed to intermediate products. 
 
**Naproxen was more readily transformed by 
contact with chlorine at pH 5.0 (99.7% naproxen 
removal after 15 min reaction) and neutral pH 7.0 
(99.2% naproxen removal) than at pH 9.0 (61.5% 
naproxen removal).  
 
**Aqueous chlorine exits primarily as hypochlorus 
acid (HOCl) at low pH , which favors NPX 
oxidation.  
 
Water Research  
41 (2007) 1001 – 1012 
Elimination of PhACs in sewage treatment plants 
in Finland 






























Activated sludge  
 
PhACs separated from aqueous 
media using SPE 
 
Extracts were chromatographed on 
a C18-column using Agilent 1100 
HPLC-system (Agilent 
Technologies, Espoo, Finland) and 
detected with a Quattro Micro 
triple-quadrupole mass 
spectrometer (Micromass, 
Manchester, UK) equipped with 
electrospray ionization source.  
 
Positive ions were acquired in the 
multiple reaction-monitoring mode. 
 
 
In the treatment plants: 
 
**Antibiotics:  
-Fluoroquinolones were eliminated by >80%; 
main elimination process was sorption to sludge in 
STPs     
-Ciprofloxacin and ofloxacin were eliminated in 
average of 84% and 83%, respectively.  
 
**Carbamazepine: (CBZ) 
-CBZ was not eliminated, in fact higher 
concentrations were frequently found in the treated 
effluent.  
-This is most likely due to enzymatic cleavage of the 
glucuronic conjugate of CBZ and release of the 
parent compound in the treatment plant. Activated 
sludge has been found to have glucuronidase 
activity. 
 
** Beta-blockers:   
-Average elimination <65%; elimination varied 
greatly between the treatment plants.  
-Dilution of raw sewage by rainwater and a 
consequent decrease in the hydraulic retention time 
of a treatment plant was found to deteriorate the 
elimination of the b-blockers.  
-Highest average elimination rates were for atenolol 
(61%) and sotalol (65%). Avgerage elimination of 
Acebutolol was 47% and the lowest elimination 
rates were observed for metoprolol (29%). 
Elimination varied greatly between STPs. 
 
**No sludge samples were analyzed,  thus it was 
not possible to differentiate between biodegration 
and sorption.  
 
** Carbamazepine and the b-blockers may reach 
recipient water. There is a need to enhance their 
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**Denitrifying biofilter: caused no further 
elimination of the target compounds. 
 
 
Water Research  
40 (2006) 2259 – 2266 
 
Ozone treatment and the depletion of detectable PhACs and atrazine herbicide in 
drinking water sourced from the upper Detroit River, Ontario, Canada 



























Has several purposes in 
DWT:  
Disinfection,  





Pilot plant:  
-Operates in real-time with the full-
scale water treatment plant,  
-Allows parallel water treatment 
streams, i.e., conventional and 
ozone plus conventional treatment 
(Fig. 2). 
 
-2 L water samples were used for 
co-extracting neutral PhACs 
(carbamazepine, caffeine, cotinine) 
and atrazine using 6mL Supelclean 
C-18 SPE cartridges (Supelco, 
Canada). 
 
 Sample Analysis: carried out on the 
same LC-ESI-MS/MS system 
 
 
**Regardless of season, conventional coagulation/ 
flocculation/sedimentation and filtration without 
O3, indicated no decrease in the water PhAC 
concentrations. 
  
**Pretreatment of ozone:  
 
   -Range of mean removal percentages were 78–
99%, 83–93%, 67–81%, and 66–96% for 
carbamazepine, cotinine, caffeine ,and atrazine, 
respectively (when ozonation was coupled with the 
flocculation-coagulation and dual media filtration) 
  
 -It was not clear whether the large concentration 
decreases are a function of the initial O3 treatment 
or the coagulation/ flocculation/sedimentation 
process 
 
  -O3 reacts rapidly with CBZ’s double bond 
yielding several ozonation products containing 
quinazoline based functional groups.  
 
**Few Canadian DWTPs incorporate ozonation 
into conventional treatment  
 
Chemosphere 63 (2006) 934–941 Adsorption of the quinolone antibiotic nalidixic acid onto anion-
exchange and neutral polymers 





















formaldehyde  Aliphatic 
acrylic   









structural integrity for 
>5 years in WTPs in 
China, lasting for 
>2000 regeneration 









adsorption experiments at different 
pH values with different polymer 
types 
 
*Polymers were pre-washed with 
propanolo and dried in a dessicator 
with a vacuum pump 
 
*pH adjustments were 
accomplished using HCl and NaOH 
 
*Standards, samples and blanks 





**Neutral form (below pKa) of NA adsorbs to a 
greater extent on neutral polymers 
 
**Anionic form (above pKa) of NA adsorbs more 
to anion-exchange polymers; due to electrostatic 
attraction between the anionic NA and the cationic 
surface of the polymer; 
 
**Aromatic ring interactions between NA and the 
surface of both neutral and anion-exchange 
polymers are important in the adsorption process; 
which has important implications for the treatment 
of PhAC-contaminated water, as many PhAC 
contaminants are ionizable and have aromatic rings 
in their structure. 
 
**There was more adsorption per gram of polymer 
to both neutral polymers (X16 and X761) than to 
the anion-exchange polymer (I402). Higher 
adsorption to the neutral polymers can be explained 
by expulsion of neutral NA from water due to the 
hydrophobic effect, as well as the lower affinity of 
neutral NA for the positively charged, hydrophilic 
I402 compared to neutral X16 and X761. 
 
**Greater NA adsorption on the polar X761 vs. the 
non-polar X16: X761 has an electronegative oxygen 
functional group not present on X16. NA has 
partial neg. and pos. charges due to carboxylic acid 
and amine functional groups, and thus likely 
interacts via dipole–dipole interactions with the 
polar X761, but not X16. 
 
**Greater adsorption by the anion-exchange 
polymer I402 vs. the two neutral polymers: 
Electrostatic attraction between anionic NA and 
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**Greater adsorption affinity of I402 at pH 7 vs. 
pH 5 and the lower adsorption affinity of X16 and 
X761 at pH 7 vs. pH 5 are also consistent with 
these results and can be explained by the 
deprotonation of NA above its pKa 
 
**Neutral aromatic polymer matrices more 
effectively remove NA than neutral aliphatic 
matrices below the NA pKa due to interactions 
between the aromatic rings on the NA and the 
polymer;  
 
**Anion-exchange polymers with styrenic matrices 
more effectively remove NA than those with acrylic 
matrices due to interactions between the aromatic 
rings on the polymer and the NA. 
 
 
Water Research  
40 (2006) 3297 – 3303 
PhAC chemicals and endocrine disrupters in municipal wastewater in Tokyo and their 
removal during activated sludge treatment 




























**PhAC concentrations were 
measured in 24-h composite 
samples of influents and secondary 
effluents collected seasonally from 





**Amide-type PhACs:  ketoprofen, and naproxen 
showed poor removal (<50% efficiency), likely due 
to their lower hydrophobicity (log Kow). 
 
**Crotamiton was very persistant during 2ndary 
treatment and most abundant PhAC in the effluent, 
with concentrations from 245 to 968 ng/L 
 
**Acidic PhACs:  
-Aspirin and ibuprofen removed most efficiently, 
>90%, while ketoprofen and naproxen averaged 
<45%, with large variability (0% to 80%).  
 
**Asprin removal mechanism:  
-Likely microbial and chemical degradation, 
including conversion to salicylic acid.. **Ibuprofen: 
Higher removal efficiencies by STPs in Tokyo are 
likely due to longer SRT (~5 days) and hydraulic 
retention time (~9 h).  
 
**Fenoprofen:  
-Relatively high removal efficiencies (avg 85%) with 
large variability (65–95%). Lower removal 
efficiencies for ketoprofen and naproxen may be 
due to their less hydrophobic nature (log Kow<3) 
and persistence under microbial attack  
 
**Phenolic PhACs:  
-Thymol: high removal efficiency (~95%), likely 
volatizes during STx due to high VP 
(0.0022mmHg) 
-Ttriclosan: Wide range of removal efficiencies (45-
93%), ~70% on average; Variability is similar to 
those observed in five EU countries (Paxeus, 2004).  
 
**Amide-type PhACs:  
(diethyltoluamide, propyphenazone, carbamazepine, 
and crotamiton) 
- Not efficiently removed: avg. removals <45% 
with large range in efficiency; poor removal is partly 
due to their hydrophilic nature (logKow <3) and 
chemical stability.  
 
- Secondary effluent concentrations were often 
higher than those in corresponding influents; 
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Environ. Sci. Technol. 2006, 40,  
7367-7373 
Enhanced Biodegradation of Iopromide and Trimethoprim in 
Nitrifying Activated Sludge 

























-Biomass from the 
stage-2 activated sludge  
- Bioreactor with long 




- Can co-metabolize 
some organic micro-





1) Ammonia oxidizing 
bacteria (AOB),  
2) Nitrite-oxidizing 
bacteria (NOB).  
- Extremely slow-
growing, thus growth in 
activated sludge is 
favored at longer SRT. 
 
**Laboratory-scale bioreactors: 
- Contain mixed liquor from 
nitrifying activated sludge; - 
- Biodegradation of  IOP and TRI 
were conducted in 2 bioreactors: 1) 
No inhibition of nitrification 
2) Nitrification was inhibited  
 
** Full-scale municipal WWTP 
analysis:   
-Conducted to corroborate the 
observed removal efficiencies 
 
**LC/MS/MS Analysis. 
- LCQ Advantage ion trap mass 
spectrometer (ITMS) equipped with 
an ESI, operated in positive ion 
mode  
 





- Much higher removal of IOP and TRI by 
nitrifying activated sludge than by conventional 
activated sludge  
 
- Inhibition of NB caused % removal to decrease 
from 97 to 86% for IOP, and from 70 to 25% for 
TRI. 
 
- IOP metabolite identified with non-inhibited NB 
was dehydroxylated iopromide at the two side 
chains.  
 
- With inhibition of NB a carboxylate metabolite 
was identified, formed by the oxidation of the 




- Analysis corroborated observed removal 
efficiencies from lab-scale study; showing higher 
removal of TRI & IOP by nitrifying sludge (SRT 49 
days) than by conventional (SRT of 6 days).  
 
-IOP removal reached 61% in nitrifying sludge and 
was negligible in conventional 
 
-TRI removal was ~1% in the conventional 




Water Science & Technology Vol 52 No 8 pp 9–14 
Q IWA Publishing 2005 
Removal of PhACly active compounds in nitrifying–
denitrifying plants 



































of C & N 
 
- Has an anoxic zone 
for denitrifying 
followed by an aerobic 
one for nitrification & 
carbon removal. 
 
 - Finally, suspended 
solids are separated 
from the effluent to 
levels below 0.1 g 





*The unit was inoculated with 2 g 
VSS/l taken from a similar unit in a 
full-scale sewage treatment plant.  
* HRT was set to 1 day. 
*Temperature and pH were 
monitored but not controlled, in 
order to maintain the same 
operating conditions as in full scale 
plants. 
 




Overall Removal:  
**Carbamazepine, diazepam and diclofenac were 
only removed to a small extent; higher removal 
rates observed for naproxen and ibuprofen (68% 
and 82%), respectively. 
 
**No adverse effects were observed on 
conventional parameters as observed in the 
evolution of carbon and nitrogen removal rates and 
suspended solids content 
 
**Diclofenac  
-Was only removed to a small extent; always below 
20%. 
 
**Carbamazepine and diazepam: 
-Were persistent with removal rates <10% 
 
**Naproxen: 68% of the influent concentration 
removed 
 
**Ibuprofen: highest removal observed at 82%  
 
**A differentiation between adsorption and 
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Environ. Sci. Technol. 2005, 39, 
8300-8306 
Photo-Fenton Degradation of Diclofenac: Identification of Main 
Intermediates and Degradation Pathway 


















- produce hydroxyl 
radicals (*OH), which 
are very reactive and 
cause the pollutant’s 




- Low cost AOP  
- Easy-to-handle 
technology 







* All experiments were performed 
in a compound parabolic collector 
(CPC) solar pilot plant 
 
*Three hydrolysis experiments were 
done at different pH (3, 7, and 9) to 
ensure results were not due to 
hydrolysis 
 
* GC/MS and LC coupled with 
time-offlight MS (LC/TOF-MS) 
  







**Rapid and complete oxidation of diclofenac after 
60 min, and total mineralization (disappearance of 
dissolved organic carbon, DOC) after 100 min 
exposure to sunlight. 
 
**Degradation takes place in the homogeneous 
phase governed by a precipitation-redissolution 
degradation process 
 
** Photolysis experiments: rapid decay of >70% 
of the diclofenac in the 1st 30 h of irradiation. No 
mineralization, with DOC concentration remaining 
stable throughout. 
 
-Such fast decomposition of diclofenac by direct 
photolysis suggests possible contribution of this 
reaction pathway to the photocatalytic process. 
 
**“Dark” Fenton reaction (Fe2+): Diclofenac 
concentration decreased quickly, reducing the initial 
amount by more than 50%. 
 
**Photo-Fenton reaction (Fe3+): The overall 
process started slowing down, but led to 
mineralization. At that moment, there are two 
effects present: (i) partial degradation of the main 
molecule, with subsequent apparition of some DPs, 
and (ii) rapid decrease of the pH, triggering 
precipitation of diclofenac - which is a very soluble 
(50 g/L at 25°C at pH 7) acidic PhAC (pKa 4.15) 
that becomes almost insoluble below pH 4. 
 
**From HPLC measurements to assess the process, 
diclofenac degradation took around 60 min and 





Envrionment Science and 
Technology. Awaiting publishing 
Ultrasound-Induced Destruction of Low Levels of Estrogen Hormones in 
Aqueous Solutions 








































*Waves pass through 
liquid, creating cavities 
due to oscillating 
acoustic pressures. 
Dissolved gases, 
organics & water vapor 
diffuse into the cavities 
from solution, cavities 
grow and ultimately 
implode. Generates 
temperatures up to 
5200K and pressures 
>1000 atm inside 
collapsing cavity, and 
~1900 K in the region 
between the solution 
and the collapsing 
bubble (19). 
*Destruction of 
pollutants occurs via: 
- Thermal degradation 
(pyrolysis) 
- Combustion reactions 
(if O2 is present).  
- Free radicals OH*, 
H*, HO2*) formed by 
thermolysis of water  
 
*Batch reactor wuth a 1.1 W/mL 
sonication unit and a continuous 
flow reactor using a 2.1 W/mL 
sonication unit. 
 
* Temperature, pH, and pressure 
were studied in lab-scale systems.  
  
*Two types (0.6 and 2 kW) of 
sonication reactors (both of 20 kHz 
frequency) were used 
 
* SPE followed GC/MS analysis 




**Degradation of estrogens follows pseudo first-
order kinetics.  
 
**Reaction likely takes place in the interfacial region 
and in the bulk solution with radical species.  
 
**Low solution pH & T is more favorable for 
destruction of estrogens.  
 
**Increasing the fluid pressure is detrimental to 
reaction efficiency. 
 
**After 25 min of sonication, 60-90% of individual 
estrogen compounds were degraded, and ~80% of 
total estrogens 
 
**Low Henry’s constant for estrogens implies little 
volatilization into the cavity thus pyrolysis inside 
the cavity is not important.  
 
**Due to their hydrophobicity (low solubility), 
estrogens would tend to diffuse into the cavity-
liquid interface. The reaction likely takes place in 
the interfacial region where high temperature and 
pressure are produced upon cavity implosion 
causing thermal degradation or supercritical 
oxidation. Oxidative degradation by strong radicals 









Treatment Media Procedural Notes / Analysis Results/Conclusions 
  
*Does not require oxidants or catalysts, and does 
not generate additional waste as with adsorption 
(spent adsorbent) or ozonation (ozone off-gas) 
processes. 
 
Chemosphere 65 (2006) 17–23 Degradation of macrolide antibiotics by ozone: A mechanistic case 
study with clarithromycin 





















decays via two routes: 
 
1)  looses dioxygen 
yielding the N-oxide 
2) dissociates into the 
ozonide radical anion 





**Lab-scale studies in which ozone 
and clarithromycin were mixed in 
appropriate ratios to achieve a 
desired product turnover to allow 
product analysis 
 
*Set amounts of ozone and 
clarithromycin were used to 




**1H-NMR spectra (in D2O) were 
run on a 500 MHz instrument 
(Bruker DRX-500 with XWIN-
NMR software). 
 
**Growth inhibition experiments 
with Pseudomonas putida DOT-




**Only the free amine reacts with ozone  
 
** Rate of reaction is pH dependent  
 
** The main reaction is a transfer of an O-atom 
yielding the N-oxide  
 
**A minor product (10%, based on formaldehyde 
yields) is demethylated clarithromycin (identified by 
HPLC/MS–MS).  
-The dimethylamino group is thought necessary for 
drug binding to target receptor; thus changes to this 
functional group, like the formation of the N-oxide 
(no longer a proton acceptor), inactivates these 
drugs. This was shown by the growth inhibition of 
Pseudomonas putida.  
 
*Biological inactivation requires only 1 molecule of 
ozone, in contrast to mineralization which requires 
100 X more. 
  
(C38H69NO13 + 100O3 ↔ 38CO2 + 34 H2O + 
HNO3 + 100O2)  
 
**Amines react well with ozone, at a rate ~4 X 106 
M-1s-1, only when the lone electron pair is not 
protonated or complexed by a transition metal ion 
such as Fe3+ in Fe(III)EDTA.   
 
**Reaction rate increases 10-fold (within the limits 
of error) per pH unit; since the concentration of 
free amine increases 10-fold per pH unit through 
deprotonation.  
 
Chemosphere 65 (2006) 
2130–2137 
Reactions of the amine-containing drugs fluoxetine and metoprolol during 
chlorination and dechlorination processes used in wastewater treatment 


























– reacts rapidly with 
PhACs during 





due to their oxidizing 





used in WWT following 
chlorination to reduce 
active chlorine residuals 
from entering the 
environment. 
Dechlorination is 
usually achieved with 





**Studied the tendency of 
fluoxetine and metoprolol to react 
with hypochlorite in pure water 
using conditions that simulate 
wastewater disinfection.  
 
**Chlorination reactions were also 
investigated in WW collected from 
an operating treatment plant.  
**Reactivity of the chlorination 
products with sulfite was studied to 
simulate WW dechlorination. 
 
**Liquid chromatography (LC) with 
several detection modes including 
ultraviolet absorbance (UV), mass 
spectrometry (MS), and post-
column reaction /reductive 
electrochemistry 




**At 10μM, both PhACs reacted rapidly (<2 min) 
to form largely N-chloramine products, stable in 
aqueous solution for at least 1h  
 
**In WW similar reactivity was noted.  
 
** Longer reaction times lead to complete 
reduction and formation of the parent PhAC 
amine. Dechlorination in WWT tends to be 
seconds long, thus these PhAC chlorination 
products may evade dechlorination and be released 
into the environment.  
 
**Fluoxetine: No peak at 5.8 min indicates that 
fluoxetine reacted completely to form one major 
product of increased hydrophobicity eluting at 21.2 
min. Complete disappearance of the parent 
fluoxetine peak was also noted for 2 min and 30 
min chlorination times.   
 
-Dechlorination: After 2 min, peak area of product 
has decreased to ~ 70% of peak area, indicating 
only a portion has been chemically reduced with 
this reaction time. At 5.8min a peak with the 
retention time of fluoxetine appears, which 
intensifies over the next 30min as the product peak 
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converted back to fluoxetine upon dechlorination, 
but only reaches ~70% of pre-chlorination 
concentration.  
 
**Metoprolol: Only one major product with 
greater hydrophobicity is formed (retention time of 
11.3 min) containing active chlorine; thus it has 
been partially reduced. The chloramine has been 
completely reduced by 20 min. – 
 
-Dechlorination: Reduction by sulfite converts the 
chloramine product back to metoprolol. After 20 
min peak area of metoprolol is ~90% of its pre-
chlorination value  
 
**Chloramines: 
-have increased hydrophobicity relative to the 
parent amine caused by replacement of H with Cl. 
At neutral pH, both fluoxetine and metoprolol are 
protonated (pKa 10.1 and 9.2, respectively), also 
enhancing their hydrophilicity.  
 
-This increase my cause the chloramines to sorb to 
surfaces such as sediments, soils, and biological 
membranes.  
 
- can transfer their active chlorine to other 
reductants, reversing the chlorination reaction-- 
freeing the bioactive parent PhAC 
 
 
Chemosphere 66 (2007) 894–904 Irrigation of treated wastewater in Braunschweig, Germany: An option to 
remove PhACs and musk fragrances 



































-inexpensive method to 
add water and nutrients.  
-digested sludge mixed 
into irrigation water; 
containing organic 
matter to improve 
water retention capacity 
of soil and the bulk of 
nutrients originally 
present in the sewage, 
(N and PO4). 
-secondary effluent is 
irrigated on agricultural 
fields.  
-In the vegetation 
period from March to 
October digested 
sludge is mixed with the 
effluent  
***The irrigation 
machines are fed with 
an effluent/sludge 
mixture which they 
distribute over a 
distribution net of 
100km. The mixture is 
irrigated to about 
40 l m-2 at each 
application. About 500 l 
m-2 (in the winter 
time only effluents) are 
applied per year 
 
 
*Water samples were taken as 24 h 
flow-proportional composite 
samples (cooled at 4 degC) from the 
outlet of the grit removal tank and 
the secondary clarifier, collected at 
midnight 
 
**water samples were collected 
from stainless steel lysimeters  in the 
selected agricultural field at 3 
different depths together with 
groundwater probes. 
 
**Several different analytical 
methods were used for PhAC 
detection – only references are 
given 
**Most PPCPs while found in irrigated WW were 
never found in lysimeter or groundwater samples 
 
**Groundwater and lysimeter samples did 
contain  diatrizoate, iopamidol, carbamazepine and 
sulfamethoxazole up to several μg/l; thus there 
were not removed by sorption or degradation 
 
**Acidic PhACs, musk fragrances, estrogens 
and ß-blockers were likely sorbed or transformed 
while passing through top soil layer.  
 
**Estrogens: Estrogenic effects are likely to 
disappear after irrigation, since the most potent 
steroid estrogens were not measurable. 
 
**Removal >90% was found for caffeine and 
ibuprofen.  
 
**Appreciable removal of: atenolol, metoprolol, 
propranolol, bezafibrate, trimethoprim, AHTN 
(tonalide) iohexol, iomeprol and iopromide. 
 
 **Removal Mechanism: 
 
-Based on the phys–chemical properties (e.g. 
polarity) and literature data elimination of caffeine, 
ibuprofen and the ICM is likely caused by 
biodegradation 
 
-For ß-blockers, lipid regulators, antiphlogistics, 
iodinated contrast media and antibiotics the  
estimated Kd values indicate that sizeable non-
specific sorption is not likely  
 
**SRT = important for the biodegradation of trace 
pollutants STP with a SRT of about 12–14 d a 
removal of three ICMs was observed, whereas in a 
previous case study with a SRT of about 4–6 d for 
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(Ternes and Hirsch, 2000). 
 
-Removal via sorption is likely for polycyclic musk 
fragrances with Kd values of 150 and 180 l.  
-For estrogens sorption could also be significant, 
but as described in literature (see above) 
accompanied with biodegradation. 
 
**Compounds appear removed by top soil passage; 
formation of stable or even toxic transformation 
products products is however possible 
 
 
Water Research 40 (2006) 
3419 – 3428 
Biodegradation of persistent polar pollutants in wastewater: Comparison of an optimised 
lab-scale membrane bioreactor and activated sludge treatment 
































- higher sludge 
retention time (SRT) 
favouriing microbial 
adaptation. 
-compared to WWTP: 
higher SC and SRT; less 
sludge production, 
smaller footprint size 
and unsurpassed 
effluent quality in terms 
of turbidity, bacteria 
and viruses, and 
occasionally, in total 
dissolved organics, 
biological oxygen 







**Lab-scale membrane bioreactor 
 
**After primary treatment a fraction 
of preclarified WW was split to the 
MBR, which was run without an 
anoxic pretreatment stage. 
 
*Analysis by GC-MS and LC-MS 
after enrichment with SPE 
 
** The MBR was filled in 
November 2003 with 




**Non-degradable micropollutants, such as 
EDTA and carbamazepine were not eliminated at 
all during WWT 
 
**MBR indicated better removals compared to 
AST for poorly biodegradable P3, such as 
diclofenac, mecoprop and sulfophenylcarboxylates. 
 
** Increased SRT and SC improved the adaptation 
rates of the microorganisms towards the degradable 
P3, whereas temperature and pH-values did not 
show a measurable effect. 
 
**Ibuprofen removal in the WWTP and the MBR 
were 97.371.3% and 98.870.7%, respectively; it rose 
from 90% to 95% by increasing the SRT up to 75 d 
 
 
** Diclofenac:  
-AST removal between 0% and 60%; MBR removal  
in the range of 28% and 78% No adsorption of 
diclofenac to the activated sludge was observed. 
 
** Clofibric acid: 
-Removals in AST were between 0% and 50%. The 
MBR obviously removed clofibric acid in 9 out of 
11 samples with a much higher efficiency compared 
to AST. Significant removals for the MBR could 
not be calculated due to concentrations below 
LOD. 
 
** 2,4-Dichlorobenzoic acid:  
-Removal by AST and MBR ranged from 36% to 
96% and 56% to 100%, respectively.  Others were 
dependent on the concentrations of 2,4-
dichlorobenzoic acid in the influents. Lower 
concentrations (< 0.40 μg/l) cause less removal. 
 
** Carbamazepine  
-Not eliminated in WW treatment, neither by AST 
nor by MBR. It was present in all corresponding 
samples at an almost steady concentration level 





Water Research  40 (2006) 
2369 – 2374 
Water remediation by micelle–clay system: Case study for tetracycline and 
sulfonamide antibiotics 






















**Isotherms of adsorption for 
micelle–clay complexes (final 
concentrations 12mM of 
BDMHDA and 10 g/L clay) were 
 
**The micelle–clay complexes (1% w/w) removed 
96–99.9% of antibiotics from their water solutions 
containing 5 to 50 mg l-1 of PhACs.  
 
**Column filters (quartz sand and BDMHDA 













(BDMHDA) were used 
 
measured for all antibiotics.  
 
**Initial concentrations of 
antibiotics were in the range of 5–50 
mg l-1. 
 
**Adsorption experiments were 
performed in triplicate. 
 
**Analysis by HPLC (Merck 
Hitachi 6200) equipped with a diode 
array detector.  
 
**SPE using 3M Empore TM SDS-
RPS (47mm) extraction disks 





-Removed 94–99.9% of PhACs from initial 
solutions containing 10 mg l-1; and 89% of 
sulfamethizole from an initial solution containing 
10 μg/L of this antibiotic.  
 
-Also efficient removal of antibiotics in the 
presence of dissolved soil organic matter removing 
89–99% of tetracycline and sulfamethizol from 
initial solutions containing 10 mg l-1of antibiotic 
and 8 mg l-1 of humic acid, or 9 mg l-1 of fulvic acid. 
 
**Adsorption isotherms were fitted by the 
Langmuir equation with R2 larger than 0.999; 
Implying that interactions btw adsorbed antibiotic 
molecules can be ignored. Electrostatic binding 
along with partitioning is suggested adsorption 
mechanism 
 
**Filters with activated carbon mixed with quartz 
were less efficient than micelle–clay–quartz systems, 
removing 45–58% of sulfonamides and 79–88% of 
tetracyclines from the initial solutions containing 10 





Environ. Sci. Technol. 2006, 
40, 7222-7227 






























potential of 2.20 & 
0.70V in acidic and 
alkaline solutions, 
respectively  
-Under acidic onditions 
it has highest redox 
potential of all oxidants 
used in WWT.  
-Spontaneous 
decomposition of 
Fe(VI) in water gives 
molecular oxygen and 
Fe(III)  
-environmentally 
friendly chemical for 
coagulation, is 
infection, and oxidation  
-Can improve removal 
of natural organic 
matter 
-Unlike ozone, it does 
not react with bromide 
ion; thus carcinogenic 
bromate ion is not 
formed in the treatment 




**Rxn kinetics determined as a 
function of pH (7.0-9.7) and Temp. 
(15-45 °C) using a stopped-flow 
spectrophotometer equipped with a 
photomultiplier (PM) detector 
under pseudo-first-order conditions 
with sulfonamides in excess. 
 
**SMX and were dissolved in 1 g of 
CD3OD before introduction in the 
AMX-360 IS, a pulse Fourier 
Transform Nuclear Magnetic 
Resonance spectrometer with a 1H 
resonance frequency of 360.13 
MHz. 
 
**IR spectral analysis 
 
**MS spectral analysis 
 
**At a stoichiometric ratio of 4:1 (Fe(VI):SMX), 
complete removal of SMX was achieved. Oxidation 
products and kinetics suggest that attack of Fe(VI) 
occurs at the isoxazole moiety and the aniline 
moiety with minimal preference. 
 
**Oxidation of sulfonamides by Fe(VI) is first-
order with respect to each reactant. Observed 
second-order rate constants decreased nonlinearly 
with increasing pH and may be related to the 
protonation of Fe(VI) and sulfonamides  
 
**HFeO4- has a faster reaction rate with the neutral 
sulfonamide species (SH) than with negatively 
charged ionized species (S-). Thus, pH dependence 
may be due to electrostatic interaction between 
Fe(VI) and sulfonamide species. It is expected that 
the attraction between the Fe(VI) species and SH 
will be stronger than that with S-. Neutral species 
(SH) (RSH) increase with a decrease in pH, and 
thus their overall contribution to reaction rate 
should be higher at lower pH. 
 
 
**Excess Fe(VI) (10-5 M or 2 mg l-1 K2FeO4) 
relative to sulfonamides in water, has a half life 
<5min at pH7 for most sulfonamides. Rate and 
thus T1/2’s are pH dependent 
 
**Fe(VI) oxidation is the destruction of the 
aromatic ring (e.g. isoxazole ring), forming a 
oxidation product with differing biological binding 
property. Oxidation of the amino group and/or 
isoxazole ring may cause it to less effectively mimic 
p-aminobenzoic acid necessary for the synthesis 















Treatment Media Procedural Notes / Analysis Results/Conclusions 
Water Science & Technology 55 
No 10 217–225, 2007 
Treatability of cefazolin antibiotic formulation effluent with O3 and O3/H2O2 
processes 

























**Synthetic samples prepared by 
dissolving appropriateamount of 
cefazolin-Na powder in deionised 
water to an initial CODof 400 mg l-
1. 
 
**Ozonation and perozonation 
processes were applied in semi-
batch mode to 1 L of synthetic 
cefazolin-Na formulation effluent in 
a 1.5 L-capacity bubble column 
 
**The experiments were carried out 
for 5, 10, 20, 40 and 60min at an 
initial pH of 11. 
 
**The acute toxicity tests run with 
the marine microalga haeodactylum 
tricornutum were performed as 
previously described by Okay et al. 
(2002). 
 
**Standard analytic method: APHA-
AWWWA-WCPF,1989 
 
**20 min of ozonation at a rate of 1,500 mg l-1-h 
removed COD by 38%, removal efficiency of 40% 
was achieved via H2O2 enhanced ozonation  
  
**Both pretreatment alternatives underwent 
elevation of the BOD5/COD ratio from 0.01 to 
0.08. The initially inert COD was reduced by 38% 
using ozonation and by 60% using H2O2 enhanced 
ozonation. In terms of the lowest achievable 
effluent. 
 
**COD levels after bio-treatment, ozonation was 
observed at 205 mg l-1, while a residual COD of 
135 mg l-1was involved for perozonation.  
 
**According acute toxicity test, ozonated and 
perozonated samples exhibited more toxicity than 
the untreated effluent after 4 days. Synthetic 
cefazolin-Na WW showed less toxicity than 
ozonated and perozonated samples.  
 
**Penetration of synthetic cefazolin-Na effluent 
with its high molecular weight had more difficultly 
than the smaller and more bioavailable ozonated 
and perozonated samples in entering cells. The ease 
in entrance through the cell can cause a higher 
toxicity. 
 
**Activated sludge inhibition test demonstrated 
that both alternatives efficiently eliminated the 
inhibition of investigated formulation effluent. 
 
Water Research 39 
(2005) 3139–3152 


























Bioreactor (MBR)  
-is a 100 PE 
(population equivalents) 
pilot plant fed with 
primary effluent from 
the conventional 
activated sludge 
treatment plant 1 
(CAS1) at a flow-rate 
variation proportional 
to full-scale inlet flow.  
 
*Fixed Bed Reactor 
(FB)  
-Consists of eight 
Biostyrs reactors with a 




*Monitoring was performed at:  
 
1) WWTP of Kloten/Opfikon, 
where (CAS1) treatment plant is run 
in parallel with a pilotscale 
membrane bioreactor (MBR).  
 
2) WWTP of Altenrhein, where a 
lane of a CAS1 is run in parallel 
with a FB reactor  
 
* The pilot was run with SRTs of 
1672, 3373 and 60–80 d and is 
equipped with stirred anaerobic and 
anoxic compartments followed by 
aerobic filtration compartments. 
 
*SPE (Oasis HLB, Waters). 
 
*Analysis using:  
-reversed-phase liquid -electrospray 
mass spectrometry in the positive 
ionization mode 
-GC/MS in single-ion monitoring 
mode (SIM). 
-Pressurized liquid extraction 
 
 
**Observed removal of PhACs was mainly due to 
biological transformation and varied from <10% 
(CBZ) to >90% (ibuprofen).   
 
**Naproxen showed significant removal (50–
80%), as did SMX and its metabolite N4-acetyl-
sulfamethoxazole; Partial removal is also seen for 
Diclofenac (20–40%).  
 
**No removal is seen for Carbamazepine. 
 
**No quantitative relationship between structure 
and activity could be set up for the biological 
transformation.  
 
**For compounds showing a sorption coefficient 
(Kd) <300 L/Kg, sorption onto secondary sludge 
was not relevant and their transformation can be 
assessed by comparing influent and effluent 
concentrations. 
 
**In some samples output loads were greater 
than influent (values >100%). This may be due to 
either (i) sampling inaccuracy, (ii) inaccuracy of the 
sorption coefficient especially for primary sludge, or 
(iii) conjugate compounds not detected in the 
influent but re-transformed into the original 
compound during wastewater treatment (e.g. de-
acetylation as occurs for N4-acetyl-SMX). 
 
**For most compounds removal did not show a 
clear dependency on reactor configuration, sludge 
age or temperature (except for iopromide and 
roxithromycin, where a significant variation but no 
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**Similar performance between the FB and the 
CAS1 indicates that  total contact time between 
wastewater and sludge (HRT) has only a minor 
influence on removal  
 
**Result of nutrient-removing WWTPs, show 
that no compounds are significantly degraded at 
low sludge ages (<2 days of sludge retention times)  
 
**Variation of the sludge age between 10 and 60–
80 days showed no significant impact on the 
transformation efficiency of the seven PhACs 
studied in this work 
 
**MBR plant shows comparable removal plants 
equipped with 2nd ary clarification, indicating that 
micro- and ultrafiltration cannot remove 
micropollutants directly by sieving ( molecular size 
is at least 100X smaller pore size) 
 
**For SMX and iopromide (IP): a correlation of 
removal and sludge age seems to be indicated in the 
data, however if inconclusive because: (i) the 
dependency is not confirmed by comparable sludge 
ages run in conventional plants, and (ii) both  SMX 
and IP show unexplained removal variations  
 
Water Research 39 (2005) 
4790–4796 






















spiked to 10L 





1) Low fat 
(LF) WW,  
(60 mg l-1) 
2) High fat 
(HF) WW, 













-Enhance removal of 
suspended solids and 
colloids; addition of 
metal salts or organic 
compounds causes the 
agglomeration of these 
particles, allowing 
elimination by 
decantation or filtration 
Flotation technique: 
-finely suspended 
particles are separated 
by adhering to the 
surface of rising 
bubbles,  
-proved to be efficient,  
practical and  reliable 
for the removal of fat, 
and other  
contaminants, such as 
oils, biomolecules or 
suspended solids from 
water . Lipophilic 
PPCPs can be removed 
from WW by flotation 
due to their 
solubilization in the 
lipid fractions or 




**Objective: to improve the 
removal efficiencies of 3 groups of 
PPCPs (musks, neutral and acidic 
PhACs), with different sorption 




-main parameters considered were 
the additives (ferric chloride, 
aluminum sulfate, and aluminum 
polychloride), their doses and the 
temperature (12 or 25 1C). 
 
-Assay carried out in a Jar-Test 
device, 1 l of liquid volume. The 




-Carried out in a unit consisting of a 
pressurized vessel of 2 l (where air 
was dissolved into the wastewater) 
and a flotation cell of 1 l  
 
**SPE of 500 ml samples using 
60mg OASIS HLB cartridges 
 
**GC/MS used to determine the 






-Initial fat content of WW and temperature were 
studied. 
-Musks were removed the most (35–60%), followed 
by Diazepam (40–50%) and diclofenac (20–45%) 
and, to a lesser extent, CBZ (20–35%), Ibuprofen 
(10–25%) and NPX (10–30%). Best results were 
usually at 25 1C, although in some cases the 
operation at 12 1C gave similar results. Removal of 
musks and neutral compounds was higher in HF 
wastewater 
 
**For compounds more hydrophilic than 
diclofenac, removals were less (with maximum 
reductions below 25%). 
 
**Carbamazepine and Ibuprofen were not 
removed under any tested condition. 
 
**Coagulant dose and temperature showed <5% 
difference in PPCPs removal in the considered 
range. 
 
**The use of an additive increased the removal 
efficiencies of all PPCPs tested except IBU and 
CBZ. 
 
**Diclofenac elimination was higher with ferric 
chloride and aluminum sulfate (around 70%) 
-With significant sorption affinity—was removed ~ 
50–70% at both temperatures independent of dose 




**Concentrations of Diazepam and Naproxen 
were reduced by 20–25%. For Diazepam there were 
no significant differences between ferric chloride 
and aluminum sulfate, Naproxen was only removed 
with ferric chloride. In both cases, PAX was the 
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**Coagulant enhanced the binding of Diclofenac 
to the suspended solids throughout the trivalent 
cations, thus allowing a further removal from the 
water phase. Diazepam and Naproxen removal was 
also improved by coagulant (20–25%), although to 
lesser extent due to their lower Kd values.  
 
**Flotation Assays:  
-Elimination of Diazepam was similar to musks 
(40–45%); no significant difference was observed 
between both temperatures.  
 
**According to its lower lipophilicity (logKow ~ 
2.4), CBZ was removed to a lesser extent (~ 20%) 
independently of the temperature.  
 
**In the HF water removal by flotation was 
increased for CBZ and Diazepam, increasing to 35 
& 50% respectivelt, uninfluenced by temperature 
 
*Anti-inflammatories: 
-Highest removal for Diclofenac (20–40%).  
-Temperature influenced removal significantly  
- Independent of the fat content, thus their removal 
patterns were similar to those observed in the 
assays with LF wastewaters: 20–45% for 
Diclofenac, 10–30% for Naproxen and 10–20% for 
Ibuprofen. 
 
*Musks: the highest values were obtained at 25 1C. 
 
** The different affinities of PPCPs for organics 
can be clearly seen with HF WWs; removal of 
lipophilic substances, such as musks, is enhanced, 
while elimination of more polar compounds 
remains unchanged. 
 
**Physico-chemical properties of the PPCPs, the 
presence of the other substances in the medium, fat 
globules, the colloidal matter or the flocs formed 
during coagulation–flocculation assays must all be 
considered. 
 
Environ. Sci. Technol. 2006, 40, 
357-363 
Removal of PhACs in Sewage Treatment Plants in Italy 
 








































**Loads and removal rates (RR) 
were studied in six sewage treatment 
plants. 
 
**Sampled influents and effluents of 
all the STPs for mass balance 
calculations. 
 
**PhACs were measured by 
reversed-phase HPLC-MS/MS, 
after combined extraction by two 
SPE columns, an OasisMCX(60 mg, 
Waters Corp., Milford, MA) at pH 
2.0 and a Lichrolut EN (200 mg, 




**Three deuterated internal 




**Total removal rates in the STPs were mostly 
lower than 40%.  
 
**PhACs could be divided into 3 groups: 
 
1) RR higher in summer than in winter; 
amoxicillin (median of about 75% in winter and 
100% in summer), atenolol (10% and 55%), 
bezafibrate (15% and 87%), enalapril (18% and 
100%), furosemide (8% and 54%), ibuprofen (38% 
and 93%), ranitidine (39% and 84%), and 
sulfamethoxazole (17% and 71%).  
 
2) RR similar in summer and winter: 
ciprofloxacin (60%), hydrochlorothiazide (30%), 
























3) No removal: carbamazepine, clarithromycin, 
erythromycin, lincomycin, salbutamol, and 
spiramycin, plus estrone. 
 
**STP effluents still contained PhACs that were 
discharged in the receiving water.  
 
**The total load of the 26 PhACs discharged 
through the STP effluents were in the range of 1-
3g/day/1000 inhabitants; about 60-180 kg/day of 
PhAC substances reach surface  
 
**RRs were generally <40%, with the exception of 
the plant in Varese Lago (64%). In two plants 
(Varese Olona and Cagliari) the RR was zero. RR 
were 0%, 16%, 31%, and 39% in the four STPs 
sampled in winter and 0%, 31%, and 64% in those 
sampled in summer RR were higher in summer 
thandue to temperature-dependent increase of 
microbial activvity.   
 
*Greater attenuation (30 to 60%) was found for 
molecules also found in the particulate 
(hydrochlorothiazide, bezafibrate, spiramycin, 
clarithromycin, estrone, and erythromycin), 
indicating that attenuation may be due to both 
sorption and degradation  
 
 -A second group of compounds with known 
persistence/stability in water had lower % 
attenuation (<30%) including: carbamazepine, 
atenolol, furosemide, enalapril, and ranitidine. 
 
- Atenolol, carbamazepine, enalapril, ranitidine, 
ofloxacin and ciprofloxin were sorbed to particulate 
suggesting sorption is important in their attenuation 
 
-Furosemide and ibuprofen, sulfamethoxazole, 
which degraded up to 70% in STPs and salbutamol 
and lincomycin which were not degraded at all, 
were not detected in the particulate, thus indicating 
a greater role for degradation.  
 
Environmental Toxicology and 
Chemistry 24,. 1, (2005)25–30 
Tracking Acidic Pharmaceuticals Caffeine and Triclosan through the Wastewater 
Treatment Process 























4 stages of WWT:  
**all WWTPs were 
similar in design, 
consisting of: 
 
1) a primary settling 
process;  
 
2) an activated sludge 
biological nutrient 
removal process (with 
anoxic zones for 
denitrification); 
 
 3) an advanced 
treatment consisting of 
phosphorous removal, 
gravity filtration, 




**Field-scale analysis of WWT plant 
effluent 
 
**Extraction via SPE with Waters 
Oasis hydrophilic–lipophilic balance 
solid phase extraction columns,  
 
**The samples were concentrated in 
an evaporating centrifuge, spiked 
with 100 ng of internal standard, 




**Anyalysis by GC/MS 
-Samples (1 ml) were injected into 
an HP 5980 GC coupled to an 
HP 5971 mass selective detector 
and quantified against calibration 
standards (0.05–33 ng/ml) using 
selected ion monitoring mode. 
Method detection limits ranged 




**The majority of compound removal (51–99%) 
occurs during secondary treatment; microbes 
present in a mixture of aerobic and anaerobic zones 
biodegrade organic matter not removed in primary 
treatment; removing a large quantity of fine 
particulate matter to which PhACs may be 
adsorbed. 
 
**A smaller portion (0–44%) is removed during 
primary treatment; suspended solids in the raw 
influent are mixed with polymet flocculant and 
allowed to settle and are then separated; removing 
large dense particles too small to be collected by the 
bar screens.  
 
**Advanced treatment removes a smaller portion 
(0–16%).  
 
** Qualitative methanol extraction of collected 
particulates showed no detectable levels of the 
acidic drugs in the particulate, supporting the 
expectation from the total suspended matter data, 
that acidic drugs are present 98% in the aqueous 
phase.  
-Conversely, triclosan was found in the qualitative 
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Water Research 40 (2006) 507 
– 516 
Performance of an up-flow anaerobic stage reactor (UASR) in the treatment of 
PhAC wastewater containing macrolide antibiotics 
























PhAC of focus 
 
**up-flow anaerobic 
stage reactor (UASR) 
 
-Biomass = anaerobic 




-Each stage of the 




substrates are in 
environments more 









**With no moving 
parts or mechanical 
mixing USAR is 
economically as a pre-
treatment system.  
 
-Reactor configuration 
protects  methanogenic 
biomass from toxic 




**Performance of the reactor was 
characterized in terms of its COD 
removal, Tylosin reduction, pH, 
VFA (volative fatty acid) 
production, methane yield and 
sludge washout. 
 
**Both reactors were seeded with 
anaerobic digested sewage sludge 
(Hexham Municipal sewage 
treatment plant). 
 
**Sample analysis included 
COD(chemical oxygen demand), 
pH, alkalinity, TKN, ammonium 
nitrogen (NH3-N), suspended solids 
(SS), volatile suspended solids 
(VSS), all according to Standard 
Methods (APHA, 1985) 
 
**Available PO4-P was measured 
by ion-chromatography,  
 
** VFA by gas–liquid 
chromatography (Unicam 610 Series 
Gas Chromatograph with auto-
injector and PU 4811 
computing integrator) 
 
**Tylosin assay was performed by 
HPLC by injecting sample 
solutions onto a 20 cm Nucleosil 





**At a total hydraulic retention time (HRT) of 4 
d and organic loading rate (OLR) of 1.86 kg 
CODm-3 d-1, no detectable levels of the acidic drugs 
in the particulate fraction were found;, COD 
reduction was 70–75%, suggesting the biomass had 
acclimated to the antibiotics;  
 
**Average reduction of 95% for Tylosin in the 
UASR, indicating efficient degradation in the 
anaerobic reactor system. 
 
**Similar COD removal efficiency occurred when 
tylosin was present at concentrations ranging from 
0 to 400 mg l-1 (mean removal 93%), 
 
**At tylosin concentrations of 600 and  800 mg l-1 
there was a slight decline in treatment efficiency to 
85% and 75% removal, respectively. Tylosin caused 
only a minor inhibition effect on the 
microorganisms within the UASR. 
 
**VFA, biomass and pH data indicate different 
metabolic processes between Stages 1–4 of the 
UASR system, each stage favour a unique 
population of microorganisms. 
 
**At a reactor OLR of 1.86 kg CODm-3 d-1 (HRT 4 
d), soluble COD reduction was ~70–75%; When 
OLR was increased  (by lowering the HRT) COD 
removal efficiency decreased, continuing to do so 
until only 45% soluble COD removal was observed 
at an OLR of 3.73 kg CODm-3 d-1. 
 
**Stages 2–4 showed a relatively minor 
contribution to total COD removal, stage 2 
contributing ~10-15% and stages 3&4 only ~5%. 
 
**50–60% COD reduction occurred in Stage 1 of 
the UASR when HRT was set to 4 d 
** Methanogenic biomass in Stages 2–4 could have 
been affected adversely by products and acidic 
conditions generated in Stage 1 
 
** While the COD removal profile showed 
reducing COD removal efficiency with increasing 
OLR, Tylosin removal efficiency remained 
relatively constant 
 
Water Research 41 (2007) 
1013 – 1021 
Occurrence and removal of PhACs and endocrine disruptors in South Korean 
surface, drinking, and waste waters 






















- system consists of an 
activated sludge tank 
followed by 
commercially available 
plate and frame type 
membrane modules 
(Pure-Envitech Co., 





**Full and Pilot-scale investigations 
 
**LC–MS/MS with electrospray 
ionization (ESI) and atmospheric 
pressure chemical ionization (APCI)  
 
**SPE - Waters HLB 
(hydrophilic–lipophilic balance) 
solid phase extraction cartridges 
 
**Conventional drinking water treatment 
methods were relatively inefficient for contaminant 
removal, while efficient removal (E99%) was 
achieved by GAC.  
 
**Observed removal appeared completely related to 
GAC at the DWTP; likely due to high sorption 
efficiencies of compounds with activated carbon 
based on hydrophobicity.  
 
**River water has low concentrations of natural 
organic matter (NOM) which results in less 
competition for the binding of micropollutants to  
the activated carbon 
 






















1) Membrane bioreactors (MBR) showed limited 
target compound removal; found to be efficient for 
hormones (e.g., estriol, testosterone, 
androstenedione) and certain PhACs (e.g., 
acetaminophen, ibuprofen, and caffeine) with 
approximately 99% removal; MBR treatment did 
not decrease the concentration of erythromycin, 
TCEP, trimethoprim, naproxen, diclofenac, and 
carbamazepine. 
 
2) Membrane filtration processes using reverse 
osmosis (RO) and nanofiltration (NF) showed 
excellent removal (>95%) for all target analytes. 
 
**the combination of membranes with UV 
irradiation did not provide enhanced removal.  
 
**RO did not display higher removal percentages 
when compared with NF. 
 
Water Research 39 
(2005) 2654–2664 
Pathways and metabolites of microbial degradation of selected acidic PhAC and their 
occurrence in municipal wastewater treated by a membrane bioreactor 




















 -Since the sludge was 
withdrawn from a 
reactor treating real 
municipal wastewater in 
which all five PhACs 
were found (Quintana 
and Reemtsma, 2004), it 
had the opportunity to 




**Laboratory biodegradation tests 
were performed in batch cultures to 
investigate the biodegradation 
of these PhACs by activated sludge 
from a municipal WWTP 
 
**Initial experiments were 
conducted with the concentration of 
PhACs at 20 mg l-1  
 
**LC-MS/MS  
- Ion-pair liquid chromatography 
was coupled to a triple quadrupole 
mass spectrometer (Quattro LC, 
Micromass, UK) with electrospray 




**Initial Lab experiment (20 mg l-1):  
 
-Only ketoprofen and the aniline control were 
degraded within 28 days; all other PhACs remained 
unaltered.  
 
-Ketoprofen transformation started on day 10 and 
it was completely transformed after 28 days; two 
new metabolites of relatively high intensity could be 
detected and tentatively identified by means of LC-
MS. While the first metabolite reached its 
maximum around 14 days, the second one 
increased until the end of the experiment 
 
-Based on these metabolites, it is proposed that 
ketoprofen is degraded along the pathway known 
for biphenyls, biphenyl ethers and related 
compounds 
 
**2nd Lab Experiment  
(Addition of carbon source for co-metabolic 
degradation):  
 
-Ketoprofen and Diclofenac were not degraded in 
this series over a period of 28 day;  The other three 
PhACs showed variable degrees of transformation 
and mineralization;  
 
-Bezafibrate was completely transformed but not 
mineralized within 5 days; One metabolite was 
detected with rapidly increasing concentration 
during the 1st 5 days; DOC removal from 
bezafibrate over the 28 days was  assessed as 30% 
 
-Naproxen degradation was slow; ~60% 
transformation within 28 days and only 1 
metabolite (O-desmethyl-NPX) detected at low 
intensity.  This ether cleavage is well documented 
for in mammalian and fungal metabolism, yet not 
for bacterial transformation.  
-Steady desmethyl-naproxen concentration during 
day 20–25 may due to steady demethylation of 
naproxen and mineralization of desmethyl-
naproxen. LC-MS analysis of a sample taken day 39 
shows neither naproxen nor desmethyl-naproxen 
present 
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WWTP is a kinetic problem. 
 
* Ibuprofen: biodegradation started after a lag 
phase of a ~5 days and was completed after 22 
days; 2 products were detected by LC-MS: two 
isomers of hydroxy-ibuprofen  
- Isomers do not accumulate, degrading easily as 
shown by their rapidly decreasing concentration 
with decreasing concentration of the parent 
compound 
 
** None of the metabolites detected in the batch 
tests were found in treated municipal wastewater. 
This agrees with the results of the batch tests that 
indicated mineralization of most of the detected 
metabolites 
 
Water Research 39 (2005) 
2219–2228 



































biological and chemical 
processes  
 
Four of the plants used 
denitrification/nitrificat






** SPE to separate Rx from waste  
   water 
 
**Liquid chromatographic    
   separation 
 
**Detection by a triple- 
    quadrupole mass spec 
 
****Risk to aquatic environment 
was estimated by a ratio of 
measured environmental 
concentration (MEC) and predicted 
no-effect concentration (PNEC). 
 
** Highest removal rate was observed for 
ibuprofen and the lowest for diclofenac, 92% +/- 
8% and 26% +/- 17%, respectively.  
 
**Due to the incomplete removal, the PhACs were 
found in rivers at the discharge points of the STP 
effluents.  
 
**Downstream of discharge points, concentrations 
decreased significantly mainly due to dilution in 
river.  
 
**Surface water concentration indicated no 
aquatic risk; however, in dry seasons or during STP 
malfunctions ibuprofen could pose a risk in small 
river systems. 
 
** Despite a high removal rate (81± 18%), 
naproxen was the most abundant PhAC in the two 
studied effluents. 
 
** Ketoprofen was removed in an average of  78± 
18% 
 
** Bezafibrate removal (51±42%) varied 
significantly between STPs; even increasing at one 
site. This may be due to analytical inaccuracy or to 
deconjugation, since 22% of bezafibrate is 
glurcuronidated.  
 
** Total removal of studied PhACs in STPs was 
75–98%.  
 
** For ibuprofen, naproxen, ketoprofen, 
diclofenac and bezafibrate, the previously 
reported removal rates are: 75–90%, 66–82%, 
23–78%, 3–75% and 50–83%, respectively 
 
**Since sludge concentrations of PhACs were not 
determined, it’s not possible to deduce whether the 
removal was due to biodegradation or adsorption to 
the sludge. 
 
** The DN process had no significant effect on 
the removal rates of the PhACs. 
 
** In the cities where part of the wastewater 
originates for instance from pulp and paper mills 
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Science of the Total Environment 377 
(2007) 255–272 
Efficiency of conventional drinking-water-treatment processes in 
removal of PhACs and other organic compounds 









































water (with FeCl3) to 
destabilize colloidal 
particles (coagulation) 
and facilitate their 
flocculation (using 
microsand) and settling 





conducted by the 





GAC Filters: 25.4 cm 






**Field analysis measuring 
occurrence of five PhACs in SPR 
influent and effluent; samples were 
collected as 24 hour composite 
samples and stored at -18degC 
 
**SPE  




** LC/MS – ESI (+) 




OVERALL DRINKING WATER 
TREATMENT 
 
**Effectiveness of treatments varied widely 
within and among classes of compounds; some 
hydrophobic compounds were strongly oxidized by 
free chlorine, and some hydrophilic compounds 
were partly removed through adsorption processes. 
 
** Effectiveness of a DWT depends on several 
factors:  
-The quality of the source water, the type and mode 
of operation of each treatment process, and 
physiochemical characteristics of compounds  
 
** Hydrophilic compounds (low log Kow and 
high solubility), such as PhACs, were detected at 
relatively low concentrations in dried-solids samples 
and were present in measurable concentrations in 





-Accounted for only 15% of the reduction in 
average concentration of OCs 
 
-None of the 32 OCs showed a decrease >75%  
 
-Mild degradation (25-75%): Sulfamethoxazole, 
acetaminophen,  dehydronifedipine; which were not 
detected in the dried solids of settled sludge 
-Removal of these hydrophilic PhACs from the 
water phase may be due to ferric chloride 
coagulation, resulting in base or acid hydrolysis 
 
-Less than 25% removal of carbamazepine, 





-Accounted for 32% of the degradation or removal 
of OCs from the water phase. 
 
- Significant removal: Sulfamethoxazole, 
acetaminophen, erythromycin–H2O, and diazinon 
were significantly lowered decreasing by at least 
75% (oxidation with free chlorine) 
 
-Low removal: Carbamazepine, caffeine, cotinine, 
and dehydronifedipine were found to have low 




**GAC FILTRATION:  
-Accounted for 53% of the removal of OCs from 
the water phase. 
 
- PhAC degradates erythromycin–H2O and 
dehydronifedipine, were lowered below detection 
limits 
 
- Carbamazepine, caffeine, cotinine, were decreased 
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Environ. Sci. Technol. 2006, 40, 
5095-5101 
Monitoring the Removal Efficiency of PhACs and Hormones in Different 
Treatment Processes of Source-Separated Urine with Bioassays 








































entering the wastewater 
stream 
-promote sustainability 
of WW management 
because urine contains 
most of the nutrients 
and a majority of 
endocrine disrupting 
compounds and PhACs 
in domestic WW but 














* Removal efficiencies were 
determined with a combination of 






1) The algal chlorophyll 
fluorescence test with green algae 
for detecting phytotoxicity 
and baseline toxicity  
The yeast estrogen screen (YES) for 
detection of estrogenic endocrine 
disruption  





**Chemical Analysis:  LC-MS/MS 
 
** Filtration methods (nanofiltration and 
electrodialysis) were highly efficient with respect to 
toxicity reduction. 
 
**Micropollutant degradation during biological 
treatment in a sequencing batch reactor was very 
compound specific.  
 
**ELECTRODIALYSIS: Diluate contained all 
remaining estrogenic activity, and removal 
efficiency with respect to estradiol equivalent 
concentrations (EEEZ) was >99%. Overall, 42-
66% of the EEEQ was recovered in the diluate. 
This can be attributed to adsorption of 
ethinylestradiol to the membranes 
 
**NANOFILTRATION (NF): Toxicity 
reduction, expressed as removal efficiency, 
amounted to 84% for urine & 89% for urine spiked 
with PhACs.  NF removed natural and xenobiotic 
compounds with a negative impact on growth and 
photosynthesis in algae. 
 
-Removal efficiencies: 59% for the basic 
propranolol ,96%for the acidic ibuprofen and 
diclofenac, and 74% for the neutral carbamazepine 
-Retention depends on size, charge & polarity 
 
**BIOREACTOR:  
-In the algal chlorophyll fluorescence test, no 
reduction of toxicity was observed in urine spiked 
with 10-5 M propranolol or 10-3 M ibuprofen, nor 
did the analytically determined concentrations 
decrease within 50 h. Note that biodegradation is 
highly dependent on the sludge 
 
** STRUVITE PRECIPITATION:  
-PhAC Removal efficiency was 97 ± 2% measured 
by algae test; and estrogens was 98 ± 2% measured 
with the YES.  
-Removal was sightly higher if struvite was washed 
prior to re-dissolving it for the toxicity assay 
 
**OZONATION: 
-An ozone dose ~1 g/L-1 reduced algal toxicity 
only by 50-60%; while removing 99% of the 
estrogenic activity 
 
-Increasing ozone dose to 2.1 g/L improved the 
reduction of algal toxicity to only 75%. Thus, 
ozonation decreases estrogenicity of estrogenic 
compounds but does not lead to mineralization 
 
-Reduction was 70-90% higher in spiked urine. 
Micropollutants in urine dropped to below LOD at 
ozone doses of 0.6-1.3 gâL-1  
 
-Partially degrades many PhACs, hormones, and 
other natural urine components, but does not lead 
to full mineralization, shows clear dose-dependency  
 
*May create reactive species; Umu test indicated 
no activity in the treated urine; however umu test 
was conducted with SPE extracts of the ozonation 
samples, and thus it’s possible that potentially 
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Environ. Sci. Technol. 2007, 
41, 3708-3714 
Elimination of Selected Acidic Pharmaceuticals from Municipal Wastewater 
by an Activated Sludge System and Membrane Bioreactors 































*Field analysis and Batch 
Elimination Test with Sludge 
Collected from the WWTP and 
MBRs 
 
-Used to investigate the degree of 




**Sampled from August to 
October at municipal WWTP 
 
*Solid retention times (SRTs) of the 
WWTP:  7 
*SRT of MBR: 15 & 65 days 
 
*Measured the amount of adsorbed 
PhAC to sludge to investigate the 
elimination pathways –ultrasonic 
solvent extraction method 
 






*Elimination was variable between compounds 
 
*Membrane bioreactors caused greater removal 
than seen at actual WWT plants 
 
*Elimination success depended on SRT’s;  
better performance was seen in the MBR with a 65 
day SRT as compared to the MBR with the 15 day 
SRT – this was particularly significant with 
diclofenac and ketoprofen 
 
*BATCH ELIMINATION TESTS:  
- revealed that the sludges in the MBRs had large 
specific sorption capacities due to their large 
specific surface areas.  
 
**Elimination Mechanism:  
 
-Despite the sorption capacities of sludges, the 
main mechanism of elimination of the PhACs 
was biodegradation. 
 
-Greater Ibuprofen and ketoprofen elimination in 
the experiments with unsterilized  sludges, thus 
elimination mechanism is likely bidegradation 
 
-Initial removal of diclofenac was likely through 
sorption; biodegradation did not appear significant, 
occuring slowly if at all 
 
 
Chemosphere 71 (2008) 
1476–1485 
Behaviour and redox sensitivity of harmaceutical residues during bank filtration – 
Investigation of residues of phenazone-type analgesics 























*Field Analysis and Lab-scale 
column study 
 
*Water sampling of surface water, 
and wells (observation and 
production) conducted monthly 
 
*HPLC-MS/MS PhAC analysis 
 
 
GENERAL OBSERVATIONS:  
 
*Greater OXIC PhAC removal: 
-Phenazone, 4-acetylaminoantipyrine (AAA), 4-
formylaminoantipyrin (FAA) and 1,5-dimethyl-1,2-
dehydro-3-pyrazolone (DP) were eliminated more 
efficiently under oxic conditions 
 
*No Removal:  
- 1-acetyl-1-methyl-2-dimethyloxamoyl-2-
phenylhydrazide (AMDOPH) was not eliminated at 
all.  
 
FIELD STUDY:  
*PhAC elimination displayed strong seasonal 
variations.  
 
*Compounds were found to be more persistent 
under anoxic field conditions. 
 
*Microbially mediated degradation appeared only 
effective under oxic conditions (encountered in 
winter) 
 
 *phenazone elimination was almost complete in 
column study( oxic conditions), but only 33% was 
eliminated in an undisturbed sediment core from 
the lake banks (largely anoxic) 
 
COLUMN STUDY: 
*Column study indicated elimination to be limited 
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Chemosphere 70 (2008) 
1525–1531 
Combined chemical treatment of pharmaceutical effluents from medical ointment 
production 




















treatment with lime 
coagulation  
 
* Fe2(SO4)3 *7H2O and 




* Batch experiments conducted in 
an Erlenmeyer flask 
 
*Permanent agitation for 1–6 h.  
 
*Catalyst (Fe2(SO4)3 *7H2O) was 
added first then reaction was 
initiated by adding H2O2 all at once 
 
*Experiments with non-catalyzed 
peroxide were conducted in same 
manner 
 
*Fenton-like oxidation showed highest eficacy at 
H2O2/COD weight ratio of 2:1, H2O2/Fe2+ molar 
ratio of 10:1 and 2 h of treatment time. 
 
 *Combining Fe(III) precipitation and lime 
coagulation improved COD and residual iron 
concentration reduction  as well as BOD and 
BOD/COD ratios in pharmaceutical effluents.  
 
*Combine treatment enhanced the quality of 
pharmaceutical effluents and improved the 
biodegradability of pharmaceutical effluents. 
 
* Both iron (III) precipitation alone and in 
combination with lime coagulation (as second step 
in fenton oxidation) indicated < 2 mg /L residual 
Fe and no hydrogen peroxide in effluents. 
 
*COD removal of 87%, 94% and 96% and BOD7 
removal of 79%, 92% and 95% were achieved. 
 
 Removal of ibuprofen from wastewater: comparing biodegradation in conventional, 
membrane bioreactor, and biological nutrient removal treatment systems 























removal treatment  
systems (BNR) 
 
BNR samples collected at: 
1) Influent to the BNR;  
2) Anaerobic tank; 
3) Effluent from anoxic tank;  
4) Effluent from aerobic 
Membrane tank 
  
WWTP samples collected at:  
1) influent to primary clarifiers;  
2) influent to aeration tanks; 
3)  influent to final secondary 
clarifiers; 




Preliminary and Primary Treatment: 
* Both plants indicated negligible removal of  
ibuprofen in preliminary and primary treatment  
 
Aeration Tank:  
*Ibuprofen removal >95% the aeration tank; 
aerobic biodegradation being the dominant 
mechanism.  
 
*First order kinetic rate constants, kbiol, for 
conventional tank and MBR were statistically 
similar (-6.8 ± 3.3 L/g SSpd and -8.4 ± 4.0 L/g 
SSpd, respectively) 
 
*BNR study indicated IBU is also anaerobically 
degraded. 
 
Anaerobic Tank:  
*%Removal of IBU in anaerobic tank was ~60%, 
and k values were similar at 1.07 1/h and 0.89 1/h 
for Trial 1 and Trial 2, respectively. 
 
Water Researc 41 (2007) 2525 
– 2532 
Bezafibrate removal by means of ozonation: Primary intermediates, kinetics, 
and toxicity assessment 

















-Can attack organics by 
a direct (ionic) 
mechanism and a 
radical one - which 
originates from its 
decomposition in water 
to generate hydroxyl 
radicals (Sotelo et al., 
1987).  




natural organic matter 




Two different experimental 
approaches (absolute and 
competition method) are adopted to 
estimate the second-order kinetic 
constants for the ozone attack at 
pH 6.0, 7.0 and 8.0. 
 
*experiments were carried out in a 
0.8 L reactor 
with a continuous supply of ozone 
gas stream 
 
*initial BZF concentration 
ranging from0.2 to 0.5mmol/L 
 
*HPLC analysis for BZF 
 
*BOD and COD used to measure 
biodegradability 
*Acute toxicity measured using 
 
*Ozonation efficiently degraded BZF: after 10 min 
of treatment ( dose = 0.73mmolL_1 of ozone) 
complete BZF removal achieved 
 
*Only a small fraction was mineralized. 
 
*Chloride release corresponding to 100% of initial 
chlorine content in BZF molecule was observed. 
 
*Mechanism: LC–MS analyses showed that ozone 
reacts mainly with unchlorinated ring, forming 
aldehydic and ketonic intermediates. 
 
*Presence of species with 3 additional oxygen 
atoms suggested that hydroxylation of both 
aromatic rings may also occur 
 
*Ozonation improved the biodegradability and 
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carbon  
-Potential for toxicity 
by  
oxidized intermediates 
in the early stage of 
ozonation to bacteria 
and microbes 
 
Microtox®  M500 toxicity analyzer, 
using Vibrio fischeri strains 
 Evaluation of ozone-based treatment processes for wastewater containing  
microcontaminants using LC-QTRAP-MS and LC-TOF/MS 

















































Mefenamic acid  
 
 
Ozone (O3) and  
 
O3 with H2O2 
 
*O3 treatments were conducted in a 
5L-stirred tank agitated at 1,000 rpm 
with a four-blade turbine. 
 
* Same conditions were used for 
O3/H2O2, with equal volumes of 
H2O2 (30% w/v) injected every 5 
min. to favour pollutant elimination 
via radicals. 
 
* LC/MS PhAC analysis 
 
*Removal >90% was seen for most analytes 
 
*5 compounds: gemfibrozil, chlorophene, diuron, 
ibuprofen and mefenamic acid indicated lower 
removal efficiencies; however still >86% 
 
* Combining O3 with H2O2 enhances oxidizing 
ability causing nearly complete elimination of 
contaminants 
 
OVERAL PhAC REMOVAL:  
*Considering all contaminants 97% removal and 
99% removal were seen for O3 and O3 with H2O2 
respectively.  
 
 Classification of the degradability of 30 pharmaceuticals in water with ozone, UV 
and H2O2 


















 Mefenamic acid 
 Naproxen 





 Disopyramide  
 Metoprolol 
 Propranolol 



















O3 with H2O2  
O3 with UV 
H2O2  with  
 
*Same batch reactor with 22L of 
solution spiked with PhACs used 
for O3 and UV studies 
 
* UV radiation source: 8W low-
pressure mercury lamps emitting 
254nm wavelength and intensity 
0.384mW/cm2. *Experiments  
performed with and without H2O2  
 
*Ozone experiments 
were started by sparging O3 
continuously into the reactor 




*Ozone Based Treatments:  
- O3 and O3-based/UV-based AOPs removed a 
variety of the PPCPs effectively,  
-However, 2-QCA, DEET and cyclophosphamide 
showed relatively low degradability 
 
-DOC concentration did not decrease with PPCP 
concentration thus evaluation of intermediates is 
necessary  
 
-All 30 PPCPs degrades linearly with time, thus 
pseudo first order K constants were calculated to 
compare degradability.  
 
- O3 with UV was most effective:  k values of 11 
PPCPs > 0.461/min, thus >90% was degraded 
within 5min. Degradation via direct photolysis by 
UV and  OH radicals from photolysis of O3 
 
-O3/H2O2 and O3/UV processes: k>0.077/min 
for most of the PPCPs except for 
cyclophosphamide. 
 
* UV treatment:: 
-Combining UV and O3 or H2O2 (that can generate 
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 Clenbuterol  
 Theophyline 
than UV alone.  
 
-Only k value of ketoprofen was > 0.461/min; 18 
PPCPs had k values < 0.077/min, thus 90%of the 
initial concentration was not degraded within 30min  
 
*UV/ H2O2 process: k values of 29 PPCPs except 
for cyclophosphamide were > 0.077/min,  
 
 
*Combining UV with O3 or H2O2 (that can 
generate OH radicals) promotes the degradation of 
the PPCPs. 
 
Water Research 42 (2008) 121 
– 128 
Phototransformation of selected pharmaceuticals during 
UV treatment of drinking water 






































* Clear aqueous sample in quartz 
tubes were irradiated by light 
emitted from a lamp situated in a 
cooling jacket at photoreactor 
centre.  
 
*Light is filtered through the 
cooling jacket and an aqueous 
solution containing the immersed 
sample tubes, serving as an optical 
filter and as a medium to control 
temperature. 
 
*UV radiation source: low-pressure 
mercury (LP Hg) lamp Heraeus 
Noblelight model TNN 15/32 
 
*HPLC PhAC analysis 
 
Effect of pH 
* pHdependent rate constants were observed for all 
PhACs except iopromide, may be due to acid–base 
equilibria 
 
Effect of UV wavelength:  
*Degradation appeared wavelength independent 
except for EE2 
 
* At the UV-C (254nm) drinking water dose of 400 
J/m-2  PhAC reduction at pH ~ 7.0 in pure water 
was: 0.4% for EE2, 27% for diclofenac, 15% for 
sulfamethoxazole, and 15% for iopromide 
 
Effect of Natural water: 
* For 3 of 4 PhACs the presence of natural water 
had little effect on phototransformation rates 
 
* EE2 phototransformation rates were greatly 
enhanced by the presence of natural water, 
increasing by a factor of 6.1; this could be due to 
formation of a carbonate radical or nitrogen dioxide 
forning a hydroxide radical. 
Desalination 202 (2007) 
156–181 
Role of membranes and activated carbon in the removal of endocrine disruptors and 
pharmaceuticals 





















































* GAC studied at bench-scale using 
small-scale column tests and at 2 
full-scale utilities. 
 
*Membrane studies conducted in 
dynamic flow-through pilot skids or 
in operational full-scale utilities 
 
*GC-MS/MS and LC-MS/MS 
used for PhAC analyses 
 
 *Virgin and fouled membranes 
were evaluated 
 
*Membrane characteristics and molecular 
properties of contaminant determine the degree of 
removal by membrane.   
 
* Microfiltration and ultrafiltration rejected few 
target compounds; some loss of steroidal type 
compounds was observed.  
 
*Nanofiltration and Reverse osmosis caused 
significant rejection of nearly all targets; but 
compounds were detectable at trace levels in 
permeates.  
 
*GAC proved highly effective at removing all target 
chemicals; hydrophilic compounds broke through 
faster than hydrophobic compounds. Removal for 
nearly all compounds was >90%. 
 
*GAC efficacy is greatly decreased by the presence 
of natural organic matter (NOM); NOM competes 
for binding sites on the GAC, blocking pores 
within the GAC structure. 
 
*Full-scale applications indicated that GAC filters 
receiving regular regeneration had little 
breakthrough of contaminants; non-regenerated 
filters showed no removal  
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contact time, and contaminant molecular 
properties; it does provide the benefit over GAC of 
being fed as a new product into the treatment 
process, and is thus a new source of carbon. 
 
*Toxicological relevance of these treatments has yet 
to be established; ultimately these treatments may 
lead to decreased concentrations of disinfection 
byproduct precursors. 
  
Environ. Sci. Technol. 2002, 
36, 3855-3863 




























*Investigated at lab and 
pilot scale and in real waterworks 
 
*Solid phase extraction and GC-MS 
analysis of analytes 
 
*Waterworks studies: batch tests 
(following OECD guidelines) 
consisting of ground water and 
surface water with different filter 
media; two waterworks setups 
investigated 
 
*Aerobic sorption studies: 
sand or gravel taken from the 
underground of a groundwater 
catchment 
 
*Sterile control were used to 
differentiate between 
biodegradation and sorption 
 
*Flocculation studies were 
conducted using a “jar-test” setup 
 
*GAC PhAC removal was studied 
via a pilot plexiglass filter operated 
in down flow mode with spiked 
ground water 
 
*Ozonation PhAC removal was 
studied via a lab-scale device; Ozone 
was bubbled into  water in 2-L glass 
bottles simulating real waterworks 
conditions; varying bubbling time 




*No significant PhAC removal in batch 
experiments with sand under natural aerobic and 
anoxic conditions; indicating low sorption and high 
persistence with non-adapted microbes. 
 
FLOCCULATION: 
*Lab-scale and waterworks studies of flocculation 
using iron (III) chloride showed little elimination of 
PhACs.  
* Relative concentrations of the PhACs (C/Co) 
ranged from 87 (clofibric acid) to 110% 
(benzafibrate); changes in concentration were 
within the RSD.  
 
OZONATION: 
* Removal is highly contaminant specific 
 
*Ozonation proved highly effective for some 
PhACs; at 0.5 mg l-1 ozone diclofenac and 
carbamazepine decreased >90%; at 1.5 mg l-1 
bezafibrate was reduced by 50%; clofibric acid was 
stable even at 3 mg l-1 ozone.  
 
*Under waterworks conditions, removal efficiencies 




GRANULAR ACTIVATED CARBON: 
*GAC proved very effective in removing PhACs; 
providing the major elimination of all but clofibric 
acid 
*Efficiency of removal is decreased by the presence 
of competing compounds such as natural organic 
matter (NOM) 
*In the pilot scale experiment, carbamazepine 
showed the highest sorption potential of all PhACs, 
and clofibric acid had the lowest. 
 
 Removal efficiency of 66 pharmaceuticals during wastewater treatment process in Japan 
 



























“Title 22 process”: 
coagulation, 
sedimentation and 
filtration followed by 




*12 WWP effluents  were collected 
from 11 WWTPs 
in Japan 
 
*2 BNR processes were studied 
with simultaneous coagulation with 
PAC  
 
*Ozonation and biological activated 
carbon (BAC) followed one of the 
BNR processes 
 
*Grab samples were taken at the 
end of biological treatment (before 
and after coagulation), before and 
after ozonation  and after BAC 
process 
 
*80% removal of the total concentration of the 
individual pharmaceuticals during biological 
treatment; except carbamazepine and crotamiton 
which had efficiencies < 30%.  
 
*Total concentration of the individual PhACs was 
1.5X greater in the CAS process effluent than that 
from BNR process. 
 
*Total concentration of the individual PhACs  in 
WWTP effluent applying activated sludge then 
ozonation, decreased to <20%. 
 
*Physico–chemical treatment train (Title 22) 
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*SPE-LC/MS/MS PhAC analysis 
 
 
*Ozonation followed by biological AC efficiently 
decreased all residual PhACs below LOQ 
 
*Sand filtration processes did not reduce PhAC 
concentration significantly  
 
*Individual PhAC effluent concentrations differed 
among the WWTPs, suggesting that the PhAC 
response differs between those followed  by 
biological treatment and those followed by 
ozonation processes. 
 
ESNT 39, 2005  Fate of Endocrine-Disruptor, PhAC, and Personal Care Product Chemicals during 
Simulated Drinking Water Treatment Processes 






















































oxidative processes to 




*Inactivates microbes;  
*Oxidizes reduced 




oxidants is dictated by 
electron density effects 
and functional group 
degree of protonation. 
*Electron-donating 
(e.g., hydroxyl, amine) 
or electron-withdrawing 
(e.g., carboxyl) groups 
increases & decreases 
reactivity, respectively, 




Increases rate of ozone 
decay, increases HO* 
concentrations. HO* 










*The transformation of several 
amine-containing antibiotics, 
diclofenac, and caffeine were 
observed in lab experiments with 
chlorine  
  
**LC/MS/MS or  
   GC/MS/MS 
 
 
**Decreased Endocrine disruptin compounds 
(EDC) and Personal care products (PPCPs) initial 
concentration by <10% to >90%;  
 
**EDC/PPCPs were likely transformed to 
oxidation byproducts.  
 
**Ozone oxidized steroids containing phenolic 
moieties (estradiol, ethynylestradiol, or estrone) 
more efficiently than those without aromatic or 
phenolic moieties (androstenedione, progesterone, 
and testosterone). 
 
**EDC/PPCP reactivity with oxidants were 
separated into three general groups: 
 
(1) Compounds easily oxidized (>80% reacted) by 
chlorine and always oxidized at least as efficiently 
by ozone;  
 
(2) Compouds poorly oxidized (<20% reacted) by 
chlorine or ozone; 6 of the 60 compounds (TCEP, 
BHC, chlordane, dieldrin, heptachlor epoxide, 
musk ketone) 
 
(3) Compounds reacting preferentially (higher 
removals) with ozone rather than chlorine.; 24 of 
the 60 compounds 
 
*The formation, fate, detection, and toxicity of 
oxidative byproducts from pesticide sand 
EDC/PPCPs is of potential concern (17, 27, 42). 
 
 
**Ozone oxidized most LC/MS/MS compounds 
by >80% except for atrazine, meprobamate, and 
TCEP, which do not contain aromatic moieties, 
and ibuprofen which has an electron-withdrawing 
functional group on an aromatic ring.  
 
**Several GC/MS/MS compounds exhibited 
minimal oxidation during ozonation (BHC, 
chlordane, dieldrin, heptachlor epoxide, mirex, or 
musk ketone). 
 
**Addition of small amounts of H2O2 prior to 
ozonation generally improved the extent of 
oxidation by 5-15%. Four compounds (including 
androstenedione and testosterone) indicated >20% 
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employs aluminum- or 
iron-based salts, which 





- removes dissolved 
calcium and 
magnesium, using lime 
and soda ash to 
precipitate calcium 
carbonate at lower pH 
and magnesium 









*Chemical coagulation and 
softening aid in removing 
suspended solids (i.e., turbidity) 
from the water and dissolved 
organic carbon (DOC).  
 
*A  PAC slurry is added at dosages 
of 1 to 25 mg l-1 to 
a solids-contact, or flocculation, 
chamber that has contact 
times of 0.5 to 5 h; removal of PAC 
(with adsorbed 
compounds) occurs during 
sedimentation and filtration 
processes (34) 
 
Addition of 5 mg l-1 of powder 
activated carbon (PAC) with a 4-h 
contact time – reflective of 
conditions employed at WTPs, and 
capable of achieving partial, but not 
complete removal, thus allowing 
relationships between compound 
structure and removal to be studied. 
 
COAGULATION:  
**Less than 25% of most of the EDC/PPCPs were 
removed. 
 
**Only 2 of the 28compounds analyzed by 
LC/MS/MS exhibited >20% removal during 
alum coagulation: (hydrocodone, 24%; 
erythromycin-H2O, 33%). 
 
**12 of 32 of the GC/MS/MS compounds 
exhibited >20% removal during alum 
coagulation; the highest removals were for PAHs.  
 
**For most EDC/PPCPs, ferric coagulation 
achieved comparable removals as equivalent alum 
dosages. 
 
**Average % removal:  
-for EDC/PPCPs detected by LC/MS/MS = 6%  
-for EDC/PPCPs dectected by GC/MS/MS = 
26% (range:  0-83%) 
 
**GC/MS/MS compounds:  
- More hydrophobic PAHs were removed better 
(60-80%);  
- log Kow > 6.5 also had  removals >20%; 
suggesting removal by partitioning onto suspended 
particulates or precipitated solids that had adsorbed 
DOC 
 
**Chemical lime softening  
-Achieved comparable EDC/PPCP removal as 
alum or ferric coagulation within experimental 
reproducibility (20%); likely having same removal 
mechanisms (sorption onto turbidity and 
precipitated solids). 
**Removed 50% to >98% of GC/MS/MS 
compounds (more volatile) and 10% to >95% of 
LC/MS/MS compounds (more polar); 
 
POWDERED ACTIVATED CARBON: 
 (PAC) 
 




- At a 1 mg l-1 PAC dosage in CRW, 3H-E2 
removal was   32, 58, and 84% after contact times 
of 1, 4, and 24 h  respectively 
 
- Increasing PAC dosage improved 3H-E2 removal, 
and the effect of contact time became less 
significant at PAC dosages of 5 and 25 mg l-1.  
  
*CRW had ~45% less 3H-E2 adsorption capacity 
than nanopure water; thus the amount and 
characteristics of DOC in the source waters may be 
important for EDC/PPCP removal. 
 
*Partial removal was seen for nearly all EDC/PPCP 
compounds spiked into the source waters. 
 
*Appears that the percentage removal of 
EDC/PPCPs is independent of initial 
concentration. 
 
*Some competition between EDC/PPCPs may 
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Influence of electrostatic interactions on the rejection with NF and assessment of the 
removal efficiency during NF/GAC treatment of pharmaceutically active compounds in 
surface water 




































Phenazone   


















1) Trisep TS-80 
membrane 
 
2) Desal HL 
 
 
NF and Subsequent 
GAC filtration 
 
*Feed water recovery =amount of 
water  produced/amount of feed 
water used 
 
*All experiments were carried out in 
a recycle mode with a single batch 
of water, with both permeate and 
concentrate recycled back into the 
feed reservoir. 
 
* Low feed water recovery (10%) 
* High feed water recovery (80%) 
 
*The pre-treated water from the 
river Schie is fed to an NF unit, 
operating at 80% recovery, with 
experiments carried out in a single-
pass (once-through) mode. The 
GAC column is fed with the 
permeate of the NF unit. 
 
*Removal efficiency is greatest for 
negative charged solutes, then 
neutral and then positive.  Again, 
rejection appears to be less 
determined by steric hindrance: 
 
*Drawback of the NF/GAC: 
Disposal of the concentrate stream 
from NF. Thus, the zero liquid 
discharge (ZLD) concept, which 
aims to decrease the volume of 
concentrated 
 
*NF is affected by charge effects:  
-Negatively charged solutes are better removed than 
uncharged solutes, which are, in turn, better 
removed than positively charged solutes; due to 
charge attractions between neg. membrane and pos. 
charged solutes that allows solutes to dissolve and 
diffuse across membrane more easily. 
- Increasing feed concentrations of positively 
charged PhACs lead to increasing rejection values, 
due to membrane charge-shielding effects. 
 
*Often high rejection values for negatively charged 
PhACs, due to repulsive forces; the negative solutes 
cannot approach the  negatively charged membrane 
surface and are thus prevented from permeating 
through the membrane  
**Rejection of neutral solutes by high-pressure 
membranes is mostly due to steric hindrance 
effects between the solutes and the membrane’s 
polymeric matrix. 
 
**Solute hydrophobicity influences the 
rejection of organic solutes in NF.  
-Hydrophobic solutes can adsorb onto the 
membrane surface and partition into the membrane 
matrix, and thus exhibit lower rejection values than 
hydrophilic solutes of the same size  
 
*Negatively charged PhACs are independent of 
their hydrophobicity. Repulsions between solute 
and membrane inhibit negatively charged solutes 
from approaching the membrane surface, inhibiting 
potential hydrophobic interactions. 
 
*For the neutral and positively charged PhACs, 
there is a decrease in rejection with increasing 
solute hydrophobicity 
 
*Rejection >85% with the Trisep TS-80 membrane. 
**Rejection values were higher for the Trisep 
membrane than for the Desal membrane for all 
PhACs, except salbutamol.  
 
*Higher rejection values with the Trisep membrane 
are due to steric hindrance effects since the 
molecular weight cut off values of the Trisep 
membrane is lower 
 
*Rejection >75% for all PhACs with the Desal HL 
membrane; less than Trisep membrane 
 
*Removal efficiency of PhACs with the 
combination NF/GAC is extremely high.  
 
*Removal by adsorption on the GAC is high 
(>98%) for all PhACs, even with the short empty 
bed contact time used (3 min).; the largest part of 
the natural organic matter (NOM) is removed by 
NF ; this NOM normally competes with PhACs for 
adsorption sites on the carbon, so its removal 
increases the adsorption capacity of the GAC 
 
*Removal efficiency with GAC is slightly lower 
for smaller positively charged solutes; likely due to 
the higher GAC influent concentrations for these 















    
Removal efficiency is greatest for negative 
charged solutes, then neutral and then positive.  
Again, rejection appears to be less determined by 
steric hindrance: 
 
*Drawback of the NF/GAC: Disposal of the 
concentrate stream from NF. Thus, the zero liquid 
discharge (ZLD) concept, which aims to decrease 
the volume of concentrated discharged is an 
important point of study. Efficient removal of all 
scaling ions in NF pre-treatment would enable the 
NF system to operate at 99% recovery, leaving only 
1% of NF concentrate to be discharged.  However, 
at higher recoveries a decrease in rejection is seen; 
thus more research into removal of PhACs at high 
feed water recoveries is necessary. 
 
*Drawback of the NF/GAC: Disposal of the 
concentrate stream from NF. Thus, the zero liquid 
discharge (ZLD) concept, which aims to decrease 
the volume of concentrated, discharge is an 
important point of study. Efficient removal of all 
scaling ions in NF pre-treatment would enable the 
NF system to operate at 99% recovery, leaving only 
1% of NF concentrate to be discharged.  However, 
at higher recoveries a decrease in rejection is seen; 
thus more research into removal of PhACs at high 





































The growing body of research concerning water treatments for pharmaceuticals indicated a 
wide range of success both between pharmaceutical and treatment types.  What appeared 
absent from the literature was a passive treatment media or system that was highly available, 
affordable, easy to use, ecologically safe and capable of successfully treating a wide variety of 
pharmaceuticals, as well as, potentially other water contaminants. Thus the following study 
was conducted to explore the response of pharmaceuticals to novel passive treatment media. 
Batch experiments were conducted consisting of a media of interest in simulated 
groundwater spiked with: carbamazepine, caffeine, naproxen, gemfibrozil, ibuprofen, 
sulfamethoxazole and clofibrate, each at a resultant concentration of 2-2.5 µg l-1. Investigated 
media were selected based on their notable reactivity, affordability, availability, durability and 


























3.1 Materials and Media 
Simulated Ground Water: Simulated ground water was prepared by dissolving CaCO3 into 20 
l of milliQ water to make a final water composition of 0.104 g l-1 CaCO3. Carbon dioxide gas 
was added to promote dissolution of the calcium carbonate, followed by bubbling with air to 
adjust the final pH to approximately 8 for use in the aerobic experiments. For the anaerobic 
experiments, the simulated groundwater was purged for a minimum of 30 min with Ar or N2 
gas prior to its use in the experiments. The simulated ground water was transferred into the 
1000 ml reaction flasks.   
 
Spike Stock Solution: A stock solution containing carbamazepine, clofibrate, ibuprofen, 
naproxen, caffeine, sulfamethoxazole, and gemfibrozil was prepared to allow simultaneous 
addition of seven PhACs to each reaction flask.  Each PhAC was added to 50:50 methanol 
(MeOH):MilliQ water, resulting in a stock solution of 2.0 mg l-1 of each PhAC; resulting in an 
environmentally relevant concentration of 2.5 µg l-1  with the addition of 1 ml of the stock 
solution to each flask, with a minimal addition of methanol. Each PhAC was measured by 
mass prior to dissolution in the 50:50 MeOH:MilliQ water mixture.  Due to light sensitivity, 
sulfamethoxazole was added last to the stock solution to minimize potential photo-
degradation.  After this final addition the stock was sonified 35 min on the day of preparation, 
and then a further 30 min on the first day of the experiment to ensure complete dissolution of 






Working Stock Simulated Groundwater for Final Batch: A stock AG water was prepared and 
distributed to each sample bottle for the batch experiments. Sodium chloride was added to this 
solution to result in a final concentraiton of 50 mg l-1 to improve the response of the Eh and 
pH probes, and to mimic natural groundwaters more closely.  The water was spiked with the 
original spike stock solution containing 2 mg l-1 concentration of each pharmaceutical. An 
additional concentration of both sulphamethoxazole and caffeine were added to the working 
stock simulated groundwater, increasing their final concentrations to 4 mg l-1 .  
 
Pharmaceutically Active Compounds: The target compounds investigated in this study were 
selected based on their environmental relevance, being either or both persistent in nature or 
commonly occurring.  Investigated compounds included: sulfamethoxazole, carbamazepine, 
ibuprofen, gemfibrozil, naproxen, and caffeine.  Information regarding each PhAC can be 
found in Table 3.1.  
 
Reactive Media: Characterization, preparation methods as well as experimental proportions 



















Table 3.1: Characterization of Pharmaceuticals 
Feature: Cabemazepine: 
 
Gemfibrozil: Naproxen: Caffeine Ibuprofen: 
Molecular 
Weight 
236.3    
B (Trenholm et al,. 2006) 
250.3   B 230.3 B 194.2 B 206.3  




*Treatment of psychomotor 
and grand mal seizures, as well 
as trigeminal neuralgia 
*Anticonvulsant properties; 
appears to act by reducing 
polysynaptic responses and 
blocking the post-tetanic 
potentiation 

















1-3%    C (Vieno et al., 2007)  1-10% D (Lindqvist, 2005)  1-10%   D 
Solubility 
(mg l-1) 17.7 mg l
-1  B 19 mg l-1   B 15.9 mg l-1    B 21600 mg l-1 B 21 mg l-1   A 
pKa 236.3   B NA  B 4.15  B 10.4 B  4.52    A 






*Potential fetal harm when 
administered during pregnancy 
*Rapid transplacental passage 
(30-60 min); accumulates in 
fetal tissue, concentrating 
specifically in liver, kidney, 
brain and lung 
 
   


















  very high prescription 






Lithium:  May increase risk of 
neurotoxic effects 
Oral contraceptives: Decrease 
plasma concentration, thus less 
effective 
CYP 3A4 inhibitors (inhibit 
CBZ metabolism) : 
cimetidine, danazol, diltiazem, 
macrolides, erythromycin, 
troleandomycin, clarithromycin, 
fluoxetine, fluvoxamine,  azoles 
nefazodone, loratadine, 
terfenadine, isoniazid,  
niacinamide, nicotinamide, 
propoxyphene, acetazolamide, 
verapamil, grapefruit juice, 
protease inhibitors, valproate. 
*CYP 3A4 inducers (increase 
CBZ metabolism): Cisplatan, 




Other anticonvulsants:  












to alterations in 
prothrombin time  
 




Delay NPX absorption  
Other NSAIDs:  
Reduce protein binding 
Increase side effects; 
Delay absorption  
Cholestyramine:   
Delay absorption 
Diurectis: Reduce 
naturetic effect of 
furosemide/thiazides, 
by inhibiting renal 
prostaglandin synthesis 
Lithium: Elevation is 
plasma lithium levels 




MTX;  ↑toxicity 
Warfarin: GI bleeding 




1A (CYP1A2  ) is the 
major enzyme 
involved in the 
metabolism; thus ther 
eis potentiaol to 
interact with drugs 
that sutstrates for 
CYP1A2 , potentially 
inhibiting or inducing 
its function.  
 




Delay NPX absorption  
Other NSAIDs:  
Reduce protein binding 
Increase side effects; 
Delay absorption  
Cholestyramine:   
Delay absorption 
Diurectis: Reduce 
naturetic effect of 
furosemide/thiazides, 
by inhibiting renal 
prostaglandin synthesis 
Lithium: Elevation is 
plasma lithium levels 




MTX;  ↑toxicity 
Warfarin: GI bleeding 
due to synergistic 
effects 
 
*Unless stated otherwise pharmaceutical information provided by RxList Inc. 2006 





Table 3.2: Characteristics, preparation and experimental proportions for Reactive Media 










* Hand sifted with a No. 8 
sieve, to ensure consistent 
grain size, then measured and 
mixed in appropriate 
proportion with either sand 
or activated carbon 
ZVFe:Sand 
Silica Sand 10% N/A *Massed in appropriate proportion to ZVI 
 
*PRB – chlorinated solvents, Cr, U, 
Tc, (Blowes et al, 2000) 
*Se(VI) (Sasaki et al, 2008) 
*Chorinated solvents (Song et al, 2005, 
Gillham et al, 1994; Farrel et al, 2000) 
*Carbothioate Herbicide (Joo et al, 
2004) 
*Cr(VI) (Hoch et al, 2008; Lui et al, 
2008;  
*Cr(VI) and Pb(II) (Ponder et al, 
2000) 
*Carbon disulfide (Mcgeough et al, 
2007) 
*As(V) (Kanel et al, 2006) 
*Atrazine, nirtophenols, N-
nitrosodimethylamin, PCBs, alkyl-




BOF Slag 12.5 % N/A 
 
*Sifted with a No.8 hand 
sieve for smaller, more 
consistent grain size. 
   






*Sifted with a No.12 hand 
sieve for smaller consistent 
media size.   
 
*PRB – Acid mine drainage; sulfate 
reduction and metal sulfide 
precipitation; nitrate (Waybrant et al, 







12.5 % N/A 
*Washed with deionized 








*Rinsed with MilliQ water  to 
remove fine particles and 
oven dried 
 
*Drinking water treatment- removal of 
fine particulates, bacteria and 
odor/taste compromising compounds 






N/A 8.75% 6.25% 
*Hand sifted and massed 
autonomously into 100 ml 
serum bottle 




50:50 Granular Activated 
Carbon 
N/A 3.75% 6.25% 
* Rinsed with MilliQ and 
over dried 
* Massed autonomously into 
100 ml serum bottle  
 
*As described Previously  





3.2 Batch Test Procedures 
 
Preliminary Batch Experiments: The batch experiments consisting of simulated groundwater, 
reactive media and/or aquifer sand and the stock solution, were carried out in 1000 ml 
reaction flasks.  The reaction flasks were each equipped with two sampling ports and one 
access port.  Caps with Teflon septa were used to seal each sampling port, allowing access by 
syringe for sample collection, as well as, addition of argon gas when needed.  A ground glass 
stopper coated with vacuum grease sealed the access port of each vessel. Each flask was 
wrapped in aluminum foil to minimize light exposure.  
All media were added to approximately 100 g dry weight within the 1000 ml reaction 
flasks (Table 3.2).  Simulated ground water (800 g) was then added into each flask, followed 
by the addition of 1 ml of the PhAC stock solution.  The volumes of simulated groundwater 
and PhAC stock solution were measured both by volume and gravimetrically. Subsequent to 
the addition of the stock solution oxygen was displaced from the vessels with argon gas. The 
sampling and access ports were secured with the caps and glass stopper, wrapped in 
aluminum foil and gently swirled by hand to mix the media and aqueous solution..  
 
Final Batch Experiment: The final batch experiments consisting of the spiked stock simulated 
groundwater and the reactive media were carried out in a series of 100 ml amber serum 
bottles.  Eighteen serum bottles were prepared for each media investigated, as well as a 
control set containing simply the spiked stock simulated groundwater.  
All media were addedd in the appropriate proportions to a final dry weight of 
approximately 10 g into the amber serum bottles (Table 3.2).  Once prepared all bottles were 




oxygen into the test mixtures.  The transferred bottles were then allowed to equilibrate within 
the glove box for 24 hrs.   
After the equilibration period, 80 g of spiked stock simulated groundwater was auto-
dispensed into each bottle. The aliquots of stock simulated groundwater were measured both 
by volume and gravimetrically within the glove box. Following the final addition of the stock 
solution, each serum bottle was sealed using a lyophization stopper and then sealed with an 
aluminum crimp top (Figure 3.2).  
 
3.3 Sample Collection and Preparation:  
Preliminary Batch Sample Collection: Each reaction vessel was sampled via a syringe 
inserted through Teflon-septa of the sampling port cap.  Samples were taken at predetermined 
time intervals starting from the time at which the PhAC stock solution had been added to the 
reaction flask.  Aqueous samples were removed using a 20 ml glass syringe rinsed with 5% 
methanol and milliQ water prior to use. Anaerobic grade argon was injected via a syringe 
through the second sampling port during sample collection for the anaerobic samples to 
prevent introduction of air into the reaction vessels. 
 
Final Batch Sample Collection: Samples were selected at random from the series of bottles 
prepared for each media and collected at predetermined time intervals.  Upon sampling, the 
bottles were opened and aqueous samples were removed and measured via a glass syringe for 





Pharmaceutical Sample Collection and Preparation: Approximately 20 ml samples were 
taken for PhAC analysis using HPLC-tandem mass spectrometry.  Samples were filtered 
through Sartorius 0.45 μm nylon syringe filters and collected into 125 ml amber glass bottles 
to minimize light exposure. The samples were then acidified to pH<2 with HPLC grade 
sulfuric acid (H2SO4) in preparation for solid phase extraction (SPE). The acidified samples 
were tested using litmus paper to ensure a pH of less than 2.  Additional 50% sulfuric acid 
was added if needed.  
In preliminary batches samples were kept in the freezer at -18°C until time of extraction, in 
final batch experiments samples were extracted via SPE within 3 days of collection.  
  The Preliminary Batch Experiment samples were diluted by 40 ml of nanopure to 20 
ml of sample to obtain a consistent volume for the SPE step. Internal standards (IS) consisting 
of caffeine-D3, carbamazepine-D10, gemfibrozil-D6, sulphamethoxazole-D4, Mecoprop 
(MEC)-D3, ibuprofen-D3, and naproxen-C13 each at a concentration of 100 μg l-1 dissolved in 
50:50 methanol was added to each sample. Sample extraction was conducted manually using 
5 cm3 Oasis HLB (hydrophilic-lipophilic balance) solid phase extraction cartridges within a 
vacuum manifold.  The cartridges were conditioned with 3 ml of methanol followed by 3 ml 
of milliQ water.  Following conditioning, the cartridges were loaded with 60 ml of sample at a 
flow rate of approximately 10 ml min-1.  After loading, the HLB cartridges were rinsed with 3 
ml of 5% methanol and then finally extracted using 3 aliquots of 2 ml methanol, drawn 
through the columns into 7 ml amber glass bottles.  An aliquot of 1 ml was then taken for 
HPLC-MS/MS analysis (Figure 3.3). 
For the final batch samples, 0.2 ml of IS stock solution containing caffeine-D3, 




naproxen- C13 each at a concentration of 10 μg l-1 dissolved in 50:50 methanol was added to 
the 20 ml undiluted PhAC sample.  Samples were then manually extracted using 3 cm3 Oasis 
HLB cartridges, deviating only from the previously described method in the volumes of 
solution.  Two-milliliter aliquots of each solvent were employed for cartridge conditioning 
and elution of the final samples, and a total sample volume of 20 ml was loaded into each 
cartridge.  
3.4 Analytical Methods and Water Chemistry: 
Water Chemistry Analyses: Approximately 10 ml and 5 ml of sample were collected for 
cation and anion analysis, respectively.  Samples were filtered through Sartorius 0.45 μm 
nylon syringe filters and collected into polypropylene bottles.  The cation samples were 
preserved to pH <2 using trace-metal grade HNO3.  All cation and anion samples were kept at 
4° until time of analysis.  Samples were analysed for sodium, calcium, magnesium, 
potassium, iron and manganese using ICP-MS.  Samples were analyzed for nitrate, phosphate, 
sulfate, fluroide and chloride using ion chromatography.  
 Alkalinity was measured on 1 to 3 ml of filtered sample using bromocresol 
green/methyl red indicator titrated with a Hach digital titrator with 1.6 or 0.6 N H2SO4.      
 Approximately 5 ml unfiltered aqueous samples were withdrawn for determination of 
pH and Eh. Immediately following sample collection the unfiltered samples were injected into 
inverted syringes holding either a pH or Eh probe.   Data was collected for 20 to 30 min for 
each sample.  The Ross combination pH electrode (Orion 815600) was calibrated prior to 
sampling with standard fresh pH 4 and 7 buffers, and then checked against a pH 10 buffer.  
The electrodes were again checked at the end of the sampling period with the pH 4 and 7 




ZoBell’s (Nordstrom, 1977) and Light’s (Light, 1972) solutions prior to and following 
analysis.   
 
Pharmaceutical Analyses: PhAC analysis was conducted using high performance liquid 
chromatography coupled with tandem mass spectrometry (HPLC-MS/MS).  
 Analyte separation was performed with an Agilent 1100 liquid chromatograph with a 
RP18, 50X4.6mm3μm column for the ESI positive PhACs and a XBD-C18, 150X4.6mm5μm 
column for the ESI negative PhACs. For gradient elution two different mobile phases were 
utilized.  For the positive mode samples eluent A was a formulation of 5 mM Am Ac 0.1% 
formic acid in nanopure MilliQ water, and eluent B was a formulation of 100% methanol with 
0.1% formic acid.  For the negative mode, eluent A was composed of acetonitrile with water 
(30:70) and 6.9 mM acetic acid and eluent B was composed of 100% acetic acid. The mobile 
phase was pumped through the column at a flow rate of 1.25 and 1 ml min-1 for the positive 
and negative modes respectively.  A sample injection volume of 15 μl and 10 μl were injected 
in a loop, with repeat injections between one to six times for the positive and negative modes 
respectively.  The total elution time of the sample in positive mode was 4 min, while the time 
for a sample run in negative mode was 45 min.   
 An Applied Biosystems/MDS Sciex 4000 QTrap mass spectrometer with triple 
quadrapole capability was utilized to detect and quantify the PhACs in the samples.  The 
nebulizer gas at the ionization source, as well as the collision gas used to fragment the parent 
ion was N2.  Ionization was conducted in two modes, either by a positive electrospray 
ionization source (ESI+) or by a negative electrospray ionization source (ESI-) depending on 




sulfamethoxazole, and the drugs analyzed by negative mode were naproxen, clofibrate, 
gemfibrozil, and ibuprofen. 
A multiple reaction monitoring scan (MRM) was applied for the purposes of 
quantification. Concentrations were quantified by means of a signal ratio between the original 
concentrations of the PhAC in comparison to the known concentration of the internal 
standard.  This method of quantification allows for management of discrepancy caused by 
sample preparation and extraction.  Each PhAC also was quantified using an external standard 
calibration curve.  The calibration curves for the PhACs consisted of an eight point 
calibration, with nonlabelled working standards between 0.2 μg l-1 and 20 μg l-1; all 
containing the same concentration of surrogate internal standard as the investigated samples. 
 
3.5 Geochemical Modeling 
Aqueous geochemistry was interpreted with the assistance of the geochemical 
equilibrium/mass transfer code MINTEQA2.  Modifications to the MINTEQA2 database 
were made to ensure its consistency with WATEQ4F (Ball and Nordstrom, 1991).  Calculated 
saturation indices provided by the model were employed to determine the mineral phases 
potentially controlling the aqueous concentrations of each mineral component.  The indices 
designate mineral phases at equilibrium by a value of zero, while values greater than zero and 
less than zero signifiy supersatuartion and undersaturation, respectively.  MINTEQA2 










Figure 3.1 Procedural flow chart for preliminary batch experiments showing outline of 









Figure 3.2 Procedural flow charts for the final batch experiment, indicating the general 












3.6 Method Evaluation: 
 
Linearity (R), range, sensitivity (limits of detection and quantitation), specificity, accuracy 
(analyte recoveries), precision (%RSD) and method recoveries were employed to evaluate the 
overall SPE-HPLC-MS/MS method. 
Three sets of standards were made for calibration and statistical evaluation.  Two sets 
of calibration standanrds were prepared in MeOH/MilliQ water (50:50, v/v); one prepared just 
prior to analysis using the same stock solution (containing all seven target pharmaceuticals) 
and IS as the samples; and the second being a set of calibration standards.  The third set of 
standards, the quality control standards, also prepared just prior to analysis, was composed of 
MilliQ water spiked with the same stock solution and IS, as well as extracted by the same 
SPE procedure, as all experimental samples.  
Sulfamethoxazole and clofibric acid results were not included in the final analyses due 
to disproportionate noise in the analytical results.  Unable to confidently integrate the peaks 
for these pharmaceuticals it was decided to omit these analytes.  Thus, for the purposes of 
analytical consistency all media and control analyses included carbazmazepine, caffeine, 
gemfibrozil, naproxen and ibuprofen. 
 
3.6.1Linearity and Range 
Standard curves were prepared within the analytical range for all of the pharmaceutical 
compounds analyzed.  Linearity of the HPLC-MS/MS method was supported by R2 values 
>0.999 and residuals less than 1% for each calibration point in the analytical range of the 
linear regression equations derived (Appendix VII). Quantification of analyte concentration 




standard peak area, and the analyte concentration. The use of internal standards for 
quantification compensates for matrix effects and any loss of analyte through extraction and 
sample preparation.  
 
Table 3.3 Calibration and linearity parameters for linear regressions 
 
Calibration Standard Linear Regressions 
Curve %Residuals Analytical range (µg l-1 ) Calibrators (n) R2 
CBZ 0.50 0.1-20  8 0.9999 
CAFF 0.50 0.1-20  8 0.9998 
GEM 0.68 0.1-20  8 1.000 
NPX 0.18 0.1-20  8 0.9998 




3.6.2 Accuracy and Precision 
 
The accuracy and precision of the instrument and method was evaluated over the complete 
analytical range for all compounds analyzed (Table 3.4).  Accuracy was assessed based upon 
the measured analyte recovery of the quality control standards with respect to the known 
spiked concentration.   Analytical precision was assessed based upon the percent relative 
standard deviation between three (n = 3) replicate HPLC-MS/MS analysis of the same 
calibration standard samples.   Potential amplification and supression of analyte peak areas, 
and thus concentrations may be the result of matrix effects introduced by the media and 
simulated groundwater composition, or by competition or common ion effects within the 











Table 3.4 Method accuracy and precision..  Accuracty was measured as the percent analyte 
concentration recovery of the quality control standards with respect to the known spiked 
concentration, at each concentration in the calibration range. Precision was calculated based upon the  
percent relative standard deviation (%RSD) between three (n = 3) replicate calibration standards run in 
the same sample set. 
 







μg  l-1 
1 










%Recovery  121.5 108.2 100.2 104.5 101.5 104.0 111.5 103.8
CBZ 
Precision  
%RSD (n=3) 0.039 0.026 0.029 0.014 0.014 0.004 0.010 0.004
Accuracy 
%Recovery  94.0 108.0 117.0 104.0 111.0 106.0 114.0 112.0
Caffeine 
Precision  
%RSD (n=3) 0.117 0.022 0.009 0.027 0.016 0.035 0.017 0.046
Accuracy 
%Recovery  102.0 99.0 99.8 103.0 101.0 100.0 99.8 99.5
Ibuprofen 
Precision  
%RSD (n=3) 0.014 0.036 0.017 0.000 .007 0.011 0.019 n/a
Accuracy 
%Recovery  100.0 99.5 98.4 125.0 116.0 126.4 130.0 100.4
Naproxen 
Precision  
%RSD (n=3) .0070 0.0107 0.0372 0.0205 0.0148 0.0107 0.0070 n/a
Accuracy 
%Recovery  122 104.5 108.2 118 121.5 103 121 115
Gemfibrozil 
Precision  
%RSD (n=3) 0 0.007 0.006 0.014 0.007 0.004 0.006 n/a
 
 
3.6.3 Sensitivity: Limits of quantification and Limits of detection 
 
Limits of detection (LOD) were defined as the lowest observable concentration giving a 
signal to noise ration of 3:1; while, limits of quantification (LOQ) were defined as the lowest 
observable concentration denoting a signal to noise ratio of 10:1.  The method detection and 
quantification limits for the samples analyzed fell within the ranges of 3-189 ng l-1 and 19.8-
763 ng l-1 (Table 3.5) respectively.  
 
3.6.4 Specificity:  
Method specificity was assessed by the analysis of blank samples. Blank samples without 
analytes, blank samples without analytes or IS and control samples with known analyte 




investigated analytes or internal standard were present upon analysis of blank samples.  
Control samples of known concentration dispersed between experimental samples indicated 
accurate measurements with respect to the analyte concentrations.   
 
3.6.5 Matrix Effects:  
Matrix effects due to the media or simulated groundwater composition can potentially affect 
the signal intensity (peak area) of measured parameters. While the use of an internal standard 
solution compensates for potential matrix effects during analyte quantification, matrix effects 
are apparent when calculating the absolute recovery of IS within the experimental samples.  
Evaluation of matrix effects was conducted based upon the extent of signal suppression (%) 
for the sample IS as compared to the average signal intensity of the IS in the spiked MilliQ 
water standards. Signal suppression was calculated using equation (1):  
  
Signal suppression (%) = [1-Is/Ix]*100 (1) 
 
Where Is is the signal intensity of the sample IS and Ix is the average signal intensity of the 
spiked MilliQ water IS. Signal suppression was investigated for all reactive media studied; the 
intensity reduction of the IS was usually in the range of 10-35% in the experimental samples 
with the exception of wood chips indicating a suppression of 84%.   
 
3.6.6 Method Recoveries:  
 
i) Absolute method IS recovery: Recoveries were determined by comparing the IS peak area 




experimental procedure. Recoveries were calculated for concentrations from 0.05 to 20 μg l-1 
and an average of these recoveries was taken for each analyte. The absolute method 
recoveries indicates losses due solely to experimental method and sample preparation and 
does not include signal suppression due to matrix effects caused by investigated media 
simulated groundwater composition.  
  
ii) Relative Method Recovery: Compares the concentration specific ratio of the analyte peak 
area to IS peak area (ie. analyte peak area/IS peak area) of the calibration standards with the 
coordinating ratio of the quality control samples.  This recovery indicates procedural losses 
and amplification due to sample analysis including all steps of the method (i.e., SPE and 
HPLC) which are not compensated or adjusted for by the surrogate IS concentrations. 
 
iii) Absolute Analyte Recovery: Recoveries were determined by comparing the analyte peak 
area of the calibration standards to that of the quality control standards, which experienced the 
entire experimental procedure. Recoveries were calculated for concentrations from 0.05-20 μg 
l-1 and an average of these recoveries was taken for each analyte. The absolute method 
recoveries indicate losses solely due to experimental method and sample preparation and does 
not include signal suppression due to matrix effects caused by media or simulated 
groundwater composition. Unlike the relative method recovery, the absolute analyte recovery 
encompasses all losses and amplifications due to method and sample preparation, having no 










Table 3.5 Method recoveries and sensitivity: Analytical limits and average recoveries for surrogate 
internal standard and analyte peak area in calibration and quality control standards 
 
Method Recoveries Analytical Limits 










Caffeine 101±10.3 120±3 121±8 0 19.8 
Carbamazepine 89±6 106±2 104±12 3 37 
Naproxen 86±5 113±10 109±2 139 763 
Gemfibrozil 90±1 116±7 110±6 15 65 





3.6.7 Sample Recoveries 
iv) Absolute Sample IS Recovery: Recoveries were determined by comparing the IS peak 
area of the calibration standards to the IS peak area of the samples. Recoveries were 
calculated for every sample collected and a unique average of these recoveries was taken for 
each specific media. The absolute sample recoveries indicate losses due to experimental 
method, sample preparation as well as signal suppression and amplification due to matrix 
effects caused by the investigated media or simulated groundwater water composition.  
Sample recoveries were in an expected range of 78±7 to 126± 7% with the exception of 











Table 3.6 Sample Recoveries. Average recovery of surrogate internal standard (IS) peak area 
for samples with respect to the media type of sample.  Surrogate IS is added to all samples 
subsequent to sampling and prior to extraction, thus IS is not exposed to media but to sample 
preparation and extraction procedures.  






















Caffeine 111.±12 115±12 94±13 93±10 102±9 111±14 104±9 120±21 97±7 93±7 89±12 
Carbamazepine 79±6 80±5 73±6 64±5 17±2 63±7 83±7 72±6 83±8 81±9 76±21 
Naproxen 103±11 101±7 93±22 94±20 78±7 95±22 100±10 99±7 84±9 85±12 78±12 
Gemfibrozil 106±10 104±8 96±22 95±14 86±4 97±20 93±4 91±6 81±8 79±15 89±16 






































4 RESULTS AND DISCUSSION: PHARMACEUTICAL RESPONSE TO REACTIVE 
MEDIA 
 
4.1 Overview and Analysis 
Experiments were conducted with batch samples containing a media of interest in simulated 
groundwater spiked with carbamazepine, caffeine, naproxen, gemfibrozil, ibuprofen, 
sulfamethoxazole and clofibrate, each at a resultant concentration of 2-2.5 µg/L, to examine 
the potential sorptive or degradative capacity of the media with respect to these 
pharmaceuticals. Samples were collected at predetermined time intervals over the course of 
10 or 15 days to observe the influence of different contact times on the removal process.   
 Media investigated included: Borden sand (BDS), Stelco-BOF slag (BOF), wood 
chips (WC), zero valent iron (ZVFe) and granular activated carbon (GAC).  These media 
were selected based on their reactivity, affordability, availability, durability and ease of use. 
The media were also chosen based upon their application for the treatment of other 
contaminants.  Borden sand, while not typically considered a reactive media, was investigated 
as a control, employed to reveal possible sorption or interactions of the pharmaceuticals with 
natural aquifer materials. Activated carbon, while already extensively investigated as a 
treatment media for removal of pharmaceuticals, was investigated in this study to explore the 
benefit of this media when applied as a mixture.  
 Two sets of batch experiments were conducted.  A preliminary batch, conducted 
solely on the bench top in 1000 ml reaction flasks; and a final batch, consisting of a series of 
100 ml serum bottles, constructed and sealed within an anaerobic glove box, remaining sealed 
until the time of sampling.  While the initial preliminary batch experiments had the benefit of 
consistency in media, in that the same media was in contact with the same water for every 




thus affecting all subsequent samplings, it did not provide a sufficiently anaerobic 
environment, and finally small difference in concentrations of pharmaceuticals occurred due 
to unique spiking of each reaction flask.  The final batch experiments attempted to remedy the 
shortfalls of the preliminary batches; each vessel was sampled only once thus eliminating 
potential contamination; samples were prepared and sealed within a glove box, which 
provided as evident by measured Eh readings, a reducing environment; and preparation of a 
working stock solution of spiked simulated ground water ensured that every sample vessel 
had the identical concentrations of pharmaceuticals.   
To ensure that the resultant changes in concentrations of pharmaceuticals with time in 
the final batch experiments were consistent, reproducible and not due to undefined variables, 
triplicate samples were prepared at every other sampling time for all media and controls.  The 
standard deviation was then calculated between these replicate samples to verify that the 
noted change or stability in pharmaceutical concentration was consistent between replicate 
samples taken at the same time interval. Calculated deviations are depicted as error bars on 
the concentration versus time profiles in Figures 4.1 and 4.2, each bar representing the 
standard deviation from the mean, represented by the data point.  Standard deviations were 
extremely small, in most cases so small that the majority of sampling times the error bars 
were not discernable.  The small observed standard deviations are indicative of the high 
reproducibility of results throughout the experiment; thus verifying that the investigated 
media was triggering the same response or outcome on pharmaceutical concentrations among 
samples. 
 The change in concentrations of pharmaceuticals over time was plotted for all media 




measured concentration of the sample at the time of sampling, and C0 being the initial 
concentration of the spiked reaction solution (as calculated using concentration and volumes 
of spike and reaction solution (see Appendix VIII).   Concentrations were calculated by 
internal and external calibration of HPLC-MS/MS results.   
Analogous information regarding all media investigated in the final batch experiments 
is depicted in Figure 4.2.  Concentrations are again plotted as C/C0 versus time; however in 
these experiments C0 was established as the average concentration of the pharmaceutical in 
the control samples.  This definition of C0 was justified in the final batches while not in the 
initial batch experiments since the simulated ground water was spiked prior to distribution to 
each sample; and thus every sample, including the controls started with the identical initial 
concentration.  Matching the analytical procedure for the preliminary batch experiment, 
concentrations were calculated by internal and external calibration of HPLC-MS/MS results.  
The analytical method accurately quantified the investigated pharmaceuticals, as indicated by 
the absolute method recoveries of 86-101%, the analyte recovery of the quality control 
standards, 95-121%, as well as the low %RSD of 0-0.117% (n=8), and % residuals of the 
calibration standards of less than 1% (-0.300-0.4268%)  (Appendix VII). Observed removals 
of parent pharmaceuticals were not the consequence of compounded recovery effects due to 
matrix and analytical influences since consistent recoveries of surrogate internal standard 
occurred within media specific samples (Table 3.6 in method validation); and percent 
removals were considered with respect to deviation from the apparent concentrations in 







Figure. 4.1 Pharmaceutical concentration versus time plotted for all media in the initial batch 
experiments.  Concentrations are expressed as C/Co; C being the measured concentration of the sample 
at the time of sampling, andCo being the initial concentration of the spiked reaction solution. Co was 
calculated using concentration and volumes of the stock spike solution and the reaction solution as 
shown in Appendix VIII.  Concentrations were calculated by internal and external calibration of 
HPLC-MS/MS results that were then corrected for earlier dilution and then subsequent concentration 
by SPE.  Two controls are depicted in the figure, representative of the two preliminary batch 
experiments conducted.  Control one denotes the control for the first preliminary batch including the 
ZVFe: sand reaction vessel; while control two denotes the second preliminary batch experiment 
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Figure. 4.2 Concentrations of pharmaceuticals versus time plotted for all media in the final 
batch experiments.  Concentrations are plotted as C/Co; C being the measured concentration of the 
sample at the time of sampling, and Co being the initial concentration of the spiked reaction 
solution. Co was calculated using concentration and volumes of the stock spike solution and the 
reaction solution as shown in Appendix VIII.  Concentrations were calculated by internal and 
external calibration of HPLC-MS/MS results which were then corrected for earlier dilution and 




Percent removals of each pharmaceutical with respect to concentration for each of the 
media investigated are illustrated in Figure 4.3.  Percent removal was calculated using 
equation (1).  
 
% Removal = (1- Cf/Co)*100       (1)  
 
Where Cf is the final pharmaceutical concentration in the treated effluent and Co  is the initial 
pharmaceutical concentration defined or calculated as described previously.  Calculations for 
preliminary batches, where Co is defined as the spiked pharmaceutical concentration, were 
further defined by equation 2:  
 
Rm = Rcc – Rcm        (2) 
 
where Rm = total percent removal by media, and Rcm and Rcc are the calculated percent 
removals of the media and the controls respectively, as calculated by equation one. Percent 
removals by media ranged from as little as 0.0% for Stelco-BOF-slag, Borden sand and wood 
chips to as great as 100.0% in samples containing granular activated carbon.  In general, the 
controls exhibited little to no reduction in pharmaceutical concentration; with the exception of 
caffeine, which saw almost 50% reduction within the control vessels.  The greatest percent 
removal was seen in the samples with GAC, either alone or in a mixture with ZVFe; 
concentrations decreased to below the LOD for all investigated pharmaceuticals before the 
first sampling.  The smallest percentage removals when considering all media were exhibited 








Figure 4.3 Percent removal of pharmaceuticals (CBZ, CAFF, IBU, GEM, NPX) by the 
investigated media.  Percent removals were calculated using the equation %Removal = (1-
C/Co)*100, where C= final Pharmaceutical concentration in solution and Co = the initial 
concentration in solution.  Co was determined based upon spiked concentrations for preliminary 
batches and upon the average concentrations in the controls for the final batch experiments.  
Percent removal for preliminary batch samples were calculated as the resultant removal 
surpassing removal experienced by control samples; thus final percent removals were calculated 
as %Removal (preliminary batches) = Rm – Rc; where Rm is the percent removal in the treated 
sample and Rc was for the control. 
 
 














































% CBZ Removed 
% Caff Removed 
% IBU Removed 
% GEM Removed 




4.2 Controls:   
For each set of batch experiments conducted, a set of controls was also established. Controls 
consisted of simulated groundwater (from the same stock used for all samples), spiked with 
the same pharmaceutical stock (containing all seven compounds) in the same concentrations 
as the media samples.  Control reaction vessels were prepared in a matching manner as the 
media reaction vessels, except for the absence of reactive media; and samples were collected 
and prepared for analysis correspondingly.  
 The initial control vessels contained approximately 2 ± 0.5 μgl-1 of each 
pharmaceutical, and the solutions were initially near neutral in pH (pH 6.7-8.6).  Eh 
measurements indicated oxidizing conditions and were in the range of 300-400 mV in the 
preliminary batch experiments, and in a slightly lower range of 230-400 mV in the final batch 
experiments, likely due to the anaerobic preparation of the samples.   Concentration versus 
time profiles for all control experiments are shown in Figures 4.1 and 4.2 for the preliminary 
and final batch experiments, respectively.  The CaCO3 and NaCl composition of the simulated 
groundwater, as well as the trace amount of methanol introduced to each reaction flask via the 
pharmaceutical stock solution did not affect the concentrations of pharmaceuticals, as 
indicated by the narrow 95% confidence intervals (ranging from 0.017 to 0.29) (Appendix 
XIII).  Little change was noted in the chemical composition of the water, including 
concentrations of cations, anions, pH (ranging from 6.7-9.5) and Eh (ranging from 230-400 
mV) in the control flasks over the course of the experiments; indicating stability in the bulk 






4.3 Reactive Media 
Reactive Media -BOF Slag:  
Stelco basic oxygen furnace (BOF) slag, an iron oxide byproduct of steel manufacturing 
demonstrated modest potential for use in pharmaceutical treatment.  BOF slag is a coarse 
grained, homogenous product comprising high concentrations of Ca (portlandite, calcium 
oxides/silicates), Fe (FeO, ferrites, and silicates), Mg, Si, and Al in the form of oxides and 
silicates (Baker et al, 1998).  In this study, BOF slag was investigated solely in the 
preliminary batch studies, where a series of sample volumes were drawn over the course of 15 
days from a 1000 ml reaction flask containing BOF slag and simulated groundwater spiked 
with the aforementioned pharmaceuticals.    
Initial spiked simulated groundwater solutions contained approximately 2-2.5 µg l-1 
concentrations of each investigated pharmaceutical, and measured initial pH values of 
approximately pH 8.  Pharmaceutical removal, potentially through degradation or sorption 
mechanisms, resulted in percent removals from 0.0% for naproxen and ibuprofen up to 71% 
for caffeine (Figure 4.3).  Profiles showing concentrations versus time are depicted in Figure 
4.2.   
The BOF-slag minimally influenced the solution concentrations of naproxen, 
ibuprofen, gemfibrozil and carbamazepine, showing percent removals of 0.0%, 0.0%, 27% 
and 3% respectively.  Paired t-test calculations comparing control concentration profiles to the 
concentration profiles of the treated samples indicated little to no difference (Appendix XII).  
Reaction with BOF slag did however result in more substantial decreases in the 




calculations comparing the control caffeine concentration profile to the concentration profile 
of the treated samples indicated a more significant difference (Appendix XII).   
Concentration changes or stability within the BOF reaction vessels were accompanied 
by an increase in pH to pH >12 and Eh values in the range of 100 to 150 (Figure 4.2).  The 
increase in pH is attributed to the dissolution of portlandite [Ca (OH)2] – the major soluble 
mineral phase in BOF slag (Baker et al, 1998).  The dissolution reaction of portlandite 
(reaction 3) causes a substantial increase in pH and dissolved Ca2+ in solution:   
 
Ca(OH)2 ↔ Ca2+ + 2OH-      (3) 
 
Geochemical analyses of water samples indicated a corresponding increase in 
concentrations of Ca2+ consistent with this reaction.  Increases were also observed in 
concentrations of other cations such as K+, Na+ and Fe (Figure 4.5).  . Anion analysis 
indicated increasing concentrations of all measured anions with time, including nitrate, 
fluoride, chloride and sulfate, with the exception of phosphate, of which none was detected 
(Figure 4.4).  The stability of nitrate and sulfate are consistent with the oxidizing conditions 
created by the BOF slag media. 
 Back extractions of the treatment media were conducted to delineate the possible 
distribution of the pharmaceutical between the solution and the solid phases. Knowledge of 
this distribution provides insight into the potential mechanism responsible for pharmaceutical 
removal as a result of the media; for example, sorption or degradation (Appendix XI).    The 
percent mass recovery from the BOF-slag for all of the evaluated pharmaceuticals was very 




nearly complete mass recovery of carbamazepine, ibuprofen and naproxen indicates that the 
small removals noted for these pharmaceuticals is likely due to the roughly 5% sorbed to the 
reactive media, and not to degradation processes.  For caffeine and gemfibrozil, the total 
masses were not accounted for by the recovery of sorbed and dissolved masses, with 94% and 
37% of mass unaccounted for each of these compounds respectively.  While these percentages 
may not reflect the actual percent of the drugs transformed, since back extractions may not 
have desorbed all of the compounds, they do indicate that sorption may not be the sole 
removal mechanism—that potentially another mechanism, such as oxidation reactions may be 
contributing to their removal. Previous studies have indicated high success using oxidative 
treatments such as ozone and chlorine dioxide with caffeine and gemfibrozil, indicating 
percent removals in the range of 91-93% and 88-98% for ozone and >60% and >90% for 
chlorine dioxide respectively (Gomez et al., 2008; Westerhoff et al., 2006); thus oxidation of 
these pharmaceuticals by BOF-slag is feasible.  However, these same oxidative treatments 
showed similarly high success for the pharmaceuticals that in this study demonstrated only 
slight removal due to BOF-slag, likely due to sorption not oxidation. The reactivity of BOF as 
an oxidative treatment may be limited by the phase of the media itself; being limited to 
surface reactions as a solid media, unlike gaseous or liquid treatment media. Similarly, neither 
the elevated pH conditions nor the high content of oxide minerals appear to promote extensive 
removal of the pharmaceuticals investigated.   
 
Reactive Media – Wood Chips:  
Organic carbon rich reactive mixtures containing such media as wood chips have been 




containerized wastewater treatment systems (e.g. Roberston et al., 2000) and permeable 
reactive barriers (PRBs) to enhance bacterial sulfate reduction and metal sulfide precipitation 
(e.g. Benner et al., 1999).  Bench-top batch experiments were conducted to evaluate the 
effectiveness of wood chips in the removal of the suite of pharmaceuticals when present in 
simulated groundwater.  Experiments including wood chips were conducted exclusively in the 
preliminary batch studies.  
Pharmaceutical removal, potentially through degradation or sorption mechanisms, 
resulted in percent removals from 0.0 % for ibuprofen up to 82% for caffeine (Figure 4.3).  
The rate at which this removal occurred is illustrated by concentrations versus time profiles  
(Figure 4.1).   
Wood chips resulted in minimal change in solution concentrations of ibuprofen and 
naproxen and only a moderate change in concentrations of caffeine, carbamazepine and 
gemfibrozil, showing percent removals of 0.0%, 7.5% 71%, 60% and 61% respectively.  
Paired t-test calculations comparing controls to the concentration profiles of the treated 
samples indicated little statistical difference for naproxen (Appendix XII) at the 5% level.  
Paired t-test values for caffeine, gemfibrozil and ibuprofen did indicate significant statistical 
difference at the 5% level; however, probabilities were still greater than 1% for gemfibrozil 
and caffeine, thus at the 1% significance level the samples were not statistically different.  
The reduction in carbamazepine however had a p-value close to zero, indicating significant 
statistical difference at even the 0.1% significance level (Appendix XII).  
The moderate reduction of pharmaceutical concentrations within the wood chip 
reaction vessel was accompanied by a decrease in pH from 7.5 to 6.17 possibly due to organic 




acetate.  The Eh of the reaction vessel did not vary greatly over the course of the study, falling 
from approximately 350 mV to 280 mV and then returning back to approximately the starting 
value by the end of the 15 days (Figure 4.1). Due to the reducing nature of organic matter a 
greater decrease in Eh was expected, thus suggesting possible ingress of oxygen into the 
reaction vessel, despite purging with argon gas. Geochemical analysis of anions did however 
indicate elevated concentrations of phosphate, up to 8.5 mg l-1 (as PO4), indicating that 
degradation of organic matter was potentially leading to the release of phosphate (Waybrant et 
al., 2002).  Increases in concentrations of Mn and Fe were also observed potentially due to 
release through degradation of organic matter (Figure 4.4). Concentrations of Ca and 
alkalinity (Figure 4.5 and 4.7) were observed to increase over the course of the experiment, 
consistent with dissolution of carbonate minerals. 
 Back extractions of wood chips were conducted to help elucidate the possible 
distribution of pharmaceuticals between solution and solid phases.  The percent mass recovery 
of pharmaceuticals from the wood chips ranged from as low as 1.5% for carbamazepine to as 
high as 16% for ibuprofen (Figure 4.8).  The complete mass recovery of ibuprofen indicates 
that the approximately 16% of mass back extracted from the wood chips accounted for all 
ibuprofen removal.  Ibuprofen, found in previous studies to degrade primarily by 
biodegradation is generally thought to have low sorption potential due to its low log Kow value 
(Smook et al., 2008; Ternes et al., 2004). Wood chips do appear to adsorb a small percentage 
of ibuprofen, however, the total ibuprofen removal in the vessel containing woodchips was 
actually no more than the observed decrease in the control vessel; thus, wood chips do not 
appear to be a promising treatment media for ibuprofen.  The total masses of carbamazepine, 




dissolved masses. The back extractions recovered approximately 10% of the mass of each 
pharmaceutical, with the exception of carbamazepine, indicating that sorption to wood chips 
is occurring and contributing to pharmaceutical removal.  For carbamazepine, back 
extractions recovered as little as 1.5% of the pharmaceutical from the woodchips (Appendix 
XI). 
 A large measure of uncertainty was encountered in the woodchip sample analysis.  
Sample recoveries of internal standard were extremely low, as low as 17% for D10-
carbamazepine and MINTEQA2 calculated high charge balance errors, up to 98.75%.  This 
uncertainty may be due to interference resulting from the high total organic carbon (TOC) 
contributed by the woodchips to the water; this natural organic matter can potentially complex 
with the analyzed constituents thus interferring with the determination of their substantiality 
in the system.  Future analysis regarding woodchips and other media rich in organic matter 
would benefit from the use of standard additions to help counteract descrepancies caused by 
organic matter interferences. 
 
Reactive Media – Borden Sand:  
Camp Borden, a Canadian forces base northwest of Toronto, is extensively used for 
groundwater research.  Following numerous investigations at this site the aquifer and 
sediments in this area are well characterized. Due to the extensive interest and 
characterization of media from this research location, Borden sand was chosen to investigate 
the potential sorption of each of the investigated pharmaceuticals to common aquifer media, 
in this case, sand. In the preliminary bench top batch experiments Borden sand was 




the suite of pharmaceuticals when present in simulated groundwater.  Borden sand was 
investigated solely in the preliminary batch studies.    
The reaction vessel initially contained simulated groundwater with 2-2.5µg/L 
concentration of each investigated pharmaceutical, and pH values of approximately pH 8.  
Pharmaceutical removal, likely due to sorption, resulted in percent removal from 20% for 
carbamazepine up to 66% for caffeine (Figure 4.3).  Figure 4.1 displays concentration versus 
time profiles for this media.   
A moderate influence on the solution concentration of carbamazepine, gemfibrozil, 
naproxen and ibuprofen was noted, showing percent removals of 20%, 51%, 64% and 53% 
respectively (Figure 4.3). Due to the characteristically low organic carbon content of Borden 
sand (organic carbon fraction, foc = 0.021%) and the hydrophobicity of the pharmaceuticals 
this removal was greater than anticipated.  Thus solid-water distribution coefficients (Kd) 
were calculated for the pharmaceuticals from predicted organic-carbon distribution coefficient 
(Koc) values using equation 4 (Schwarzenbach et al., 2003), to delineate the theoretical 
sorptive behaviour of the pharmaceuticals.  Koc values for each pharmaceutical were 
determined as described by Carballa et al. (2008) using the pH dependent octanol-water 
distribution coefficient (Dow), which accounts for the pH of the system, as well as the pKa of 
the pharmaceutical (equation 5).   
Kd = Kow * foc       (4) 
LogKoc = 0.74 * logDow + 0.15   (5) 
LogDow = logKow     (6) 





The Dow is calculated based upon the type of pharmaceutical.  For neutral compounds 
such as carbamazepine or caffeine, Dow is calcuated using equation 6 (Carballa et al., 2008); 
while determination of Dow for acidic compounds, such as ibuprofen, is calculated using 
equation 7 (Carballa et al., 2008).  Calculated Kd values for the pharmaceuticals indicated that 
at simulated groundwater conditions gemfibrozil should show the greatest sorption, followed 
in order by carbamazepine, ibuprofen, caffeine and finally naproxen.  This trend was not 
observed for the experimental results, since despite its hydrophilic nature, caffeine showed the 
greatest removal and carbamazepine removal was lower than the less hydrophobic 
compounds.   
The removal of the pharmaceuticals relative to each other was not the only unexpected 
result with respect to Borden sand.  As previously mentioned the amount of removal was 
greater than anticipated given the low foc.  A recent investigation by Ran et al. (2003) noted 
that prior studies (Curtis et al., 1986a,b; Roberts et al., 1986; Goltz and Roberts, 1987; Ball 
and Roberts, 1991a,b; Ptacek and Gillham, 1992) all indicated that organic compound uptake 
by Borden sand was slow, and that measured Kd values tended to be greater than those 
calculated based upon Kow and foc values. The Ran et al. study proposed that kerogen, a 
condensed type of natural organic matter (NOM), was present in the Borden aquifer material; 
and that it was this NOM that played the leading role in the uptake of organic chemicals. The 
Koc values for Borden sand were higher than those determined by a Koc-Kow correlation, due 
to the kerogen having a condensed rigid physical nature and reduced chemical composition 
capable of trapping organic chemicals. Larger organic chemicals have less accessibility to the 
kerogen and are thus less likely to be trapped within the parallel aromatic sheets of the NOM.  




removal within this study; and further explain why caffeine, having the smallest molecular 
weight, indicated the greatest removal, while less removal was seen by the other 
pharmaceuticals, all having larger molecular weights. 
 
 
Table 4.1 Solid-water distribution coefficients (Kd) were calculated for each pharmaceutical 
in Borden sand using the relationship between Kd and Koc and foc as described by equation 4. 
Koc values were calculated as described by equations 5, 6 and 7.  Calculations were based 
upon a pH value of pH 8.  Gemfibrozil was assumed to be neutral at these pH conditions since 
no pKa value could be found for this pharmaceutical in the literature.  
 
Pharmaceutical pKa pH logKow logDow logKoc Koc foc 
(%) 
Kd 
Carbamazepine 14 8 2.45 2.45 1.96 91.83 0.021 0.02
Caffeine 10.4 8 -0.07 -0.07 0.098 1.25 0.021 0.00026
Naproxen 4.15 8 3.18 -0.6 -0.29 0.51 0.021 0.00011
Gemfibrozil n/a 8 4.77 4.77 3.68 4784.10 0.021 1.00
Ibuprofen 4.52 8 3.97 0.52 0.53 3.43 0.021 0.00072
 
While the final percent removals with respect to concentration were higher than 
expected, paired t-test calculations, comparing controls to concentration profiles of treated 
samples, did in fact indicate no statistical difference in the pharmaceutical concentrations at 
the 5% level for the majority of the pharmaceuticals (Appendix XII).  Caffeine was the only 
pharmaceutical to show a significant decrease in solution concentration, resulting, as 
previously noted, in a 66 % removal.  Paired t-test calculations comparing controls to the 
concentration profiles of caffeine in treated samples indicated significant statistical difference 
at the 5% level (Appendix XII). Over the course of the experiment, there was little change in 
the bulk chemical composition of the water. The pH in the reaction vessel was for the most 
part stable, ranging from 7.9 to 9.0, similar to control vessels (Figure 4.1). The pH stability is 
likely the result of pH buffering due to the high carbonate content of the Borden sand and 




investigation also mirrored control samples, ranging from 330 mV to 430 mV (Figure 4.1). 
Similarly results of anion and cation geochemical analysis deviated little from those of the 
controls, with the exception of an initial increase and subsequent decrease in Fe concentration, 
possibly due to the dissolution of iron mineral components (Figure 4.4 and Figure 4.5). 
 Back extractions of Borden sand conducted to interpret the possible apportioning of 
pharmaceuticals between solution and solid phases recovered approximately 1-3% of the mass 
of each pharmaceutical investigated. The greatest mass recovered was for caffeine which 
showed the greatest overal removal.  While caffeine recovery from the sand was less than 
expected, at only 3% of the total mass, adsorption is still considered the probable removal 
mechanism.  This is the most conceivable removal mechanism when one considers the 
scarcity of strong oxidants or reductants in Borden sand. The small amount of mass recovered 
from the sand for the other pharmaceuticals was expected due to the insignificant changes in 
pharmaceutical concentration between control and treated samples. This is supported by a 
study conducted by Ternes el al. (2002) that found no significant removal in pharmaceuticals 
in batch experiments with sand under natural aerobic and anaerobic conditions; as well as, 
Carrara et al. (2008) who found minimal pharmaceutical removal specifically in Borden sand.  
 
Reactive Media – Zero Valent Iron (ZVFe):  
 Zero valent iron (ZVFe) has been investigated extensively and is used for the treatment of a 
wide range of water contaminants. Laboratory and field applications of ZVFe, including 
permeable reactive barriers (PRBs) containing ZVFe, have been used to treat chlorinated 
solvents, Cr(VI), U, Tc, Se, Pb(II), carbon disulfide, As(V), carbothioate herbicides, atrazine, 




agent relative to many redox-labile compounds, such as hydrogen ions, carbonates, sulfates, 
nitrates, oxygen and alkyl halides, due to the standard reduction potential of -0.440 V for its 
reduction reaction with dissolved aqueous Fe2+ (eq. 6, Matheson et al., 1994).  Zero valent 
iron reduces a large number of contaminants through a reaction known as a dissolving metal 
reduction; a reaction equivalent to iron corrosion, where the contaminant is acting as the 
oxidizing agent (Matheson et al, 1994).  An example of this reaction is shown in equation 7 
for the treatment of an alkyl halide. In an anaerobic environment water alone can act as the 
oxidant; and the corrosion of iron results in oxidative dissolution of the metal and production 
of ferrous iron (Fe2+) and H2 (eq 8); thus three possible reductants are present: Fe0, Fe2+ and 
H2 (Matheson et al., 1994). 
 
  Fe2+ + 2e- ↔ Fe0        (6) 
 
  Fe0 + R-X + H+ ↔ Fe2+ + R-H + X-        (7)     
   
  Fe0   + 2H2O ↔ Fe2+ + H2 + 2OH-      (8) 
 
The reductive potential, availability, affordability and ease of use of ZVFe as a treatment 
media, has made it a popular choice for the remediation of a number of contaminants.  To our 
knowledge the use of ZVFe in the treatment of pharmaceuticals has not been explored.  Thus, 
bench top batch experiments were conducted to evaluate the influence of ZVFe on the 
behaviour of the suite of experimental pharmaceutical compounds when present in simulated 




series of samples was drawn over the course of 10 days from the same 1000 ml reaction flask, 
and the final batch studies, where a series of 100 ml serum bottles were assembled and sealed 
inside a glove box, drawn on only at the time of sampling, then wasted.    
Initial spiked simulated groundwater in both preliminary and final batches contained 
approximately 2-2.5 µg l-1 concentration of each pharmaceutical, with the exception of 
caffeine, which was increased to approximately 4.5µg l-1 in final batch samples. Initial water 
chemistry exhibited pH values of approximately pH 7 for the preliminary batch experiments 
and approximately pH 8 for the final batch experiments (Figures 4.1 and 4.2).  
Pharmaceutical removal, potentially through degradation or sorption mechanisms, resulted in 
percent removals from 27% for ibuprofen and up to 94% for caffeine in the preliminary 
ZVFe-sand reaction mixture; and from 79% for ibuprofen and up to 99% for caffeine and 
carbamazepine in the 100% ZVFe final batch reactions (Figure 4.3).  Concentration versus 
time profiles depicted in Figures 4.1 and 4.2 indicate that most removal was seen within 6 
days in the preliminary batches and within 24 hours in the final batch samples.   
The preliminary batch samples composed of ZVFe and silica sand in a ratio of 20:80 
indicated little to moderate amendment to the solution concentrations of ibuprofen and 
naproxen with percent removals of 28% and 66% respectively.  The statistical weight of these 
reductions, by paired t-test calculations, indicates no statistical difference between the control 
and treated samples for naproxen and borderline statistical differences for ibuprofen, at the 
5% level (Appendix XII). Greater % removals of 89%, 85% and 94% were seen for 
carbamazepine, gemfibrozil, and caffeine, respectively. Paired t-test results comparing 




these changes for carbamazepine and caffeine, with p values less than alpha even at the 1% 
level (Appendix XII).  
The final batch samples, prepared within a glove box and composed of 100% ZVFe 
caused much greater and more rapid decreases in pharmaceutical concentrations for each of 
the pharmaceuticals studied. Overall, while the removals were accelerated and larger, the 
general removal trend remained similar with the least percent removal occurring once again 
for ibuprofen and then naproxen.  Percent removals of 78.6%, 96.6%, 98.5, 99.1% and 99.4% 
for ibuprofen, naproxen, gemfibrozil, caffeine, and carbamazepine, respectively, all indicated 
significant statistical difference at the 1% level between control and treated samples with p 
values of 0.000 for all pharmaceuticals (Figure 4.3; Appendix XII).  
The greater percent removals seen in the final batch experiments are likely due to one 
or a combination of two things: the increased wt % of ZVFe from 2.5% to 12.5% with respect 
to the solution mass, or the more fully anaerobic nature of the samples.  A number of studies 
have indicated that the reaction kinetics of contaminant degradation by ZVFe are controlled 
by the available reactive surface area of the metal, with linear relationships between the first-
order rate constant and the specific surface area (McGeough et al, 2007, Farrel et al., 2000; 
Joo et al., 2004; Johnson et al., 1996).  The final batch samples having a greater proportion of 
ZVFe would thus have a larger amount of reactive surface area, therefore, accounting for at 
least in part to the faster and greater removals exhibited by the pharmaceuticals in the final 
batch.  However, O2 exposure may have played a role in decreasing the efficiency of the 
preliminary batch as well. While the preliminary batches were sparged with argon gas upon 
sampling, O2 entry into the system was apparent by the unexpectedly high Eh values that 




a much more reducing environment. The presence of O2 in the preliminary batch may have 
decreased the degradation potential of the ZVFe by competing with the pharmaceuticals (Joo 
et al., 2004). Oxygen reduction by ZVFe (eq 8 and 9) produces Fe2+ that with further 
oxidation produces Fe3+.  This oxidation is expectedly coupled with subsequent precipitation 
of particulate iron oxyhydroxides that may have coated the ZVFe surface, decreasing the 
available reactive surface area and consequently the reaction rate (Blowes et al., 1997; Pratt et 
al., 1997; Joo et al., 2004).  
As previously noted, even under anaerobic conditions iron corrosion can occur, with 
water acting as the oxidant (equation 8).  This reaction produces hydroxide and thus should 
result in an increase in pH.   The pH in the preliminary and final batch samples did not 
however show a significant increase in pH.  Preliminary batch samples remained in the range 
of pH 7.37 to 8.45, and only a small increase from 7.04 to 7.72 occurred in the final batch 
samples (Figures 4.1 and 4.2).   Thus, while the decrease in Eh values in both batches 
indicates the gradual dissolution of Fe0 to Fe2+, the steady pH measurements indicate that the 
hydroxide produced by iron corrosion is potentially balanced by additional processes within 
the system, possibly by the formation of iron hydroxides (Matheson et al., 1994).  
Geochemical speciation calculations using MINTEQA2 indicated the water was 
supersaturated with respect to iron oxide and hydroxide phases thus supporting this 
hypothesis. An initial increase in concentration of total iron was observed during the 
experiment. According to speciation analysis using MINTEQA2 almost 100% of this total 
iron is present as Fe2+, and thus this increase in concentration suggests that ZVFe corrosion 
occurred (Figure 4.5). Geochemical analyses also indicated corresponding initial increases in 




batches, and decreases in nitrate concentration in the final batch samples, both indicative of a 
reducing environment.  Subsequent decreases in Mn and Fe concentrations over the course of 
the experiment, as well as a significant decrease in dissolved Ca and alkalinity suggests the 
formation of secondary carbonate minerals (Figures 4.5 and 4.7). MINTEQA2 calculations 
indicate the water is slightly supersaturated with respect to siderite in both ZVFe experiments, 
suggesting precipitation of carbonate containing minerals may be limiting concentrations of 
these dissolved constituents (Figure 4.6).  
 Back extractions of ZVFe performed to delineate the possible distribution of the 
pharmaceuticals between solution and solid phases recovered less than 1% of the mass of all 
pharmaceuticals investigated with the exception of ibuprofen, where approximately 2% was 
recovered. The small amount of mass recovered from the ZVFe accounts for very little of the 
mass loss in the reaction vessels, thus implying that an alternative removal mechanism is 
occurring. To the best of our knowledge ZVFe has not been previously explored in the 
treatment of pharmaceuticals, and thus one can only predict that removal mechanisms are by 
means of reduction as confirmed in the treatment of other contaminants such as chlorinated 
solvents, Cr(VI) and Se  (Gillham, 1994, Blowes et al., 1997; Farrell et al., 2000; Ponder et 
al., 2000; Lui et al, 2008; Song et al., 2005; Sasaki et al., 2008). 
 
Reactive Media – Granular Activated Carbon (GAC) and GAC: ZVFe mixtures:  
Granular activated carbon (GAC) has been used extensively in drinking water treatment 
systems due to its high sorption capacity.  It is employed to capture fine particulate matter and 
bacteria, and to counteract compounds that may cause unpleasant odors or taste (Stackelberg 




the best available technologies for the treatment of regulated organic pollutants by the USEPA 
(Westerhoff et al., 2005).  GAC generally facilitates contaminant removal by sorption, based 
upon hydrophobic interactions; thus the media most effectively removes non-polar 
contaminants.  In this study GAC was investigated, both alone and as a mixture with ZVFe, in 
the final batch studies, where a series of 100 ml serum bottles were filled and sealed inside a 
glove box, each opened and appraised only at the time of sampling.   
The reaction vessels at the outset enclosed simulated groundwater with approximately 
2-2.5 µg/L concentration of each investigated pharmaceutical, with the exception of caffeine, 
which was increased to approximately 4.5µg/L in final batch samples. Initial water chemistry 
of the input solution was similar to that of the controls, with pH values of approximately 8 
and Eh values in the range of 300-400 mV.   
Pharmaceutical removal, expectedly by sorption, resulted in final concentrations 
below LOD for all pharmaceuticals investigated and thus recorded percent removals of 100% 
(Table 4.3).  Concentrations versus time profiles depicted in Figure 4.2 indicate that 
pharmaceutical removal occurred rapidly, decreasing to levels below detection before the first 
sampling time at 1 hr.   Integrated peak analyses indicated below-detection concentrations as 
low as 3.48x10-4 μg l-1 for caffeine. However, removal was to such an extent for some 
pharmaceuticals, that no peak was distinguishable for pharmaceuticals such as 
carbamazepine. Paired t-test calculations, conducted simply for reasons of consistency, 
predictably supported that the removals were statistically significant even at the 0.1% 
significance level when comparing controls to the concentration profiles of the treated 
samples (Appendix XII). Pharmaceutical removal within the GAC reaction vessel was 




The pH of the system increased to 9.7 where it remained for the duration of experiment; while 
the Eh starting initially around 360 mV, decreased to 100 mV by day 3 and then continually 
increased returning to approximately 300 mV by the end of the study (Figure 4.2).   
Previous laboratory studies investigating pharmaceutical removal support the above 
findings that GAC efficiently removes pharmaceuticals (Stackelberg et al., 2007; Westerhoff 
et al., 2005; Snyder et al., 2007; Ternes et al., 2002). In a study conducted by Snyder et al. 
(2007) GAC was capable of removing nearly all evaluated pharmaceuticals by greater than 
90%, while both caffeine and carbamazepine showed greater than 90% removals in the study 
be Stackelberg et al. (2007).    
While the results of the final batch experiments provided little information from which 
to explore trends and patterns, due to the sudden decrease in concentration, previous studies, 
such as the one conducted by Westerhoff et al. (2005), allowed some general conclusions to 
be reached concerning the contaminant-specific removal effectiveness of activated carbon. 
Such studies indicated that at low doses of powdered activated carbon (PAC) a trend was 
identified between the log Kow of the contaminant and the % removal; higher removals being 
seen for those compounds with high log Kow values.  Also, protonated bases appeared to have 
superior removal, while deprotonated acids and compounds with low log Kow values tended to 
be the most challenging to remove. 
 If one considers solely the percent removals of pharmaceuticals from the final batch 
experiments, as well as some previously conducted investigations one may consider the 
USEPA to be correct in saying that GAC is one of the best available technologies for the 
treatment of many regulated organic pollutants. However, activated carbon studies conducted 




when used in the field. In the Stackelberg et al. (2007) study, removals extended from16 to 
93% for spiked surface-water samples, where it was acknowledged that the presence of 
organic carbon affected pharmaceutical removal by PAC, by competing for adsorption sites. 
Specifically, correlations between the removal efficiency and the aromatic carbon content, 
and the molecular weight and hydrophobicity of the DOC were observed. Similar 
observations were made by Ternes et al. (2002) and Snyder et al. (2007) where it was noted 
that AC efficiency was deeply diminished by the presence of natural organic matter that 
competes for binding sites and blocks pores within the AC structure.  It has also been 
recognized that the efficacy of GAC filter banks is dependent upon the age and the condition 
of the GAC; and thus its effectiveness in application such as drinking water treatment (DWT) 
varies widely within and among classes of compounds (Stackelberg et al., 2007). Saturated 
GAC may not allow for adsorption of contaminants; and desorption from GAC is possible 
during equilibration with aqueous phase concentrations, being that in GAC systems adsorbed 
contaminant concentrations equilibrate with influent-phase concentrations (Westerhoff et al., 
2005; Stackelberg et al., 2007).  In fact DWT plants with high total organic carbon using 
GAC filtration without frequent replacement or regeneration experience very little 
pharmaceutical removal (Snyder et al., 2007); thus indicating that GAC has finite life when 
used in the field.  
 
GAC and ZVFe mixtures:  
Given the potential downfalls and coinciding enormous potential of AC as a treatment media 
for pharmaceuticals, further investigations were conducted on AC when used in conjunction 




 Two mixtures of GAC and ZVFe were investigated in the final batch studies, with one 
series of 100 ml serum bottles containing a mixture of ZVFe: GAC in the ratio 50:50%wt and 
the other 70:30%wt. With the exception of caffeine, which was increased to an approximate 
concentration of 4.5 μgl-1, an initial concentration of 2-2.5 μg l-1 of each investigated 
pharmaceutical was spiked in to the artifical groundwater distributed to both series of reaction 
vessels. The initial input solution water chemistry was similar to that of the controls indicating 
pH values of approximately 8 and Eh values in the range of 300-400 mV.   
Pharmaceutical removal within these reaction vessels paralleled that of the 100% GAC 
sample vessels, resulting in final concentrations below LOD for all investigated 
pharmaceuticals; thus, percent removals were recorded as 100% (Figure 4.3).  No visible 
peak was present to integrate in late time analyses for ibuprofen, while the lowest 
concentration to be integrated below detection limits was that of 6.38 x 10-6 μg l-1 for caffeine. 
Also following the GAC reaction samples, concentrations versus time profiles depicted in 
Figure 4.2 indicate that pharmaceutical removal was very rapid, decreasing to levels below 
detection before the first sampling time at 1 hour.   Paired t-test calculations supported that the 
removals were statistically significant even at the 0.1% significance level when comparing 
controls to the concentration profiles of the treated samples (Appendix XII).  
While the rapid decline of pharmaceutical concentration in these reaction vessels 
provided minimal insight into mechanisms of pharmaceutical removal, subsequent changes in 
water chemistry did provide information regarding potential benefits of pairing these two 
media. The decrease in Eh values in both the 50:50 wt% and 70:30 wt% ZVFe-GAC mixtures 
were more rapid and consistently lower than in the reaction flask containing ZVFe alone. 




to that of the 100% ZVFe samples indicate that the difference in these two parameters 
between sample types is significant at the 5% level. In the 50:50 wt% and 70:30 wt% ZVFe-
GAC reaction vessels Eh values decreased to -220 mV and -340 mV within one day, further 
decreasing as low as -430 mV and -420 mV by day 15, respectively.  Eh values in the 100% 
ZVFe reaction vessels decreased less rapidly and less extensively, reaching only 100 mV by 
day one, declining only to -380 mV by day 15 of the experiment.  These results indicate the 
presence of a more reducing environment in the ZVFe-GAC mixture reaction vessels than for 
the GAC media alone. 
The slight difference in pH between the mixture reaction vessels and the 100% ZVFe 
vessels is also of interest; further supporting the suggestion that the environment may well be 
more favourable to contaminant reduction or iron corrosion.  The pH in the 100% ZVFe 
vessels starts at pH 7.04 increasing and decreasing modestly throughout the experiment 
resting at a final value of pH 7.72 by day 15.  As mentioned previously the generation of 
hydroxyl by iron corrosion should lead to an expected increase in pH, and the absence of such 
an increase indicates that alternative processes within the system likely balance hydroxyl 
production.  In the 50:50 wt% ZVFe-GAC reaction vessels the pH was measured at a higher 
pH of pH 8.42 by hour 3, a value largely maintained throughout the study, ending on day 15 
with a pH of 8.4. In the 70:30 wt% ZVFe-GAC reaction vessels pH measurements started 
similarly to that of 100% ZVFe at pH 7.28, however, increasing consistently throughout the 
experiment to pH 8.26 by the last day.  The consistently higher pH values in the 50:50 wt% 
ZVFe-GAC vessels, as well as the steadily increasing pH in the 70:30 wt% vessels implies 




The faster, more extensive decreases in Eh in the ZVFe-GAC mixtures in this study 
potentially indicate a greater reducing environment, where improved iron corrosion (or 
contaminant reduction) reactions are converting more Fe0 to Fe2+.  The higher pH values, and 
decreasing saturation indices for iron (oxy)hydroxides, as calculated by MINTEQA2, suggest 
that hydroxide is being produced and that iron (oxy)hydroxides, that may offset the pH affect 
of this hydroxide production, are either not being formed or are being sequestered in some 
fashion (Figure 4.6).  The strongly undersaturated conditions of numerous mineral phases, 
such as lepidocrocite, goethite, maghemite, calcite, aragonite and ferrihydrate, and the 
dramatic decreases in aqueous Ca2+, Fe2++ and Mn2+ in these reaction vessels, alludes that the 
GAC in the mixture may in fact be adsorbing one or both the reaction products of iron 
corrosion, or other competing compounds within the water (Figure 4.4). As noted in previous 
studies, available surface area on ZVFe tends to decrease over time, as iron corrosion 
products of Fe2+ and Fe3+ form iron oxyhydroxides which can coat the ZVFe surface (Joo et 
al., 2004). Thus the adsorption of these products or competing compounds to GAC may 
prevent or slow the formation of this coating, leaving a greater available surface area for 
contaminant reduction.  Past studies evaluating ZVFe have identified contaminant degradation 
rates as dependent on the extent of available reactive surface area (Johnson et al., 1996; 
McGeough et al, 2007, Farrel et al., 2000; Joo et al., 2004). Thus, the addition of GAC may 
increase both the efficiency as well as the life span of ZVFe treatment systems for both 









Figure 4.4 Concentrations of anions as a function of time for preliminary (series 1a and 1b) 
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Figure 4.5 Concentrations of cations as a function of time for for preliminary (series 1a and 
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Figure 4.7 Akalinity measurements for Preliminary and Final Batch Experiments 
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Figure 4.8 Calculated Mass balances and distributions of recovered pharmaceuticals. The left bank of figures 
indicates the distribution of pharmaceuticals between the solid, solution and what was unaccounted for, while the 
right hand bank of figures indicates purely the distribution of the recovered pharmaceutical mass between 
solution and solid phases.  The mass of pharamceutical bound to solid was calculated from the concentration 
back extracted from a sediment sample.  Moisture contents were determined for sediment sample to calculate the 
dry mass.  This dry mass was then used to calculate the amount of pharmaceutical per gram of sediment by 
dividing the HPLC calculated mass by the dry mass.  Knowing the mass of sorbed pharmaceutical per gram of 
media, it was then possible to calculate the total mass of sorbed pharmaceutical by multiplying this by the total 
known mass of sediment in the reaction vessel.  (Appendix X). 
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4.4 Evaluating the Promise of each Media in Pharmaceutical Water Treatment 
When considering the success of a treatment media with respect to a contaminant, one must 
consider more than simply the percent removal. As previously mentioned, success is also a 
measure of affordability, availability, durability and ease of use.  Since the bulk of the media 
evaluated in this study were selected with these criteria in mind, assuming that these standards 
are met, one can consider the effectiveness of each media based upon three experimental 
criteria: the removal efficiency, as measured by percent removal; the statistical significance of 
this removal, as calculated by paired t-test analyses; and media limitations, as noted by 
previous investigations.  Table 4.3 summarizes the findings of this investigation in terms of 
these three experimental traits. Based upon specific definitions of these qualifications, 
conclusions were drawn as to the potential of each media in the treatment of each 
pharmaceutical.  The media were considered a promising treatment if they indicated a 
statistically significant percent removal greater than 75%, with to the best of our knowledge 
no deleterious limitations.  Statistical significance was defined by a p-value less than alpha at 
a 5% significance level (α = 0.05), therefore indicating that the observed removal could not be 
ascribed to chance alone 95% of the time.  Limitations were considered deleterious if they 
resulted in either decreased water quality, or environmental harm; for example, the production 
of reactive species as seen in chlorination and ozonation processes (Dantas, 2007; Huber et 
al., 2005; Virender et al., 2006; Skender et al., 2007).  
The evaluation of the investigated media revealed that GAC and ZVFe, both 
independently and combined hold promise as pharmaceutical water treatments, having 
surpassed the defined demands.  While both media do on their own experience limitations 




two media may just prove to remedy this inadequacy.  According to removal alone, GAC 
appeared to be an excellent treatment, exhibiting exceptional removal of all the 
pharmaceuticals. However, as previously noted, earlier studies have identified GACs 
limitations in the field, having both a limited lifespan and efficiency, influenced by GAC age 
and condition, as well as, the molecular weight and hydrophobicity of the DOC and aromatic 
carbon content of the treated water (Stackleberg et al., 2007).  Meanwhile, albeit zero valent 
iron did not show as high of pharmaceutical removals as GAC, it is not bounded by these like 
limitations, and has the added benefit of successfully treating other important contaminants 
such as chlorinated solvents, or PCBs (see Table 3.2). Thus, ZVFe holds the potential to be a 
maintenance-free passive treatment media for the treatment of water experiencing both 
pharmaceutical as well as further types of contamination.  
In general, while fulfilling many desired treatment qualities, the success of the other 
investigated treatment media was highly dependent upon the type of pharmaceutical, as 
illustrated by the wide range of percentage removals. As a point of comparison between the 
media investigated in this study and those accounted for in the review, percent removals for 
the pharmaceuticals specifically evaluated in this study by previously investigated treatments 
are listed in Table 4.3.  As with all treatments, investigated in this study or otherwise, the 
achievement of each treatment is reliant on numerous provisions, and proper evaluation is 












Table 4.2 Experimental Results Summary 
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No No No Yes Yes Yes Yes Yes 
 Caffeine 
























No No No Yes Yes Yes Yes Yes 
 Ibuprofen 
























No No No No Yes Yes Yes Yes 
 Gemfibrozil 
























No No No Yes Yes Yes Yes Yes 
 Naproxen 
























No No No No Yes Yes Yes Yes 
Note: Removals reported as 100% indicate that no visible peak was present for the analyzed pharmaceutical.  
Percent removals greater than 99% reported for 100%AC, 100%ZVFe and ZVFe-AC 50:50 % wt and 70:30%wt 





Table 4.3 Success of Previously studied Treatments in the Removal of Investigated PhACs.  When more than 
one study is recorded for removal efficiencies, superscripts denote which percent removal coincides with which 
study.  
 
Success/Percent Removal Source 
Treatment Type Carbamazep






85%* 88%    Stackelberg et al., 2007 
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25-75% b 
Huber et al., 2005a 
 
Westerhoff et al, 
2006 b 
Anaerobic sludge with O3 
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0%     
 
Carballa et al., 
2007 
Ozone coupled with 
flocculation, coagulation 
and dual filtration 
78-99% 67-81%    
 

















Gomez et al., 
2008a 
Westerhoff et al, 
2006 b 
Ternes et al., 2002 
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5 SUMMARY AND CONCLUSIONS: 
 
Little is known of the potential consequences of chronic PhAC exposure.  Thus, it is not 
unanticipated that treatment of pharmaceuticals in water has been and is in recent times a 
focus of investigation.  The review of numerous articles has unearthed a large mass of 
information concerning this new field, and amid this information are common discoveries and 
common limitations.  To date most treatments appear to be limited by the chemically-variable 
nature of the PhACs themselves, each treatment method successful in the removal of only a 
small number of compounds; or limited by the adaptability or expense of the treatment media.   
There exists minimal information on novel, affordable, amendable treatment media that can 
be employed on numerous scales and water varieties, with the potential to treat a variety of 
PhACs as well as other water contaminants. 
 The aim of this study was to evaluate the removal of a suite of environmentally 
relevant pharmaceuticals from water in response to contact with reactive media and/or natural 
organic matter.  The study explored the potential sorption and/or chemical degradation of 
these PhACs by affordable and readily available media, already employed in the treatment of 
other water contaminants, using batch reactor style experiments.  
The experiments were conducted with batch samples containing a media of interest in 
simulated ground water spiked with carbamazepine, caffeine, naproxen, gemfibrozil, 
ibuprofen, sulfamethoxazole and clofibrate, each at an environmentally relevant initial 
concentration of 2-2.5 µg/L.  Investigated media included: Stelco-BOF slag, wood chips, 
Borden sand, zero valent iron (ZVFe), and granular activated carbon (GAC).  Samples were 
collected at predetermined time intervals over the course of 10 or 15 days to observe the 




water chemistry and pharmaceutical concentrations were calculated by internal and external 
calibration of HPLC-MS/MS results. 
Removal efficiencies, based on the change in concentration, were calculated for all 
batch reactors. In general, the controls exhibited 0% removal and narrow confidence intervals. 
For each of the reactive media, at least a small percentage of removal was seen for at least 
three of the five pharmaceuticals studied. The greatest percent removal, of 100%, was 
observed for all pharmaceuticals with concentrations dropping below the LOD, in GAC and 
ZVFe-GAC mixtures; the smallest percentage removal when considering all media, of 0%, 
was experienced by ibuprofen and naproxen in BOF, BDS and WC samples.   Most removal 
was observed within the first 24 hours for the majority of the drugs that showed measurable 
removals.    
 For the most part minimal to no removal was observed for any of the three controls or 
Borden sand over the course of the experiment.  Indicating that little attenuation of the 
pharmaceuticals was occurring due to the composition of the groundwater or duration of the 
study, and supporting previous research, asserting that Borden sand possessed little sorptive 
capacity with respect to the investigated pharmaceuticals (Carrara et al., 2008).  The one 
exception was ibuprofen, which in the preliminary batch experiments showed a 50% decrease 
in concentration, potentially indicating its oxidative sensitivity.  Decreases in pharmaceutical 
concentrations in the Borden sand reaction vessels ranged from zero to 56%, however all 
showed removals that were designated as statistically insignificant by paired t-test analysis at 
the 5% significance level.   
 Despite notable changes in water chemistry pharmaceutical removal in the ST-BOF 




ibuprofen up to 71% removal for caffeine. Removal within these vessels appeared to be 
highly dependent upon the type of pharmaceutical, as indicated by the wide range of removal 
efficiencies. Sorption to reactive media appeared to be a potential removal mechanism for 
Borden sand, Stelco BOF-slag and woodchips as suggested by results of sediment back 
extractions, media properties and water chemistry. 
 More consistently successful removal was observed for the ZVFe and GAC reaction 
vessels, both independently and as mixtures.  While ZVFe in the preliminary batch 
experiment showed slightly more variable success, with percent removals ranging from 28 to 
94%, increasing the concentration and control of the redox environment proved to likewise 
increase the efficiency of the media, increasing and narrowing the range of percent removal 
up to 79 to 100%.  Removal demonstrated in the ZVFe reaction vessels did not appear as 
dependent on pharmaceutical type as previously mentioned media, as indicated by more 
precise range of removal effciencies.  Recovery of pharamaceuticals from sediment back 
extractions suggests that sorption is not a significant removal mechanism for this media.  
 GAC and GAC-ZVFe mixture reaction vessels indicated 100% removal for all 
pharmaceuticals, decreasing their concentrations to below LOD before the first sampling time.  
While the removal efficiency of the GAC was impressive, and supported by previous studies, 
such as Snyder et al., (2007) that found the media capable of removing all evaluated PhACs 
by >90%, previous studies have also indicated that GAC is greatly limited by availability of 
adsorption sites as controlled by age, condition and presence of competing compounds 
(Ternes et al., 2002; Snyder et al., 2007).   
 The limitation of GAC with respect to reactive surface area is also a consideration for 




Available surface area tends to decrease over time, as products of oxidative dissolution coat 
the ZVFe surface (Joo et al., 2004). So while the percent removals in the ZVFe-GAC 
mixtures were impressive, they were not the sole result of interest in these reaction vessels.  
Water chemistry, including Eh, pH, anion and cation analysis, in combination with 
MINTEQA2 results suggested that the addition of activated carbon may prove beneficial for 
the reactivity and life span of ZVFe.   
This investigation demonstrated itself to be a stepping stone into the investigation of 
novel treatment media for pharmaceutical contamination in all water types.  Further 
exploration into the reaction intermediates and removal mechanisms of all the involved media 
would prove useful in understanding each media’s full potential.  In particular, GAC and 
ZVFe independently, or more importantly as mixtures, merit further research concerning their 
effectiveness with an even wider variety of pharmaceutical compounds, and a more in depth 
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Appendix I: Stock Solution Preparation for Batch Tests 
 
Table 1.1 PhAC masses for preparation of PhAC working stock solution.  Each drug was 
massed as a solid, than dissolved in 1000 ml 50:50 wt% methanol and nanopure water with 
subsequent sonification to ensure dilution. Exact masses of each PhAC are listed. 
PhAC Mass Added To Solution 
(ng) 
Carbamazepine 1.995 x 10-6 
Clofibrate 2.206 x 10-6 
Ibuprofen 2.001 x 10-6 
Naproxen 1.976 x 10-6 
Caffeine 1.970 x 10-6 
Sulfamethoxazole 1.973 x 10-6 
Gemfibrozil 1.942 x 10-6 
   
Table 1.2 Masses of isotope-labeled-PhAC standards for preparation of surrogate 
internal standard working stock solution.  Each standard contained the isotope labeled 
PhAC dissolved in 50:50 wt% methanol-nanopure water.  Each standard was measured both 
volumetrically and gravimetrically and combined to form a final volume of 20 ml with the 
addition of 50:50 wt% methanol-nanopure water. 
Solution Concentration of 
Standard 
Mass of Standard  
Added 
IS STOCK ONE   
MeOH:Nanopure 5050 % wt 18.6 
Caffeine-D3 1 X 106 ngL-1 0.182 
Gemfibrozil-D6 1 X 106 ngL-1 0.182 
Carbamazepine-
D10 
1 X 106 ngL-1 0.182 
Sulfamethoxazole-
D4 
1 X 106 ngL-1 0.183 
MEC-D3 1 X 106 ngL-1 0.183 
Ibuprofen-D3 1 X 106 ngL-1 0.184 
Naproxen-C13 1 X 106 ngL-1 0.184 
IS STOCK TWO   
MeOH:Nanopure 5050 % wt 18.6 
Caffeine-D3 1 X 106 ngL-1 0.180 
Gemfibrozil-D6 1 X 106 ngL-1 0.183 
Carbamazepine-
D10 
1 X 106 ngL-1 0.181 
Sulfamethoxazole-
D4 
1 X 106 ngL-1 0.183 
MEC-D3 1 X 106 ngL-1 0.180 
Ibuprofen-D3 1 X 106 ngL-1 0.182 





Appendix II: Composition of Quality Control Standards 
 
Table A2. Quality control standards were prepared gravimetrically and volumetrically 
using a hand pipette.  Standard PhAC stock solutions were used and adjusted to the 
appropriate concentration using nanopure water. 
 
Final Concentration 











10 x 103 200 x 103 1000 x 103 19.0 x 106 
5 x 103 200 x 103 500 x 103 19.5 x 106 
2 x 103 200 x 103 200 x 103 19.8 x 106 
1 x 103 100 x 103 200 x 103 19.8 x 106 
0.5 x 103 50 x 103 200 x 103 19.8 x 106 
02 x 103 20 x 103 200 x 103 19.8 x 106 
0.1 x 103 10 x 103 200 x 103 19.8 x 106 
0.05 x 103 5 x 103 200 x 103 19.8 x 106 
0.02 x 103 2 x 103 200 x 103 19.8 x 106 
0.01 x 103 1 x 103 200 x 103 19.8 x 106 































Appendix III: Composition of Reaction Flasks for Preliminary Batch Experiments.   
 
Table A3. Media was massed into each flask, followed by the addition of Simulated 
Ground (AG) water and subsequent spiking with the PhAC working stock solution 
containing all investigated PhACs.  Total mass includes reaction flask, caps, tubing, 







Mass of AG 
water (g) 
Mass of PhAC 




Control One 0 800.04 0.95 1189.10 
ZVFe 100.03 800.01 0.95 1210.04 
Control Two  0 799.24 1.08 1174.68 
ST-BOF 100.09 800.31 0.90 1176.95 
Borden Sand 103.18 800.61 102 1289.13 


































Appendix IV: Time and Volume and Reactive Media Data for Final Batch Samples.   
Table A4. A set of 18 Sample vessels was constructed for each investigated media and 
control.  The volume of spiked AG water, as well as the time of the addition was recorded for 
every sample in the sample sets.  The contribution of reactive media in each sample vessel is 
also indicated by the recorded mass of each component.  
Sample ZVFe AC AG water Spike Time Sample Time 
 (mg) (mg) (mg)  Day  Time  Duration (hrs) 
1 0 0 83.049 10:34 3 12:58 48.10 
2 0 0 82.598 10:26 5 12:20 96.08 
3 0 0 82.886 10:38 5 12:25 96.07 
4 0 0 82.787 10:29 2 13:35 24.13 
5 0 0 83.019 10:41 1 11:41 0.04 
6 0 0 85.637 10:33 10 10:05 215.98 
7 0 0 83.037 10:47 12 12:30 264.07 
8 0 0 83.202 10:48 1 13:48 0.13 
9 0 0 82.982 10:30 7 12:00 144.06 
10 0 0 83.051 10:43 10 10:15 215.98 
11 0 0 82.975 10:31 15 13:25 336.12 
12 0 0 82.716 10:39 2 13:30 24.12 
13 0 0 83.102 10:42 15 13:45 336.13 
14 0 0 83.338 10:40 1 16:40 0.25 
15 0 0 83.116 10:46 5 12:07 96.06 
16 0 0 82.21 10:36 2 16:20 24.24 
17 0 0 83.255 10:44 15 13:40 336.12 
18 0 0 82.971 10:35 10 10:20 215.99 
19 10.07 0 83.306 11:09 10 10:35 215.98 
20 10 0 83.12 12:27 2 13:47 24.06 
21 10 0 82.893 12:23 5 12:40 96.01 
22 10 0 83.267 11:10 1 17:13 0.25 
23 10.03 0 82.667 12:22 5 12:50 96.02 
24 10.01 0 86.095 11:07 15 14:40 336.15 
25 10.06 0 82.659 12:21 15 14:30 336.09 
26 10.07 0 83.209 12:26 7 13:20 144.04 
27 10.05 0 83.214 11:08 5 12:55 96.07 
28 10.05 0 82.91 12:25 2 14:46 24.10 
29 10 0 83.177 12:24 3 13:35 48.05 
30 10.05 0 82.597 11:05 12 13:00 264.08 
31 10.03 0 84.892 11:14 15 14:35 336.14 
32 10.06 0 83.12 11:07 1 12:07 0.04 
33 10.01 0 82.352 12:20 1 15:20 0.13 
34 10.01 0 82.884 11:12 10 10:45 215.98 
35 10 0 83.253 11:06 10 10:50 215.99 
36 10.04 0 82.84 11:11 2 13:50 24.11 
37 0 10 82.895 10:57 10 11:00 216.00 
38 0 10.03 83.312 10:52 1 11:52 0.04 
39 0 10 83.477 11:04 1 14:17 0.13 
40 0 9.99 83.619 10:59 2 15:00 24.17 




42 0 10.02 83.1 10:58 15 15:20 336.18 
43 0 10.02 83.449 10:53 2 13:42 24.12 
44 0 10.01 83.37 10:55 3 14:00 48.13 
45 0 10.05 83.165 10:50 10 11:15 216.02 
46 0 10.03 83.184 10:56 2 13:38 24.11 
47 0 9.99 82.551 11:00 5 13:25 96.10 
48 0 9.99 82.804 11:01 15 15:25 336.18 
49 0 9.99 83.335 10:52 7 13:45 144.12 
50 0 10.06 83.146 10:54 1 16:58 0.25 
51 0 10.06 83.003 11:02 10 11:20 216.01 
52 0 10.05 83.457 11:03 5 13:20 96.10 
53 0 10.01 83.208 10:49 12 13:15 264.10 
54 0 10.03 83.254 10:58 5 13:00 96.08 
55 4.99 4.96 83.289 9:26 2 12:14 24.12 
56 4.99 5.07 83.918 9:23 10 11:46 216.10 
57 5 4.95 82.97 9:27 5 13:40 96.18 
58 5.03 4.99 83.114 9:19 1 12:20 0.13 
59 5.04 5.05 83.36 9:20 2 12:12 24.12 
60 5.08 5 83.169 9:32 15 12:40 336.13 
61 5 4.98 82.896 9:31 3 12:30 48.12 
62 4.99 5.01 84.118 9:30 10 11:35 216.09 
63 5.09 4.97 82.809 9:28 7 12:35 144.13 
64 5.07 4.97 83.628 9:29 2 12:00 24.10 
65 5.07 5 83.46 9:24 5 13:55 96.19 
66 5.07 5.03 82.944 9:17 1 15:17 0.25 
67 5 5 83.379 9:25 15 13:00 336.15 
68 5.02 4.97 83.318 9:31 15 12:55 336.14 
69 5.05 5.09 83.541 9:25 12 12:30 264.13 
70 5 5.04 82.85 9:18 1 10:18 0.04 
71 5.02 5.05 83.539 9:22 5 13:48 96.18 
72 5.04 4.98 83.568 9:21 10 11:50 216.10 
73 7.07 3 81.41 9:37 15 13:10 336.15 
74 7.04 2.97 81.918 9:36 1 10:36 0.04 
75 7.02 3.05 83.752 9:39 2 12:47 24.13 
76 7.06 2.94 83 9:37 10 12:05 216.10 
77 7.06 2.97 83.546 9:45 10 12:15 216.10 
78 6.99 2.98 83.775 9:47 1 12:47 0.13 
79 7.07 2.98 83.456 9:34 12 13:00 264.14 
80 7.05 2.98 84.052 9:46 1 15:50 0.25 
81 7 2.98 82.926 9:44 7 13:30 144.16 
82 7.08 2.97 83.659 9:40 15 13:10 336.15 
83 7 2.98 83.631 9:41 2 13:25 24.16 
84 6.99 2.97 82.941 9:42 15 13:30 336.16 
85 7.06 2.97 83.602 9:43 10 12:20 216.11 
86 7.01 2.97 82.783 9:35 3 12:50 48.14 
87 7.07 3 82.981 9:38 2 12:30 24.12 
88 7.07 3.01 83.141 9:33 5 12:40 96.13 
89 6.99 2.97 82.932 9:34 5 12:50 96.14 





Appendix V: Results for Preliminary Batch Experiments.   
 
Raw data from the HPLC/MS is recorded, including analyte and IS peak areas and 
calculated concentrations.  Concentrations are based upon linear regressions of (analyte 
peak area / IS peak area) versus time.  Factored HPLC/MS concentrations represent 
final calculated experimental concentrations after dilutions and/or concentration have 
been compensated for.  (Sample ID:  c = control 1; Co, K = control 2; BDS = Borden 
Sand; ZVFe = zero valent iron; WC = wood chips; BOF = stelco BOF slag). 
 












  (µgl-1) (µgl-1) 
BDS43 6.37E+05 9.31E+04 6.84E+00 8.17E+00 2.45E+00 9.91E-01
BDS44 6.50E+05 9.12E+04 7.13E+00 8.53E+00 2.56E+00 1.03E+00
BDS45 9.85E+05 1.31E+05 7.52E+00 8.98E+00 2.69E+00 1.09E+00
BDS48 7.66E+05 1.32E+05 5.80E+00 6.90E+00 2.07E+00 8.37E-01
BDS51 1.10E+06 1.59E+05 6.92E+00 8.21E+00 2.46E+00 9.96E-01
BDS54 1.01E+06 1.41E+05 7.16E+00 8.54E+00 2.56E+00 1.04E+00
BDS57 1.15E+06 1.71E+05 6.73E+00 8.01E+00 2.40E+00 9.71E-01
BDS60 1.13E+06 1.63E+05 6.93E+00 8.23E+00 2.47E+00 9.98E-01
BDS63 9.22E+05 2.20E+05 4.19E+00 4.92E+00 1.48E+00 5.97E-01
BDS66 8.08E+05 1.38E+05 5.86E+00 6.93E+00 2.08E+00 8.40E-01
BDS69 6.73E+05 1.32E+05 5.10E+00 6.01E+00 1.80E+00 7.29E-01
sedBDS72 5.41E+05 1.47E+05 3.68E+00 4.27E+00 1.28E+00 5.18E-01
bds95 4.81E+05 1.30E+05 3.70E+00 3.81E+00 1.14E+00 4.62E-01
   
   
c1 5.95E+05 1.72E+05 3.46E+00 3.90E+00 1.17E+00 5.08E-01
c2 1.42E+06 1.79E+05 7.93E+00 9.16E+00 2.75E+00 1.19E+00
c3 9.73E+05 1.82E+05 5.35E+00 6.13E+00 1.84E+00 7.98E-01
c10 1.03E+06 1.49E+05 6.91E+00 7.96E+00 2.39E+00 1.04E+00
c13 1.26E+06 1.69E+05 7.46E+00 8.64E+00 2.59E+00 1.12E+00
c31 8.38E+05 1.29E+05 6.50E+00 7.74E+00 2.32E+00 1.01E+00
c16 8.92E+05 1.58E+05 5.65E+00 6.49E+00 1.95E+00 8.45E-01
c19 1.02E+06 1.51E+05 6.75E+00 7.76E+00 2.33E+00 1.01E+00
c22 9.54E+05 1.23E+05 7.76E+00 8.98E+00 2.69E+00 1.17E+00
c25 1.40E+06 1.53E+05 9.15E+00 1.06E+01 3.18E+00 1.38E+00
c34 9.75E+05 1.39E+05 7.01E+00 8.38E+00 2.51E+00 1.09E+00
   
   
Co37 1.79E+05 9.38E+04 1.91E+00 2.14E+00 6.42E-01 2.45E-01
Co38 7.91E+05 9.55E+04 8.28E+00 9.94E+00 2.98E+00 1.14E+00




Co46 1.23E+06 1.61E+05 7.64E+00 9.16E+00 2.75E+00 1.05E+00
Co49 1.05E+06 1.33E+05 7.89E+00 9.43E+00 2.83E+00 1.08E+00
Co52 1.04E+06 1.33E+05 7.82E+00 9.38E+00 2.81E+00 1.07E+00
Co55 1.39E+06 1.95E+05 7.13E+00 8.49E+00 2.55E+00 9.71E-01
Co58 1.36E+06 1.55E+05 8.77E+00 1.05E+01 3.15E+00 1.20E+00
Co61 1.39E+06 1.82E+05 7.64E+00 9.13E+00 2.74E+00 1.04E+00
Co64 1.30E+06 1.53E+05 8.50E+00 1.02E+01 3.06E+00 1.17E+00
Co67 1.20E+06 1.70E+05 7.06E+00 8.39E+00 2.52E+00 9.59E-01
Co70 6.98E+05 1.56E+05 4.47E+00 5.25E+00 1.58E+00 6.00E-01
cO96 9.84E+05 1.20E+05 8.20E+00 8.67E+00 2.60E+00 9.91E-01
   
   
q28 1.07E+06 1.46E+05 7.33E+00 8.49E+00 2.55E+00 9.71E-01
q29 4.66E+05 1.58E+05 2.95E+00 3.27E+00 9.81E-01 3.74E-01
q30 9.09E+04 1.56E+05 5.83E-01 4.84E-01 1.45E-01 5.53E-02
   
Sediments:    
SBDS75 6.55E+04 1.44E+05 4.55E-01 3.40E-01 1.02E-01 3.89E-02
SBOF76 1.70E+05 1.56E+05 1.09E+00 1.12E+00 3.36E-01 1.28E-01
sWC97 2.27E+05 1.29E+05 1.76E+00 1.73E+00 5.19E-01 1.98E-01
Sz77 1.87E+04 1.30E+05 1.44E-01 <0 0.00E+00 
BOF74 1.62E+05 1.31E+05 1.24E+00 1.17E+00 3.51E-01 1.34E-01
   
   
BOF40 5.90E+05 9.01E+04 6.55E+00 7.82E+00 2.35E+00 1.07E+00
BOF41 5.20E+05 9.67E+04 5.38E+00 6.38E+00 1.91E+00 8.76E-01
BOF42 5.23E+05 8.99E+04 5.82E+00 6.93E+00 2.08E+00 9.52E-01
BOF47 7.93E+05 1.46E+05 5.43E+00 6.46E+00 1.94E+00 8.87E-01
BOF50 7.17E+05 1.35E+05 5.31E+00 6.30E+00 1.89E+00 8.65E-01
BOF53 8.37E+05 1.56E+05 5.37E+00 6.32E+00 1.90E+00 8.68E-01
BOF56 7.66E+05 1.63E+05 4.70E+00 5.53E+00 1.66E+00 7.60E-01
BOF59 8.73E+05 1.55E+05 5.63E+00 6.65E+00 2.00E+00 9.13E-01
BOF62 8.80E+05 1.88E+05 4.68E+00 5.51E+00 1.65E+00 7.57E-01
BOF65 7.78E+05 1.73E+05 4.50E+00 5.29E+00 1.59E+00 7.27E-01
BOF68 6.19E+05 1.40E+05 4.42E+00 5.17E+00 1.55E+00 7.10E-01
BOF71 7.29E+05 1.62E+05 4.50E+00 5.27E+00 1.58E+00 7.24E-01
BOF93 4.92E+05 1.19E+05 4.13E+00 4.30E+00 1.29E+00 5.91E-01
   
   
WC81 8.51E+05 1.24E+05 6.86E+00 8.19E+00 2.46E+00 1.00E+00
WC82 8.26E+05 1.23E+05 6.72E+00 7.99E+00 2.40E+00 9.78E-01
WC83 9.69E+05 1.48E+05 6.55E+00 7.79E+00 2.34E+00 9.54E-01
WC84 8.89E+05 1.29E+05 6.89E+00 8.24E+00 2.47E+00 1.01E+00
wc85 8.47E+05 1.38E+05 6.14E+00 6.44E+00 1.93E+00 7.89E-01
wc86 7.09E+05 1.16E+05 6.11E+00 6.39E+00 1.92E+00 7.82E-01




WC88 6.04E+05 1.22E+05 4.95E+00 5.16E+00 1.55E+00 6.32E-01
WC89 5.52E+05 1.24E+05 4.45E+00 4.64E+00 1.39E+00 5.68E-01
WC90 6.64E+05 1.28E+05 5.19E+00 5.44E+00 1.63E+00 6.66E-01
WC91 4.31E+05 1.15E+05 3.75E+00 3.86E+00 1.16E+00 4.73E-01
WC92 3.57E+05 1.14E+05 3.13E+00 3.22E+00 9.66E-01 3.94E-01
WC94 3.83E+05 1.27E+05 3.02E+00 3.09E+00 9.27E-01 3.78E-01
   
   
z7 1.06E+06 1.42E+05 7.46E+00 8.61E+00 2.58E+00 1.12E+00
z8 1.07E+06 1.59E+05 6.73E+00 7.74E+00 2.32E+00 1.01E+00
z9 1.17E+06 1.71E+05 6.84E+00 7.92E+00 2.38E+00 1.03E+00
z12 1.18E+06 1.42E+05 8.31E+00 9.63E+00 2.89E+00 1.25E+00
z32 8.67E+05 1.44E+05 6.02E+00 7.15E+00 2.15E+00 9.30E-01
z15 6.85E+05 1.61E+05 4.25E+00 4.84E+00 1.45E+00 6.30E-01
z18 5.05E+05 1.64E+05 3.08E+00 3.44E+00 1.03E+00 4.48E-01
z21 3.97E+05 1.61E+05 2.47E+00 2.71E+00 8.13E-01 3.53E-01
z24 2.23E+05 1.58E+05 1.41E+00 1.47E+00 4.41E-01 1.91E-01
z27 1.68E+05 1.47E+05 1.14E+00 1.15E+00 3.45E-01 1.50E-01
z36 1.52E+05 1.30E+05 1.17E+00 1.24E+00 3.72E-01 1.61E-01
 












    (µgl-1) (µgl-1)  
Co1 147000 17300 8.49711 7.85 2.355 1.007271
Co2 171000 19600 8.72449 8.05 2.415 1.032934
Co3 153000 18300 8.360656 7.72 2.316 0.99059
Co10 149000 17300 8.612717 7.95 2.385 1.020103
Co13 145000 16800 8.630952 8.03 2.409 1.030368
Co16 138000 15900 8.679245 8.06 2.418 1.034217
Co19 153000 17700 8.644068 8.04 2.412 1.031651
Co22 123000 14300 8.601399 7.95 2.385 1.020103
Co25 154000 17500 8.8 8.14 2.442 1.044482
Co31 163000 18500 8.810811 8.13 2.439 1.043199
Co34 136000 15800 8.607595 8 2.4 1.026518
Co78 113000 13100 8.625954 8.02 2.406 1.029085
   
   
Z7 135000 16200 8.333333 7.72 2.316 0.990167
Z8 120000 14600 8.219178 7.59 2.277 0.973493
Z9 129000 15800 8.164557 7.59 2.277 0.973493
Z12 125000 16000 7.8125 7.2 2.16 0.923472
Z32 112000 20100 5.572139 5.03 1.509 0.645147
Z15 71900 16700 4.305389 3.85 1.155 0.493801
Z18 48800 16800 2.904762 2.49 0.747 0.319367




Z24 23000 19500 1.179487 0.837 0.2511 0.107354
Z27 18400 20000 0.92 0.588 0.1764 0.075417
Z36 15600 20500 0.760976 0.436 0.1308 0.055921
sedZ77 9020 17200 0.524419 0.207 0.0621 0.02655
   
   
K37 32000 7050 4.539007 4.06 1.218 0.457551
K38 109000 12600 8.650794 8.02 2.406 0.903832
K39 111000 12800 8.671875 8.08 2.424 0.910594
K46 136000 15600 8.717949 8.11 2.433 0.913974
K49 141000 16300 8.650307 8.04 2.412 0.906086
K52 131000 15000 8.733333 8.09 2.427 0.911721
K55 161000 19100 8.429319 7.8 2.34 0.879038
K58 127000 14600 8.69863 8.04 2.412 0.906086
K61 138000 16000 8.625 8.02 2.406 0.903832
K64 133000 15200 8.75 8.09 2.427 0.911721
K67 140000 16200 8.641975 7.98 2.394 0.899324
K70 98600 11700 8.42735 7.78 2.334 0.876784
K96 138000 16100 8.571429 7.95 2.385 0.895943
   
   
ST40 80700 13300 6.067669 5.03 1.509 0.681264
ST41 82800 14600 5.671233 4.7 1.41 0.636569
ST42 75300 11800 6.381356 5.28 1.584 0.715124
ST47 107000 16500 6.484848 5.4 1.62 0.731377
ST50 88500 14400 6.145833 5.08 1.524 0.688036
ST53 69600 13300 5.233083 4.32 1.296 0.585102
ST56 50400 12900 3.906977 3.2 0.96 0.433409
ST59 45600 14700 3.102041 2.52 0.756 0.341309
ST62 31900 14300 2.230769 1.78 0.534 0.241084
ST65 20000 14600 1.369863 1.05 0.315 0.142212
ST68 14300 11900 1.201681 0.909 0.2727 0.123115
ST71 23800 13400 1.776119 1.4 0.42 0.189616
ST93 10600 16300 0.650307 0.439 0.1317 0.059458
sedST74 8840 12600 0.701587 0.486 0.1458 0.065824
   
BD43 90900 13100 6.938931 5.78 1.734 0.690837
BD44 92900 13600 6.830882 5.67 1.701 0.677689
BD45 119000 17300 6.878613 5.75 1.725 0.687251
BD48 84400 14300 5.902098 4.89 1.467 0.584462
BD51 94000 16500 5.69697 4.7 1.41 0.561753
BD54 82300 15800 5.208861 4.3 1.29 0.513944
BD57 88300 17600 5.017045 4.13 1.239 0.493625
BD60 83100 16500 5.036364 4.15 1.245 0.496016
BD63 68000 21000 3.238095 2.63 0.789 0.314343
BD66 67800 19300 3.512953 2.86 0.858 0.341833
BD69 63700 17900 3.558659 2.91 0.873 0.347809
BD72 56000 16300 3.435583 2.79 0.837 0.333466




sedBD75 16900 15900 1.062893 0.794 0.2382 0.0949
   
W81 134000 15700 8.535032 7.96 2.388 0.960579
W82 107000 14300 7.482517 6.94 2.082 0.83749
W83 113000 16500 6.848485 6.39 1.917 0.771118
W84 108000 16800 6.428571 5.97 1.791 0.720434
W85 116000 16700 6.946108 6.48 1.944 0.781979
W86 121000 16100 7.515528 6.98 2.094 0.842317
W87 114000 16400 6.95122 6.48 1.944 0.781979
W88 109000 14800 7.364865 6.85 2.055 0.826629
W89 106000 14200 7.464789 6.95 2.085 0.838697
W90 124000 15300 8.104575 7.58 2.274 0.914722
W91 41200 15000 2.746667 2.42 0.726 0.292035
W92 36300 14000 2.592857 2.26 0.678 0.272727
W94 40900 14500 2.82069 2.48 0.744 0.299276
sedW97 14000 11900 1.176471 0.903 0.2709 0.10897
   
Q28 140000 14400 9.722222 8.15 2.445 
Q29 55600 24200 2.297521 1.84 0.552 
Q30 14100 12400 1.137097 0.854 0.2562 
 
Table A5.3 Carbamazepine Results 
 
CBZ sample Analyte peak 
area 








Co1 1.35E+05 2.29E+04 5.90E+00 8.44E+00 2.53E+00 1.05E+00
Co2 1.39E+05 2.43E+04 5.72E+00 8.18E+00 2.45E+00 1.02E+00
Co3 1.40E+05 2.37E+04 5.91E+00 8.45E+00 2.54E+00 1.05E+00
Co10 1.27E+05 2.11E+04 6.02E+00 8.56E+00 2.57E+00 1.07E+00
Co13 1.43E+05 2.39E+04 5.98E+00 8.54E+00 2.56E+00 1.07E+00
Co16 1.33E+05 2.22E+04 5.99E+00 8.57E+00 2.57E+00 1.07E+00
Co19 1.35E+05 2.28E+04 5.92E+00 8.46E+00 2.54E+00 1.05E+00
Co22 1.07E+05 1.81E+04 5.91E+00 8.48E+00 2.54E+00 1.05E+00
Co25 1.32E+05 2.18E+04 6.06E+00 8.62E+00 2.59E+00 1.08E+00
Co31 1.24E+05 2.08E+04 5.96E+00 8.53E+00 2.56E+00 1.06E+00
Co34 1.26E+05 2.10E+04 6.00E+00 8.57E+00 2.57E+00 1.07E+00
Co78 9.53E+04 1.61E+04 5.92E+00 8.44E+00 2.53E+00 1.05E+00
   
Z7 1.38E+05 2.31E+04 5.97E+00 8.51E+00 2.55E+00 1.06E+00
Z8 1.30E+05 2.18E+04 5.96E+00 8.51E+00 2.55E+00 1.06E+00
Z9 1.27E+05 2.13E+04 5.96E+00 8.51E+00 2.55E+00 1.06E+00
Z32 1.06E+05 2.09E+04 5.07E+00 7.24E+00 2.17E+00 9.03E-01
Z12 1.19E+05 2.03E+04 5.86E+00 8.36E+00 2.51E+00 1.04E+00
Z15 7.38E+04 2.34E+04 3.15E+00 4.52E+00 1.36E+00 5.62E-01
Z18 5.30E+04 2.29E+04 2.31E+00 3.32E+00 9.96E-01 4.13E-01
Z21 3.57E+04 2.25E+04 1.59E+00 2.27E+00 6.81E-01 2.84E-01
Z24 1.89E+04 2.41E+04 7.84E-01 1.12E+00 3.36E-01 1.41E-01




Z36 1.20E+04 1.93E+04 6.22E-01 8.95E-01 2.69E-01 1.12E-01
sedZ77 1.80E+03 1.92E+04 9.38E-02 1.43E-01 4.29E-02 1.86E-02
   
K37 2.64E+04 1.39E+04 1.90E+00 2.71E+00 8.13E-01 2.98E-01
K38 8.71E+04 1.42E+04 6.13E+00 8.77E+00 2.63E+00 9.60E-01
K39 9.12E+04 1.47E+04 6.20E+00 8.84E+00 2.65E+00 9.71E-01
K46 1.22E+05 1.96E+04 6.22E+00 8.91E+00 2.67E+00 9.74E-01
K49 1.13E+05 1.93E+04 5.85E+00 8.37E+00 2.51E+00 9.16E-01
K52 1.16E+05 1.92E+04 6.04E+00 8.58E+00 2.57E+00 9.45E-01
K55 1.33E+05 2.33E+04 5.71E+00 8.17E+00 2.45E+00 8.93E-01
K58 1.12E+05 1.81E+04 6.19E+00 8.87E+00 2.66E+00 9.68E-01
K61 1.17E+05 1.93E+04 6.06E+00 8.66E+00 2.60E+00 9.48E-01
K64 1.23E+05 2.02E+04 6.09E+00 8.67E+00 2.60E+00 9.53E-01
K67 1.22E+05 2.05E+04 5.95E+00 8.48E+00 2.54E+00 9.31E-01
K96 1.29E+05 2.14E+04 6.03E+00 8.64E+00 2.59E+00 9.43E-01
   
ST40 7.22E+04 1.40E+04 5.16E+00 7.52E+00 2.26E+00 9.70E-01
ST41 7.33E+04 1.51E+04 4.85E+00 7.09E+00 2.13E+00 9.13E-01
ST42 6.76E+04 1.32E+04 5.12E+00 7.50E+00 2.25E+00 9.63E-01
ST47 9.08E+04 1.79E+04 5.07E+00 7.42E+00 2.23E+00 9.54E-01
ST50 8.47E+04 1.64E+04 5.16E+00 7.53E+00 2.26E+00 9.72E-01
ST53 8.76E+04 1.67E+04 5.25E+00 7.65E+00 2.30E+00 9.87E-01
ST56 8.86E+04 1.71E+04 5.18E+00 7.58E+00 2.27E+00 9.75E-01
ST59 1.01E+05 1.91E+04 5.29E+00 7.70E+00 2.31E+00 9.95E-01
ST62 9.43E+04 1.86E+04 5.07E+00 7.41E+00 2.22E+00 9.54E-01
ST65 9.16E+04 1.79E+04 5.12E+00 7.46E+00 2.24E+00 9.63E-01
ST68 9.11E+04 1.78E+04 5.12E+00 7.50E+00 2.25E+00 9.63E-01
ST71 1.08E+05 2.09E+04 5.17E+00 7.57E+00 2.27E+00 9.72E-01
ST93 8.76E+04 1.70E+04 5.15E+00 7.53E+00 2.26E+00 9.69E-01
sedST74 1.76E+04 2.09E+04 8.42E-01 1.22E+00 3.66E-01 1.60E-01
   
BD43 7.98E+04 1.34E+04 5.96E+00 8.71E+00 2.61E+00 9.89E-01
BD44 8.70E+04 1.49E+04 5.84E+00 8.52E+00 2.56E+00 9.69E-01
BD45 1.13E+05 1.90E+04 5.95E+00 8.66E+00 2.60E+00 9.87E-01
BD48 8.28E+04 1.66E+04 4.99E+00 7.27E+00 2.18E+00 8.28E-01
BD51 1.00E+05 1.72E+04 5.81E+00 8.54E+00 2.56E+00 9.65E-01
BD54 8.92E+04 1.51E+04 5.91E+00 8.66E+00 2.60E+00 9.81E-01
BD57 1.06E+05 1.86E+04 5.70E+00 8.35E+00 2.51E+00 9.46E-01
BD60 9.85E+04 1.76E+04 5.60E+00 8.18E+00 2.45E+00 9.29E-01
BD63 8.17E+04 2.15E+04 3.80E+00 5.54E+00 1.66E+00 6.31E-01
BD66 8.65E+04 1.70E+04 5.09E+00 7.42E+00 2.23E+00 8.45E-01
BD69 9.06E+04 1.80E+04 5.03E+00 7.36E+00 2.21E+00 8.36E-01
BD72 7.85E+04 1.62E+04 4.85E+00 7.07E+00 2.12E+00 8.05E-01
BD95 8.18E+04 1.74E+04 4.70E+00 6.85E+00 2.06E+00 7.81E-01
sedBD75 9.19E+03 1.71E+04 5.37E-01 7.79E-01 2.34E-01 9.09E-02
   
W81 2.90E+04 5.81E+03 4.99E+00 7.31E+00 2.19E+00 8.37E-01
W82 2.25E+04 5.35E+03 4.21E+00 6.15E+00 1.85E+00 7.05E-01




W84 1.59E+04 4.06E+03 3.92E+00 5.73E+00 1.72E+00 6.57E-01
W86 1.38E+04 3.71E+03 3.72E+00 5.44E+00 1.63E+00 6.24E-01
W87 1.19E+04 4.63E+03 2.57E+00 3.75E+00 1.13E+00 4.32E-01
W88 1.11E+04 3.98E+03 2.79E+00 4.08E+00 1.22E+00 4.68E-01
W89 1.13E+04 4.04E+03 2.80E+00 4.08E+00 1.22E+00 4.70E-01
W90 1.24E+04 4.55E+03 2.73E+00 3.99E+00 1.20E+00 4.58E-01
W91 1.04E+04 3.77E+03 2.76E+00 4.03E+00 1.21E+00 4.63E-01
W92 9.86E+03 4.25E+03 2.32E+00 3.38E+00 1.01E+00 3.90E-01
W94 8.51E+03 3.93E+03 2.17E+00 3.16E+00 9.48E-01 3.64E-01
sedW97 4.36E+02 4.86E+03 8.97E-02 1.22E-01 3.66E-02 1.68E-02
   
Q28 1.25E+05 2.20E+04 5.68E+00 8.30E+00 2.49E+00 1.01E+00
Q29 5.52E+04 2.32E+04 2.38E+00 3.48E+00 1.04E+00 4.25E-01
Q30 1.04E+04 2.15E+04 4.84E-01 7.00E-01 2.10E-01 8.79E-02
 
Table A5.4 Ibuprofen Results 
 







ID Area Area C C*3/10  
   
BDS433 2.23E+05 5.59E+04 3.99E+00 5.29 1.587 0.622597
BDS44 2.17E+05 5.26E+04 4.13E+00 5.49 1.647 0.646136
BDS45 3.47E+05 7.76E+04 4.47E+00 5.95 1.785 0.700275
BDS48 2.84E+05 7.44E+04 3.82E+00 5.06 1.518 0.595528
BDS51 3.83E+05 1.03E+05 3.72E+00 4.82 1.446 0.567281
BDS54 3.78E+05 8.39E+04 4.51E+00 5.86 1.758 0.689682
BDS57 4.26E+05 9.96E+04 4.28E+00 5.56 1.668 0.654374
BDS60 4.18E+05 8.79E+04 4.76E+00 6.2 1.86 0.729698
BDS63 3.80E+05 1.18E+05 3.22E+00 4.14 1.242 0.48725
BDS66 3.13E+05 8.33E+04 3.76E+00 4.86 1.458 0.571989
BDS69 2.84E+05 7.88E+04 3.60E+00 4.65 1.395 0.547273
BDS72 2.35E+05 7.54E+04 3.12E+00 4 1.2 0.470773
bds95 2.02E+05 8.47E+04 2.38E+00 3.02 0.906 0.355434
   
   
c1 1.60E+05 6.35E+04 2.52E+00 3.22 0.966 0.406737
c10 1.86E+05 8.42E+04 2.21E+00 2.79 0.837 0.352421
c13 2.10E+05 8.75E+04 2.40E+00 3.06 0.918 0.386526
c31 1.89E+05 7.09E+04 2.67E+00 3.46 1.038 0.437053
c19 1.80E+05 7.68E+04 2.34E+00 2.97 0.891 0.375158
c2 2.36E+05 7.50E+04 3.15E+00 4.07 1.221 0.514105
c22 1.62E+05 7.03E+04 2.30E+00 2.93 0.879 0.370105
c25 2.24E+05 8.76E+04 2.56E+00 3.26 0.978 0.411789
c3 1.68E+05 7.32E+04 2.30E+00 2.91 0.873 0.367579
c34 1.65E+05 8.02E+04 2.06E+00 2.61 0.783 0.329684
c78 2.45E+05 8.06E+04 3.04E+00 3.89 1.167 0.491368
  0.959182 




Co37 7.44E+04 5.43E+04 1.37E+00 1.67 0.501 0.185281
Co38 2.75E+05 5.19E+04 5.30E+00 7.1 2.13 0.787722
Co39 2.52E+05 5.29E+04 4.76E+00 6.36 1.908 0.705621
Co46 4.40E+05 9.45E+04 4.66E+00 6.07 1.821 0.673447
Co49 3.32E+05 7.62E+04 4.36E+00 5.8 1.74 0.643491
Co52 3.46E+05 7.43E+04 4.66E+00 6.22 1.866 0.690089
Co55 5.19E+05 1.16E+05 4.47E+00 5.83 1.749 0.64682
Co58 4.91E+05 9.08E+04 5.41E+00 7.08 2.124 0.785503
Co61 4.89E+05 9.90E+04 4.94E+00 6.45 1.935 0.715607
Co64 3.95E+05 8.12E+04 4.86E+00 6.35 1.905 0.704512
Co67 4.36E+05 9.30E+04 4.69E+00 6.11 1.833 0.677885
Co70 2.48E+05 8.27E+04 3.00E+00 3.83 1.149 0.424926
cO96 2.87E+05 6.92E+04 4.15E+00 5.4 1.62 0.599112
  1.815 
   
q28 4.22E+05 8.11E+04 5.20E+00 6.84 2.052 
q29 1.84E+05 8.35E+04 2.20E+00 2.78 0.834 
q30 5.32E+04 8.72E+04 6.10E-01 0.631 0.1893 
   
   
SBDS75 5.28E+04 7.99E+04 6.61E-01 0.674 0.2022 
SBOF76 7.12E+04 8.11E+04 8.78E-01 0.967 0.2901 
Sz77 4.38E+04 7.27E+04 6.02E-01 0.594 0.1782 
sWC97 8.73E+04 6.92E+04 1.26E+00 1.51 0.453 
sBOF74 8.92E+04 7.73E+04 1.15E+00 1.36 0.408 
   
   
BOF40 2.07E+05 4.91E+04 4.22E+00 5.59 1.677 0.745333
BOF41 1.91E+05 5.81E+04 3.29E+00 4.32 1.296 0.576
BOF42 1.95E+05 5.05E+04 3.86E+00 5.11 1.533 0.681333
BOF47 3.10E+05 8.15E+04 3.80E+00 5.04 1.512 0.672
BOF50 3.34E+05 8.23E+04 4.06E+00 5.38 1.614 0.717333
BOF53 4.32E+05 9.18E+04 4.71E+00 6.13 1.839 0.817333
BOF56 4.22E+05 9.34E+04 4.52E+00 5.88 1.764 0.784
BOF59 4.99E+05 8.97E+04 5.56E+00 7.29 2.187 0.972
BOF62 4.91E+05 1.06E+05 4.63E+00 6.04 1.812 0.805333
BOF65 4.52E+05 1.03E+05 4.39E+00 5.72 1.716 0.762667
BOF68 3.53E+05 7.83E+04 4.51E+00 5.87 1.761 0.782667
BOF71 3.87E+05 9.95E+04 3.89E+00 5.03 1.509 0.670667
BOF93 3.00E+05 6.76E+04 4.44E+00 5.78 1.734 0.770667
   
   
WC81 3.57E+05 6.55E+04 5.45E+00 7.13 2.139 0.847129
WC82 3.64E+05 6.92E+04 5.26E+00 6.89 2.067 0.818614
WC83 4.14E+05 7.57E+04 5.47E+00 7.17 2.151 0.851881
WC84 3.98E+05 6.56E+04 6.07E+00 7.97 2.391 0.946931
WC89 3.46E+05 6.68E+04 5.18E+00 6.78 2.034 0.805545
WC91 2.96E+05 6.05E+04 4.89E+00 6.39 1.917 0.759208




WC92 2.96E+05 5.58E+04 5.30E+00 6.94 2.082 0.824554
WC94 2.91E+05 5.91E+04 4.92E+00 6.44 1.932 0.765149
wc85 3.88E+05 7.08E+04 5.48E+00 7.18 2.154 0.853069
wc86 3.44E+05 6.22E+04 5.53E+00 7.26 2.178 0.862574
WC87 3.61E+05 6.37E+04 5.67E+00 7.43 2.229 0.882772
WC88 3.54E+05 6.41E+04 5.52E+00 7.23 2.169 0.85901
   
   
z7 1.84E+05 6.79E+04 2.71E+00 3.47 1.041 0.438131
z8 1.91E+05 7.22E+04 2.65E+00 3.38 1.014 0.426768
z9 2.08E+05 8.79E+04 2.37E+00 3 0.9 0.378788
z32 1.70E+05 8.42E+04 2.02E+00 2.57 0.771 0.324495
z15 1.62E+05 8.61E+04 1.88E+00 2.35 0.705 0.296717
z18 1.57E+05 8.59E+04 1.83E+00 2.28 0.684 0.287879
z21 1.46E+05 8.31E+04 1.76E+00 2.18 0.654 0.275253
z24 1.07E+05 8.25E+04 1.30E+00 1.56 0.468 0.19697
z27 1.36E+05 8.60E+04 1.58E+00 1.94 0.582 0.244949
  0.525 
 














    (µgl-1) (µgl-1)  
1ppb 4.77E+04 5.15E+04 9.26E-01 1.16 0.348 
1ppb 5.38E+04 6.11E+04 8.81E-01 1.1 0.33 
   
   
BDS43 1.47E+05 3.23E+04 4.55E+00 6.46 1.938 0.769964
BDS44 1.45E+05 3.03E+04 4.79E+00 6.8 2.04 0.810489
BDS45 2.29E+05 4.60E+04 4.98E+00 7.08 2.124 0.843862
BDS48 1.94E+05 4.74E+04 4.09E+00 5.79 1.737 0.690107
BDS51 2.76E+05 5.98E+04 4.62E+00 6.16 1.848 0.734207
BDS54 2.64E+05 5.08E+04 5.20E+00 6.96 2.088 0.829559
BDS57 3.11E+05 6.09E+04 5.11E+00 6.84 2.052 0.815256
BDS60 2.96E+05 5.88E+04 5.03E+00 6.74 2.022 0.803337
BDS63 2.53E+05 8.06E+04 3.14E+00 4.14 1.242 0.493445
BDS66 1.83E+05 5.13E+04 3.57E+00 4.72 1.416 0.562574
BDS69 1.73E+05 4.79E+04 3.61E+00 4.78 1.434 0.569726
BDS72 1.19E+05 5.22E+04 2.28E+00 2.96 0.888 0.352801
bds95 8.83E+04 4.64E+04 1.90E+00 2.47 0.741 0.294398
   
   
c1 9.69E+04 6.48E+04 1.50E+00 1.98 0.594 0.253305
c2 1.73E+05 6.38E+04 2.71E+00 3.74 1.122 0.478465
c3 1.26E+05 5.97E+04 2.11E+00 2.86 0.858 0.365885
c10 1.39E+05 5.41E+04 2.57E+00 3.53 1.059 0.451599
c13 1.56E+05 6.01E+04 2.60E+00 3.56 1.068 0.455437




c16 1.06E+05 5.48E+04 1.93E+00 2.6 0.78 0.332623
c19 1.12E+05 5.63E+04 1.99E+00 2.71 0.813 0.346695
c22 1.27E+05 4.61E+04 2.75E+00 3.79 1.137 0.484861
c25 1.71E+05 5.38E+04 3.18E+00 4.39 1.317 0.56162
c34 1.34E+05 4.88E+04 2.75E+00 3.81 1.143 0.48742
c78 2.03E+05 4.95E+04 4.10E+00 5.44 1.632 0.695949
   
   
Co37 5.13E+04 3.50E+04 1.47E+00 1.95 0.585 0.219101
Co38 1.93E+05 3.43E+04 5.63E+00 8.04 2.412 0.903371
Co39 1.55E+05 2.99E+04 5.18E+00 7.4 2.22 0.831461
Co46 2.87E+05 5.54E+04 5.18E+00 6.92 2.076 0.777528
Co49 2.19E+05 4.37E+04 5.01E+00 7.14 2.142 0.802247
Co52 2.33E+05 4.72E+04 4.94E+00 7.04 2.112 0.791011
Co55 3.37E+05 7.16E+04 4.71E+00 6.29 1.887 0.706742
Co58 3.61E+05 5.77E+04 6.26E+00 8.42 2.526 0.946067
Co61 3.31E+05 5.87E+04 5.64E+00 7.57 2.271 0.850562
Co64 2.61E+05 5.43E+04 4.81E+00 6.44 1.932 0.723596
Co67 3.03E+05 6.06E+04 5.00E+00 6.7 2.01 0.752809
Co70 1.59E+05 5.59E+04 2.84E+00 3.73 1.119 0.419101
cO96 2.03E+05 4.14E+04 4.90E+00 6.62 1.986 0.74382
   
   
q28 3.49E+05 5.33E+04 6.55E+00 9.24 2.772 
q29 1.55E+05 5.71E+04 2.71E+00 3.73 1.119 
q30 3.26E+04 5.31E+04 6.14E-01 0.72 0.216 
   
SBDS75 2.05E+04 4.88E+04 4.20E-01 0.389 0.1167 
SBOF76 5.56E+04 5.53E+04 1.01E+00 1.2 0.36 
BOF74 5.75E+04 4.44E+04 1.30E+00 1.63 0.489 
sWC97 3.62E+04 4.46E+04 8.12E-01 0.953 0.2859 
Sz77 1.39E+04 4.44E+04 3.13E-01 0.241 0.0723 
   
BOF40 1.45E+05 3.21E+04 4.52E+00 6.43 1.929 0.868137
BOF41 1.34E+05 3.81E+04 3.52E+00 4.97 1.491 0.671017
BOF42 1.33E+05 3.06E+04 4.35E+00 6.16 1.848 0.831683
BOF47 2.09E+05 5.10E+04 4.10E+00 5.8 1.74 0.783078
BOF50 2.37E+05 5.02E+04 4.72E+00 6.72 2.016 0.907291
BOF53 3.49E+05 5.50E+04 6.35E+00 8.54 2.562 1.153015
BOF56 3.35E+05 5.34E+04 6.27E+00 8.45 2.535 1.140864
BOF59 4.01E+05 5.88E+04 6.82E+00 9.21 2.763 1.243474
BOF62 3.96E+05 6.85E+04 5.78E+00 7.76 2.328 1.047705
BOF65 3.57E+05 6.24E+04 5.72E+00 7.67 2.301 1.035554
BOF68 2.84E+05 5.18E+04 5.48E+00 7.35 2.205 0.992349
BOF71 2.99E+05 6.03E+04 4.96E+00 6.63 1.989 0.89514
BOF93 2.19E+05 4.55E+04 4.81E+00 6.5 1.95 0.877588
   
   




WC82 2.77E+05 3.97E+04 6.98E+00 9.42 2.826 1.133574
WC83 3.23E+05 5.08E+04 6.36E+00 8.56 2.568 1.030084
WC84 2.96E+05 4.28E+04 6.92E+00 9.33 2.799 1.122744
wc85 2.73E+05 4.72E+04 5.78E+00 7.87 2.361 0.947052
wc86 2.55E+05 3.82E+04 6.68E+00 9.08 2.724 1.092659
WC87 2.55E+05 3.73E+04 6.84E+00 9.33 2.799 1.122744
WC88 2.55E+05 4.05E+04 6.30E+00 8.57 2.571 1.031288
WC89 2.01E+05 4.15E+04 4.84E+00 6.57 1.971 0.790614
WC90 2.56E+05 4.20E+04 6.10E+00 8.28 2.484 0.99639
WC91 1.45E+05 4.13E+04 3.51E+00 4.71 1.413 0.566787
WC92 8.99E+04 3.71E+04 2.42E+00 3.2 0.96 0.385078
WC94 9.85E+04 4.04E+04 2.44E+00 3.22 0.966 0.387485
   
   
z7 1.43E+05 5.29E+04 2.70E+00 3.73 1.119 0.476982
z8 1.42E+05 5.49E+04 2.59E+00 3.55 1.065 0.453964
z9 1.50E+05 5.72E+04 2.62E+00 3.6 1.08 0.460358
z12 1.52E+05 5.08E+04 2.99E+00 4.14 1.242 0.529412
z32 1.08E+05 5.12E+04 2.11E+00 2.89 0.867 0.369565
z15 9.04E+04 5.78E+04 1.56E+00 2.08 0.624 0.265985
z18 7.41E+04 6.07E+04 1.22E+00 1.59 0.477 0.203325
z21 6.33E+04 5.42E+04 1.17E+00 1.51 0.453 0.193095
z24 4.14E+04 5.34E+04 7.75E-01 0.951 0.2853 0.121611
z27 3.47E+04 5.33E+04 6.51E-01 0.773 0.2319 0.098849









































Appendix VI: Results for Final Batch Experiments: 
 
Raw data from the HPLC/MS is recorded, including analyte and IS peak areas and 
calculated concentrations.  Concentrations are based upon linear regressions of (analyte 
peak area / IS peak area) versus time.  Factored HPLC concentrations represent final 
calculated experimental concentrations after dilutions and/or concentration have been 
compensated for. Percent removals calculated as indicated in Appendix VI are also 
shown.  (Samples type (ie. Type of reactive media) are listed as a subheading within 
sample ID column).  
 
















Control   (µgl-1) (µgl-1)  
5 2.22E+06 1.24E+05 1.79E+01 1.28E+01 1.28E+00 1.02E+00 -2.30
8 2.58E+06 1.44E+05 1.79E+01 1.28E+01 1.28E+00 1.02E+00 -2.38
14 2.44E+06 1.37E+05 1.78E+01 1.27E+01 1.27E+00 1.02E+00 -1.77
 2.30E+06 1.31E+05 1.76E+01 1.25E+01 1.25E+00 1.00E+00 -0.32
1 2.38E+06 1.31E+05 1.82E+01 1.30E+01 1.30E+00 1.04E+00 -3.81
2 2.17E+06 1.27E+05 1.71E+01 1.22E+01 1.22E+00 9.76E-01 2.37
3 2.26E+06 1.33E+05 1.70E+01 1.21E+01 1.21E+00 9.71E-01 2.90
15 2.52E+06 1.46E+05 1.73E+01 1.23E+01 1.23E+00 9.86E-01 1.37
6 2.22E+06 1.31E+05 1.69E+01 1.21E+01 1.21E+00 9.68E-01 3.17
11 2.48E+06 1.40E+05 1.77E+01 1.27E+01 1.27E+00 1.01E+00 -1.22
13 2.46E+06 1.43E+05 1.72E+01 1.23E+01 1.23E+00 9.83E-01 1.70
    
ZVFe-100    
32 2.13E+06 1.25E+05 1.70E+01 1.22E+01 1.22E+00 9.74E-01 2.63
33 1.63E+06 1.35E+05 1.21E+01 8.62E+00 8.62E-01 6.90E-01 31.01
28 1.49E+06 1.56E+05 9.55E+00 6.82E+00 6.82E-01 5.46E-01 45.43
29 1.04E+06 1.55E+05 6.71E+00 4.79E+00 4.79E-01 3.83E-01 61.66
21 7.10E+05 1.30E+05 5.46E+00 3.90E+00 3.90E-01 3.12E-01 68.80
23 7.85E+05 1.38E+05 5.69E+00 4.06E+00 4.06E-01 3.25E-01 67.50
27 7.90E+05 1.43E+05 5.52E+00 3.95E+00 3.95E-01 3.16E-01 68.44
19 4.45E+05 1.32E+05 3.37E+00 2.41E+00 2.41E-01 1.93E-01 80.74
24 5.22E+05 1.35E+05 3.87E+00 2.76E+00 2.76E-01 2.21E-01 77.91
25 4.86E+05 1.38E+05 3.52E+00 2.51E+00 2.51E-01 2.01E-01 79.88
31 5.09E+05 1.32E+05 3.86E+00 2.75E+00 2.75E-01 2.20E-01 77.97
    
AC-100    
38 2.08E+04 1.15E+05 1.81E-01 1.29E-01 1.29E-02 1.03E-02 98.97
39 6.81E+04 1.59E+05 4.28E-01 3.05E-01 3.05E-02 2.44E-02 97.56
50 1.01E+04 1.33E+05 7.59E-02 5.36E-02 5.36E-03 4.29E-03 99.57
40 9.19E+03 1.39E+05 6.61E-02 4.66E-02 4.66E-03 3.73E-03 99.63
44 4.76E+03 1.37E+05 3.47E-02 2.42E-02 2.42E-03 1.94E-03 99.81




52 1.73E+03 1.40E+05 1.24E-02 8.22E-03 8.22E-04 6.57E-04 99.93
54 1.77E+03 9.29E+04 1.91E-02 1.30E-02 1.30E-03 1.04E-03 99.90
37 5.03E+03 1.51E+05 3.33E-02 2.32E-02 2.32E-03 1.85E-03 99.81
41 6.81E+03 1.78E+05 3.83E-02 2.67E-02 2.67E-03 2.14E-03 99.79
42 9.83E+02 9.71E+04 1.01E-02 6.62E-03 6.62E-04 5.30E-04 99.95
48 6.00E+03 1.50E+05 4.00E-02 2.80E-02 2.80E-03 2.24E-03 99.78
    
Z50:A50    
70 7.54E+04 1.35E+05 5.59E-01 3.98E-01 3.98E-02 3.19E-02 96.81
58 4.02E+04 1.11E+05 3.62E-01 2.58E-01 2.58E-02 2.06E-02 97.94
66 6.36E+04 1.17E+05 5.44E-01 3.88E-01 3.88E-02 3.10E-02 96.90
55 1.72E+04 1.53E+05 1.12E-01 7.97E-02 7.97E-03 6.37E-03 99.36
61 9.27E+03 1.23E+05 7.54E-02 5.32E-02 5.32E-03 4.26E-03 99.57
57 6.17E+03 1.38E+05 4.47E-02 3.13E-02 3.13E-03 2.51E-03 99.75
65 5.26E+03 1.25E+05 4.21E-02 2.94E-02 2.94E-03 2.36E-03 99.76
71 4.68E+03 1.33E+05 3.52E-02 2.45E-02 2.45E-03 1.96E-03 99.80
62 1.06E+03 1.08E+05 9.81E-03 6.40E-03 6.40E-04 5.12E-04 99.95
60 2.39E+03 1.48E+05 1.61E-02 1.09E-02 1.09E-03 8.74E-04 99.91
67 5.84E+03 1.45E+05 4.03E-02 2.82E-02 2.82E-03 2.25E-03 99.77
68 1.22E+03 1.42E+05 8.59E-03 5.53E-03 5.53E-04 4.42E-04 99.96
    
Z70:A30    
74 9.36E+04 9.58E+04 9.77E-01 1.04E+00 1.04E-01 8.32E-02 91.68
80 1.02E+05 1.24E+05 8.23E-01 8.53E-01 8.53E-02 6.82E-02 93.18
87 5.75E+04 1.51E+05 3.81E-01 3.08E-01 3.08E-02 2.46E-02 97.54
86 1.24E+04 9.25E+04 1.34E-01 3.11E-03 3.11E-04 2.49E-04 99.98
88 9.03E+03 1.25E+05 7.22E-02 < 0 0.00E+00 0.00E+00 100.00
90 6.08E+03 1.26E+05 4.83E-02 < 0 0.00E+00 0.00E+00 100.00
89 1.69E+04 1.32E+05 1.28E-01 < 0 0.00E+00 0.00E+00 100.00
76 7.62E+03 1.22E+05 6.25E-02 < 0 0.00E+00 0.00E+00 100.00
     
 
















Control    
14 6.33E+06 2.97E+05 2.13E+01 2.17E+01 2.17E+00 9.50E-01 4.988583507
1 6.64E+06 3.01E+05 2.21E+01 2.24E+01 2.24E+00 9.83E-01 1.660468084
2 6.64E+06 2.98E+05 2.23E+01 2.26E+01 2.26E+00 9.93E-01 0.670601579
3 5.46E+06 2.64E+05 2.07E+01 2.10E+01 2.10E+00 9.22E-01 7.802523794
15 6.09E+06 2.74E+05 2.22E+01 2.26E+01 2.26E+00 9.91E-01 0.918434548
6 6.58E+06 2.90E+05 2.27E+01 2.31E+01 2.31E+00 1.01E+00 -1.146970709
11 6.48E+06 2.79E+05 2.32E+01 2.36E+01 2.36E+00 1.04E+00 -3.536747841
13 6.96E+06 2.98E+05 2.34E+01 2.37E+01 2.37E+00 1.04E+00 -4.11574088
17 6.71E+06 2.81E+05 2.39E+01 2.43E+01 2.43E+00 1.06E+00 -6.448231167
    
ZVFe-100    




33 2.43E+06 2.67E+05 9.10E+00 9.25E+00 9.25E-01 4.06E-01 59.42093855
22 1.64E+06 2.81E+05 5.84E+00 5.93E+00 5.93E-01 2.60E-01 73.97318084
29 9.27E+05 3.13E+05 2.96E+00 3.01E+00 3.01E-01 1.32E-01 86.78624955
21 2.91E+05 2.67E+05 1.09E+00 1.11E+00 1.11E-01 4.87E-02 95.12927168
23 3.87E+05 2.62E+05 1.48E+00 1.50E+00 1.50E-01 6.60E-02 93.40336063
27 3.51E+05 2.84E+05 1.24E+00 1.26E+00 1.26E-01 5.52E-02 94.47838445
19 9.63E+04 2.57E+05 3.75E-01 3.84E-01 3.84E-02 1.68E-02 98.31702783
24 9.08E+04 2.81E+05 3.23E-01 3.31E-01 3.31E-02 1.45E-02 98.5469188
25 8.31E+04 2.78E+05 2.99E-01 3.07E-01 3.07E-02 1.35E-02 98.65483319
31 1.00E+05 2.69E+05 3.72E-01 3.81E-01 3.81E-02 1.67E-02 98.33022566
    
AC-100    
38 2.09E+04 2.54E+05 8.23E-02 8.65E-02 8.65E-03 3.80E-03 99.62044704
39 4.41E+04 2.64E+05 1.67E-01 1.73E-01 1.73E-02 7.57E-03 99.242639
50 1.10E+04 2.54E+05 4.33E-02 4.69E-02 4.69E-03 2.06E-03 99.79417573
40 1.79E+04 2.48E+05 7.22E-02 7.63E-02 7.63E-03 3.35E-03 99.66549253
44 9.65E+02 2.40E+05 4.02E-03 7.00E-03 7.00E-04 3.07E-04 99.96928562
47 3.01E+03 2.43E+05 1.24E-02 1.55E-02 1.55E-03 6.80E-04 99.93199601
52 2.05E+03 2.59E+05 7.92E-03 1.10E-02 1.10E-03 4.81E-04 99.95192796
54 2.01E+03 2.63E+05 7.64E-03 1.07E-02 1.07E-03 4.69E-04 99.95314245
37 4.03E+02 2.31E+05 1.74E-03 4.69E-03 4.69E-04 2.06E-04 99.97943148
41 1.91E+03 2.81E+05 6.80E-03 9.82E-03 9.82E-04 4.31E-04 99.95691078
42 5.45E+02 2.70E+05 2.02E-03 4.97E-03 4.97E-04 2.18E-04 99.9782105
48 2.37E+03 3.05E+05 7.77E-03 1.08E-02 1.08E-03 4.74E-04 99.95257233
    
Z50:A50    
70 2.76E+04 2.42E+05 1.14E-01 1.19E-01 1.19E-02 5.21E-03 99.4788565
58 6.93E+03 2.22E+05 3.12E-02 3.46E-02 3.46E-03 1.52E-03 99.84806814
66 1.50E+04 2.24E+05 6.70E-02 7.10E-02 7.10E-03 3.11E-03 99.68872894
55 2.74E+03 2.64E+05 1.04E-02 1.35E-02 1.35E-03 5.91E-04 99.94094642
61 4.78E+03 2.43E+05 1.97E-02 2.29E-02 2.29E-03 1.00E-03 99.89952939
57 5.04E+02 2.33E+05 2.16E-03 5.11E-03 5.11E-04 2.24E-04 99.9775661
65 1.23E+03 2.14E+05 5.75E-03 8.76E-03 8.76E-04 3.84E-04 99.96158865
71 3.90E+03 2.59E+05 1.51E-02 1.82E-02 1.82E-03 7.99E-04 99.92009024
62 9.91E+03 2.18E+05 4.55E-02 4.91E-02 4.91E-03 2.15E-03 99.78458531
60 5.15E+03 3.20E+05 1.61E-02 1.93E-02 1.93E-03 8.45E-04 99.91547323
67 1.73E+03 3.34E+05 5.18E-03 8.18E-03 8.18E-04 3.59E-04 99.96412049
68 1.31E+03 2.96E+05 4.43E-03 7.41E-03 7.41E-04 3.25E-04 99.96748112
    
Z70:A30    
74 2.37E+04 1.61E+05 1.47E-01 1.48E-01 1.48E-02 6.49E-03 99.35087719
80 1.91E+04 2.34E+05 8.16E-02 7.92E-02 7.92E-03 3.47E-03 99.65263158
87 1.10E+04 2.46E+05 4.47E-02 4.07E-02 4.07E-03 1.79E-03 99.82149123
86 4.90E+03 1.44E+05 3.40E-02 2.96E-02 2.96E-03 1.30E-03 99.87017544
88 2.63E+03 1.78E+05 1.48E-02 9.69E-03 9.69E-04 4.25E-04 99.9575
90 3.21E+03 1.87E+05 1.72E-02 1.22E-02 1.22E-03 5.35E-04 99.94649123
89 5.16E+03 1.97E+05 2.62E-02 2.15E-02 2.15E-03 9.43E-04 99.90570175






















Control    (µgl-1) (µgl-1)   
14 6.33E+06 2.97E+05 2.13E+01 2.17E+01 2.17E+00 9.50E-01 4.99
1 6.64E+06 3.01E+05 2.21E+01 2.24E+01 2.24E+00 9.83E-01 1.66
2 6.64E+06 2.98E+05 2.23E+01 2.26E+01 2.26E+00 9.93E-01 0.67
3 5.46E+06 2.64E+05 2.07E+01 2.10E+01 2.10E+00 9.22E-01 7.80
15 6.09E+06 2.74E+05 2.22E+01 2.26E+01 2.26E+00 9.91E-01 0.92
6 6.58E+06 2.90E+05 2.27E+01 2.31E+01 2.31E+00 1.01E+00 -1.15
11 6.48E+06 2.79E+05 2.32E+01 2.36E+01 2.36E+00 1.04E+00 -3.54
13 6.96E+06 2.98E+05 2.34E+01 2.37E+01 2.37E+00 1.04E+00 -4.12
17 6.71E+06 2.81E+05 2.39E+01 2.43E+01 2.43E+00 1.06E+00 -6.45
    
ZVFe-100    
32 3.74E+06 2.58E+05 1.45E+01 1.47E+01 1.47E+00 6.46E-01 35.37
33 2.43E+06 2.67E+05 9.10E+00 9.25E+00 9.25E-01 4.06E-01 59.42
22 1.64E+06 2.81E+05 5.84E+00 5.93E+00 5.93E-01 2.60E-01 73.97
29 9.27E+05 3.13E+05 2.96E+00 3.01E+00 3.01E-01 1.32E-01 86.79
21 2.91E+05 2.67E+05 1.09E+00 1.11E+00 1.11E-01 4.87E-02 95.13
23 3.87E+05 2.62E+05 1.48E+00 1.50E+00 1.50E-01 6.60E-02 93.40
27 3.51E+05 2.84E+05 1.24E+00 1.26E+00 1.26E-01 5.52E-02 94.48
19 9.63E+04 2.57E+05 3.75E-01 3.84E-01 3.84E-02 1.68E-02 98.32
24 9.08E+04 2.81E+05 3.23E-01 3.31E-01 3.31E-02 1.45E-02 98.55
25 8.31E+04 2.78E+05 2.99E-01 3.07E-01 3.07E-02 1.35E-02 98.65
31 1.00E+05 2.69E+05 3.72E-01 3.81E-01 3.81E-02 1.67E-02 98.33
    
AC-100    
38 2.09E+04 2.54E+05 8.23E-02 8.65E-02 8.65E-03 3.80E-03 99.62
39 4.41E+04 2.64E+05 1.67E-01 1.73E-01 1.73E-02 7.57E-03 99.24
50 1.10E+04 2.54E+05 4.33E-02 4.69E-02 4.69E-03 2.06E-03 99.79
40 1.79E+04 2.48E+05 7.22E-02 7.63E-02 7.63E-03 3.35E-03 99.67
44 9.65E+02 2.40E+05 4.02E-03 7.00E-03 7.00E-04 3.07E-04 99.97
47 3.01E+03 2.43E+05 1.24E-02 1.55E-02 1.55E-03 6.80E-04 99.93
52 2.05E+03 2.59E+05 7.92E-03 1.10E-02 1.10E-03 4.81E-04 99.95
54 2.01E+03 2.63E+05 7.64E-03 1.07E-02 1.07E-03 4.69E-04 99.95
37 4.03E+02 2.31E+05 1.74E-03 4.69E-03 4.69E-04 2.06E-04 99.98
41 1.91E+03 2.81E+05 6.80E-03 9.82E-03 9.82E-04 4.31E-04 99.96
42 5.45E+02 2.70E+05 2.02E-03 4.97E-03 4.97E-04 2.18E-04 99.98
48 2.37E+03 3.05E+05 7.77E-03 1.08E-02 1.08E-03 4.74E-04 99.95
    
Z50:A50    
70 2.76E+04 2.42E+05 1.14E-01 1.19E-01 1.19E-02 5.21E-03 99.48
58 6.93E+03 2.22E+05 3.12E-02 3.46E-02 3.46E-03 1.52E-03 99.85
66 1.50E+04 2.24E+05 6.70E-02 7.10E-02 7.10E-03 3.11E-03 99.69
55 2.74E+03 2.64E+05 1.04E-02 1.35E-02 1.35E-03 5.91E-04 99.94




57 5.04E+02 2.33E+05 2.16E-03 5.11E-03 5.11E-04 2.24E-04 99.98
65 1.23E+03 2.14E+05 5.75E-03 8.76E-03 8.76E-04 3.84E-04 99.96
71 3.90E+03 2.59E+05 1.51E-02 1.82E-02 1.82E-03 7.99E-04 99.92
62 9.91E+03 2.18E+05 4.55E-02 4.91E-02 4.91E-03 2.15E-03 99.78
60 5.15E+03 3.20E+05 1.61E-02 1.93E-02 1.93E-03 8.45E-04 99.92
67 1.73E+03 3.34E+05 5.18E-03 8.18E-03 8.18E-04 3.59E-04 99.96
68 1.31E+03 2.96E+05 4.43E-03 7.41E-03 7.41E-04 3.25E-04 99.97
    
Z70:A30    
74 2.37E+04 1.61E+05 1.47E-01 1.48E-01 1.48E-02 6.49E-03 99.35
80 1.91E+04 2.34E+05 8.16E-02 7.92E-02 7.92E-03 3.47E-03 99.65
87 1.10E+04 2.46E+05 4.47E-02 4.07E-02 4.07E-03 1.79E-03 99.82
86 4.90E+03 1.44E+05 3.40E-02 2.96E-02 2.96E-03 1.30E-03 99.87
88 2.63E+03 1.78E+05 1.48E-02 9.69E-03 9.69E-04 4.25E-04 99.96
90 3.21E+03 1.87E+05 1.72E-02 1.22E-02 1.22E-03 5.35E-04 99.95
89 5.16E+03 1.97E+05 2.62E-02 2.15E-02 2.15E-03 9.43E-04 99.91


















Control    (µgl-1) (µgl-1)  
C5 3.89E+05 2.36E+04 1.65E+01 2.43E+01 2.43E+00 1.01E+00 -1.33
C8 4.45E+05 2.76E+04 1.61E+01 2.37E+01 2.37E+00 9.88E-01 1.17
C14 3.95E+05 2.46E+04 1.61E+01 2.37E+01 2.37E+00 9.88E-01 1.17
C4 4.05E+05 2.66E+04 1.52E+01 2.25E+01 2.25E+00 9.38E-01 6.17
C16 5.24E+04 2.02E+04 2.59E+00 3.82E+00 0.00E+00 
C1 4.33E+05 2.76E+04 1.57E+01 2.31E+01 2.31E+00 9.63E-01 3.67
C15 4.11E+05 2.51E+04 1.64E+01 2.41E+01 2.41E+00 1.00E+00 -0.50
C3 4.30E+05 2.49E+04 1.73E+01 2.55E+01 2.55E+00 1.06E+00 -6.34
C2 4.36E+05 2.74E+04 1.59E+01 2.34E+01 2.34E+00 9.76E-01 2.42
C10 4.25E+05 2.51E+04 1.69E+01 2.49E+01 2.49E+00 1.04E+00 -3.84
C7 4.06E+05 2.67E+04 1.52E+01 2.24E+01 2.24E+00 9.34E-01 6.59
C17 4.50E+05 2.63E+04 1.71E+01 2.52E+01 2.52E+00 1.05E+00 -5.09
C13 4.87E+05 2.95E+04 1.65E+01 2.44E+01 2.44E+00 1.02E+00 -1.75
    
ZVFe-100    
Z32 2.83E+05 2.12E+04 1.33E+01 1.93E+01 1.93E+00 8.05E-01 19.52
Z33 1.67E+05 2.29E+04 7.29E+00 1.05E+01 1.05E+00 4.38E-01 56.21
Z22 1.16E+05 2.36E+04 4.92E+00 7.11E+00 7.11E-01 2.96E-01 70.35
Z20 5.43E+04 2.12E+04 2.56E+00 3.69E+00 3.69E-01 1.54E-01 84.61
Z28 3.41E+04 2.65E+04 1.29E+00 1.86E+00 1.86E-01 7.76E-02 92.24
Z36 5.82E+04 2.05E+04 2.84E+00 4.09E+00 4.09E-01 1.71E-01 82.94
Z29 3.98E+04 2.44E+04 1.63E+00 2.35E+00 2.35E-01 9.80E-02 90.20
Z21 1.24E+04 2.22E+04 5.59E-01 7.96E-01 7.96E-02 3.32E-02 96.68
Z23 1.44E+04 2.30E+04 6.26E-01 8.96E-01 8.96E-02 3.74E-02 96.26
Z27 1.39E+04 2.57E+04 5.41E-01 7.73E-01 7.73E-02 3.22E-02 96.78




Z19 3.12E+03 2.21E+04 1.41E-01 1.97E-01 1.97E-02 8.21E-03 99.18
Z34 3.47E+03 2.31E+04 1.50E-01 2.10E-01 2.10E-02 8.76E-03 99.12
Z35 3.69E+03 2.39E+04 1.54E-01 2.16E-01 2.16E-02 9.01E-03 99.10
Z30 2.65E+03 1.95E+04 1.36E-01 1.89E-01 1.89E-02 7.88E-03 99.21
Z25 2.61E+03 2.47E+04 1.06E-01 1.45E-01 1.45E-02 6.05E-03 99.40
Z24 2.61E+03 2.50E+04 1.04E-01 1.43E-01 1.43E-02 5.96E-03 99.40
    
AC-100    
A38 1.48E+03 2.73E+04 5.42E-02 7.11E-02 7.11E-03 2.96E-03 99.70
A39 2.21E+03 2.73E+04 8.10E-02 1.10E-01 1.10E-02 4.59E-03 99.54
A50 4.16E+02 2.32E+04 1.79E-02 1.88E-02 1.88E-03 7.84E-04 99.92
A46 6.51E+01 3.25E+04 2.00E-03 < 0 0.00E+00 0.00E+00 100.00
A43 8.42E+01 2.70E+04 3.12E-03 < 0 0.00E+00 0.00E+00 100.00
A40 9.84E+02 2.44E+04 4.03E-02 5.12E-02 5.12E-03 2.13E-03 99.79
A44 1.76E+02 2.68E+04 6.57E-03 2.46E-03 2.46E-04 1.03E-04 99.99
A54 2.21E+02 2.63E+04 8.40E-03 5.09E-03 5.09E-04 2.12E-04 99.98
A52 2.14E+02 2.66E+04 8.05E-03 4.56E-03 4.56E-04 1.90E-04 99.98
A47 1.36E+02 2.48E+04 5.48E-03 8.65E-04 8.65E-05 3.61E-05 100.00
A49 3.30E+02 2.44E+04 1.35E-02 1.25E-02 1.25E-03 5.21E-04 99.95
A37 6.21E+02 2.68E+04 2.32E-02 2.64E-02 2.64E-03 1.10E-03 99.89
A51 7.76E+02 2.33E+04 3.33E-02 4.11E-02 4.11E-03 1.71E-03 99.83
A53 5.33E+02 2.35E+04 2.27E-02 2.56E-02 2.56E-03 1.07E-03 99.89
A41 1.04E+02 3.10E+04 3.35E-03 < 0 0.00E+00 0.00E+00 100.00
A42 1.23E+02 2.74E+04 4.49E-03 < 0 0.00E+00 0.00E+00 100.00
A48 4.68E+02 2.91E+04 1.61E-02 1.62E-02 1.62E-03 6.75E-04 99.93
    
Z50:A50    
AZ70 1.18E+03 2.42E+04 4.88E-02 7.86E-02 7.86E-03 3.28E-03 99.67
AZ58 3.50E+02 2.07E+04 1.69E-02 3.14E-02 3.14E-03 1.31E-03 99.87
AZ66 1.05E+03 2.47E+04 4.25E-02 6.92E-02 6.92E-03 2.89E-03 99.71
AZ64 1.87E+02 2.99E+04 6.25E-03 1.57E-02 1.57E-03 6.55E-04 99.93
AZ55 3.15E+02 2.64E+04 1.19E-02 2.40E-02 2.40E-03 1.00E-03 99.90
AZ59 2.46E+02 2.80E+04 8.79E-03 1.94E-02 1.94E-03 8.09E-04 99.92
AZ61 2.38E+02 2.38E+04 1.00E-02 2.12E-02 2.12E-03 8.84E-04 99.91
AZ57 3.70E+02 2.20E+04 1.68E-02 3.12E-02 3.12E-03 1.30E-03 99.87
AZ71 4.38E+02 2.34E+04 1.87E-02 3.40E-02 3.40E-03 1.42E-03 99.86
AZ65 3.13E+02 2.43E+04 1.29E-02 2.54E-02 2.54E-03 1.06E-03 99.89
AZ63 1.04E+02 2.34E+04 4.44E-03 1.30E-02 1.30E-03 5.42E-04 99.95
AZ62 7.63E+02 2.21E+04 3.45E-02 5.72E-02 5.72E-03 2.39E-03 99.76
AZ56 5.06E+02 2.24E+04 2.26E-02 3.97E-02 3.97E-03 1.66E-03 99.83
AZ72 4.20E+02 2.43E+04 1.73E-02 3.20E-02 3.20E-03 1.33E-03 99.87
AZ69 2.96E+02 2.58E+04 1.15E-02 2.34E-02 2.34E-03 9.76E-04 99.90
AZ60 3.94E+02 2.71E+04 1.45E-02 2.79E-02 2.79E-03 1.16E-03 99.88
AZ68 5.75E+01 2.83E+04 2.03E-03 9.46E-03 9.46E-04 3.94E-04 99.96
AZ67 1.13E+02 3.04E+04 3.72E-03 1.19E-02 1.19E-03 4.96E-04 99.95
    




ZZ74 1.68E+03 1.78E+04 9.44E-02 1.46E-01 1.46E-02 6.09E-03 99.39
ZZ78 5.05E+01 2.52E+01 2.00E+00 2.96E+00 2.96E-01 1.23E-01 87.66
ZZ80 1.35E+03 2.99E+04 4.52E-02 7.29E-02 7.29E-03 3.04E-03 99.70
ZZ87 4.47E+02 2.82E+04 1.59E-02 2.98E-02 2.98E-03 1.24E-03 99.88
ZZ75 3.41E+02 2.57E+04 1.33E-02 2.60E-02 2.60E-03 1.08E-03 99.89
ZZ83 2.40E+02 2.54E+04 9.45E-03 2.04E-02 2.04E-03 8.51E-04 99.91
ZZ86 2.07E+02 1.92E+04 1.08E-02 2.23E-02 2.23E-03 9.30E-04 99.91
ZZ88 4.89E+02 2.37E+04 2.06E-02 3.69E-02 3.69E-03 1.54E-03 99.85
ZZ90 4.89E+02 2.52E+04 1.94E-02 3.50E-02 3.50E-03 1.46E-03 99.85
ZZ89 2.72E+02 2.41E+04 1.13E-02 2.31E-02 2.31E-03 9.63E-04 99.90
ZZ81 1.66E+02 2.31E+04 7.19E-03 1.71E-02 1.71E-03 7.13E-04 99.93
ZZ76 4.29E+02 2.55E+04 1.68E-02 3.13E-02 3.13E-03 1.31E-03 99.87
ZZ77 6.60E+02 2.16E+04 3.06E-02 5.15E-02 5.15E-03 2.15E-03 99.79
ZZ85 4.23E+02 2.39E+04 1.77E-02 3.25E-02 3.25E-03 1.36E-03 99.86
ZZ79 6.48E+02 2.93E+04 2.21E-02 3.90E-02 3.90E-03 1.63E-03 99.84
ZZ82 3.69E+02 2.75E+04 1.34E-02 2.62E-02 2.62E-03 1.09E-03 99.89
ZZ73 1.94E+02 2.89E+04 6.71E-03 1.63E-02 1.63E-03 6.80E-04 99.93
ZZ84 2.03E+02 2.55E+04 7.96E-03 1.82E-02 1.82E-03 7.59E-04 99.92
    
QA/QC    
Q91 4.12E+05 2.61E+04 1.58E+01 2.32E+01 2.32E+00 9.67E-01 3.25
Q92 1.95E+05 2.54E+04 7.68E+00 1.13E+01 1.13E+00 4.71E-01 52.88



















Control    (µgl-1) (µgl-1)  
C5 7.84E+05 2.09E+04 3.75E+01 3.88E+01 3.88E+00 9.31E-01 11.62
C8 8.61E+05 1.99E+04 4.33E+01 4.48E+01 4.48E+00 1.07E+00 -2.05
C14 7.47E+05 2.04E+04 3.66E+01 3.79E+01 3.79E+00 9.09E-01 13.67
C12 6.66E+05 1.57E+04 4.24E+01 4.40E+01 4.40E+00 1.06E+00 -0.23
C4 7.98E+05 1.90E+04 4.20E+01 4.35E+01 4.35E+00 1.04E+00 0.91
C16 6.88E+04 1.98E+04 3.47E+00 3.33E+00 0.00E+00 
C1 8.65E+05 1.83E+04 4.73E+01 4.89E+01 4.89E+00 1.17E+00 -11.39
C15 7.60E+05 1.89E+04 4.02E+01 4.15E+01 4.15E+00 9.96E-01 5.47
C3 7.86E+05 1.81E+04 4.34E+01 4.50E+01 4.50E+00 1.08E+00 -2.51
C2 8.16E+05 1.95E+04 4.18E+01 4.33E+01 4.33E+00 1.04E+00 1.37
C9 8.07E+05 1.84E+04 4.39E+01 4.53E+01 4.53E+00 1.09E+00 -3.19
C6 8.19E+05 1.89E+04 4.33E+01 4.49E+01 4.49E+00 1.08E+00 -2.28
C10 7.98E+05 1.89E+04 4.22E+01 4.36E+01 4.36E+00 1.05E+00 0.68
C18 7.85E+05 1.86E+04 4.22E+01 4.37E+01 4.37E+00 1.05E+00 0.46
C7 7.41E+05 1.69E+04 4.38E+01 4.53E+01 4.53E+00 1.09E+00 -3.19
C11 8.44E+05 2.02E+04 4.18E+01 4.32E+01 4.32E+00 1.04E+00 1.59
C17 8.92E+05 1.95E+04 4.57E+01 4.73E+01 4.73E+00 1.13E+00 -7.74
C13 9.31E+05 2.10E+04 4.43E+01 4.60E+01 4.60E+00 1.10E+00 -4.78
    




ZVFe-100    
Z32 4.32E+05 1.93E+04 2.24E+01 2.46E+01 2.46E+00 5.90E-01 43.96
Z33 2.17E+05 1.72E+04 1.26E+01 1.37E+01 1.37E+00 3.29E-01 68.79
Z22 1.42E+05 1.98E+04 7.17E+00 7.64E+00 7.64E-01 1.83E-01 82.60
Z20 6.33E+04 1.53E+04 4.14E+00 4.32E+00 4.32E-01 1.04E-01 90.16
Z28 7.55E+04 1.76E+04 4.29E+00 4.74E+00 4.74E-01 1.14E-01 89.20
Z36 6.72E+04 1.47E+04 4.57E+00 4.79E+00 4.79E-01 1.15E-01 89.09
Z29 5.38E+04 1.72E+04 3.13E+00 3.20E+00 3.20E-01 7.68E-02 92.71
Z21 2.45E+04 2.06E+04 1.19E+00 1.04E+00 1.04E-01 2.49E-02 97.63
Z23 2.52E+04 1.89E+04 1.33E+00 1.21E+00 1.21E-01 2.90E-02 97.24
Z27 2.23E+04 2.28E+04 9.78E-01 8.14E-01 8.14E-02 1.95E-02 98.15
Z26 1.61E+04 2.18E+04 7.39E-01 5.45E-01 5.45E-02 1.31E-02 98.76
Z19 1.13E+04 1.99E+04 5.68E-01 3.54E-01 3.54E-02 8.49E-03 99.19
Z34 1.47E+04 2.24E+04 6.56E-01 4.54E-01 4.54E-02 1.09E-02 98.97
Z35 1.30E+04 2.33E+04 5.58E-01 3.44E-01 3.44E-02 8.25E-03 99.22
Z30 1.35E+04 2.40E+04 5.63E-01 3.53E-01 3.53E-02 8.47E-03 99.20
Z25 1.28E+04 2.52E+04 5.08E-01 2.88E-01 2.88E-02 6.91E-03 99.34
Z31 1.34E+04 2.32E+04 5.78E-01 3.66E-01 3.66E-02 8.78E-03 99.17
Z24 1.43E+04 2.25E+04 6.36E-01 4.33E-01 4.33E-02 1.04E-02 99.01
    
AC-100    
A38 8.75E+03 1.55E+04 5.65E-01 3.54E-01 3.54E-02 8.49E-03 99.19
A39 1.17E+04 1.56E+04 7.50E-01 5.58E-01 5.58E-02 1.34E-02 98.73
A50 5.73E+03 1.48E+04 3.87E-01 1.56E-01 1.56E-02 3.74E-03 99.64
A46 4.94E+03 1.91E+04 2.59E-01 1.30E-02 1.30E-03 3.12E-04 99.97
A43 5.04E+03 1.71E+04 2.95E-01 5.39E-02 5.39E-03 1.29E-03 99.88
A40 6.02E+03 1.53E+04 3.93E-01 1.62E-01 1.62E-02 3.89E-03 99.63
A44 5.16E+03 1.50E+04 3.44E-01 1.07E-01 1.07E-02 2.57E-03 99.76
A54 4.98E+03 1.72E+04 2.90E-01 4.71E-02 4.71E-03 1.13E-03 99.89
A52 5.79E+03 1.63E+04 3.55E-01 1.21E-01 1.21E-02 2.90E-03 99.72
A47 6.02E+03 1.63E+04 3.69E-01 1.35E-01 1.35E-02 3.24E-03 99.69
A49 6.47E+03 1.68E+04 3.85E-01 1.53E-01 1.53E-02 3.67E-03 99.65
A37 5.51E+03 1.39E+04 3.96E-01 1.64E-01 1.64E-02 3.93E-03 99.63
A51 5.96E+03 1.54E+04 3.87E-01 1.56E-01 1.56E-02 3.74E-03 99.64
A45 4.96E+03 1.71E+04 2.90E-01 4.77E-02 4.77E-03 1.14E-03 99.89
A53 5.51E+03 1.59E+04 3.47E-01 1.11E-01 1.11E-02 2.66E-03 99.75
A41 6.83E+03 1.80E+04 3.79E-01 1.46E-01 1.46E-02 3.50E-03 99.67
A42 6.07E+03 1.50E+04 4.05E-01 1.75E-01 1.75E-02 4.20E-03 99.60
A48 4.84E+03 1.86E+04 2.60E-01 1.45E-02 1.45E-03 3.48E-04 99.97
    
Z50:A50    
AZ70 9.47E+03 1.71E+04 5.54E-01 2.82E-01 2.82E-02 6.77E-03 99.36
AZ58 5.94E+03 1.20E+04 4.95E-01 2.19E-01 2.19E-02 5.25E-03 99.50
AZ66 8.76E+03 1.54E+04 5.69E-01 2.98E-01 2.98E-02 7.15E-03 99.32
AZ64 5.94E+03 1.95E+04 3.05E-01 2.22E-02 2.22E-03 5.33E-04 99.95
AZ55 5.40E+03 1.74E+04 3.10E-01 2.75E-02 2.75E-03 6.60E-04 99.94
AZ59 5.57E+03 1.79E+04 3.11E-01 2.82E-02 2.82E-03 6.77E-04 99.94
AZ61 5.60E+03 1.74E+04 3.22E-01 3.94E-02 3.94E-03 9.45E-04 99.91




AZ71 5.51E+03 1.63E+04 3.38E-01 5.77E-02 5.77E-03 1.38E-03 99.87
AZ65 5.94E+03 1.46E+04 4.07E-01 1.29E-01 1.29E-02 3.09E-03 99.71
AZ63 4.30E+03 1.66E+04 2.59E-01 < 0 0 0 100
AZ62 4.44E+03 1.68E+04 2.64E-01 < 0 0 0 100
AZ56 5.46E+03 1.68E+04 3.25E-01 4.37E-02 4.37E-03 1.05E-03 99.90
AZ72 5.56E+03 1.82E+04 3.05E-01 2.30E-02 2.30E-03 5.52E-04 99.95
AZ69 4.07E+03 1.71E+04 2.38E-01 < 0 0 0 100
AZ60 5.86E+03 1.94E+04 3.02E-01 1.98E-02 1.98E-03 4.75E-04 99.95
AZ68 6.32E+03 1.74E+04 3.63E-01 8.27E-02 8.27E-03 1.98E-03 99.81
AZ67 5.24E+03 1.84E+04 2.85E-01 2.39E-03 2.39E-04 5.73E-05 99.99
    
Z70:A30    
ZZ74 1.11E+04 1.36E+04 8.16E-01 5.54E-01 5.54E-02 1.33E-02 98.74
ZZ78 3.14E+03 0.00E+00 #DIV/0! < 0 0 0 100
ZZ80 1.31E+04 1.92E+04 6.82E-01 4.13E-01 4.13E-02 9.91E-03 99.06
ZZ87 7.71E+03 2.07E+04 3.72E-01 9.33E-02 9.33E-03 2.24E-03 99.79
ZZ75 6.84E+03 1.67E+04 4.10E-01 1.31E-01 1.31E-02 3.14E-03 99.70
ZZ83 7.65E+03 1.96E+04 3.90E-01 1.12E-01 1.12E-02 2.69E-03 99.74
ZZ86 4.77E+03 1.38E+04 3.46E-01 6.45E-02 6.45E-03 1.55E-03 99.85
ZZ88 6.04E+03 1.73E+04 3.49E-01 6.94E-02 6.94E-03 1.66E-03 99.84
ZZ90 5.74E+03 1.81E+04 3.17E-01 3.48E-02 3.48E-03 8.35E-04 99.92
ZZ89 6.13E+03 1.83E+04 3.35E-01 5.42E-02 5.42E-03 1.30E-03 99.88
ZZ81 5.07E+03 1.81E+04 2.80E-01 < 0 #VALUE! #VALUE! #VALUE! 
ZZ76 5.59E+03 1.68E+04 3.33E-01 5.10E-02 5.10E-03 1.22E-03 99.88
ZZ77 6.93E+03 1.48E+04 4.68E-01 1.92E-01 1.92E-02 4.61E-03 99.56
ZZ85 5.56E+03 1.54E+04 3.61E-01 8.08E-02 8.08E-03 1.94E-03 99.82
ZZ79 7.39E+03 1.91E+04 3.87E-01 1.08E-01 1.08E-02 2.59E-03 99.75
ZZ82 6.01E+03 1.88E+04 3.20E-01 3.86E-02 3.86E-03 9.26E-04 99.91
ZZ73 5.10E+03 1.74E+04 2.93E-01 1.01E-02 1.01E-03 2.42E-04 99.98
ZZ84 4.61E+03 1.63E+04 2.83E-01 2.66E-04 2.66E-05 6.38E-06 100.00
    
QA/AC    
Q91 3.99E+05 1.72E+04 2.32E+01 2.40E+01 2.40E+00 5.76E-01 45.33
Q92 1.95E+05 1.58E+04 1.23E+01 1.25E+01 1.25E+00 3.00E-01 71.53























Residual for Ibuprofen Linear Regression
Concentration (microgram/L)











Residual for Carbamazepine Linear Regression
Concentration (microgram/L)











Residual for Naproxen Linear Regression
Concentration (microgram/L)











Residual for Gemfibrozil Linear Regression
Concentration (microgram/L)











Residual for Caffeine Linear Regression
Concentration (microgram/L)














Appendix VIII: Calculation of Expected Concentration for Preliminary Batches. 
Expected concentration are calculated for preliminary batches using the mass of PhAC 
in the PhAC working stock solution, the volume of this stock added as well as the total 
volume of the reaction vessel sample solution.  
 
 
Table A8.1 Calculation of initial carbamazepine spiked concentration (expected 
concentration) in preliminary reaction vessel.  This concentration is used as Co in percent 
removal calculations. 
  
Reaction flask Mass Carbamazepine in 
stock (mg) 
Vol. Stock Added Vol. of Sample Expected Drug 
Concentrationn (mg l-1) 
Expected 
Concentration (µgl-1)
   
Control 1 1.9950 0.0010 0.8004 0.0024 2.3679
Control 2 1.9950 0.0011 0.7992 0.0027 2.6958
DK BOF 1.9950 0.0009 0.8004 0.0023 2.2931
ST BOF 1.9950 0.0009 0.8003 0.0022 2.2435
ZVFe 1.9950 0.0010 0.8000 0.0024 2.3690
BDS 1.9950 0.0010 0.8006 0.0025 2.5417
WC 1.9950 0.0010 0.8005 0.0025 2.5171
 
 
Table A8.2 Calculation of initial gemfibrozil spiked concentration (expected concentration) 
in preliminary reaction vessel.  This concentration is used as Co in percent removal 
calculations. 
 
Reaction flask Mass Gemfibrozil in 
stock (mg) 
Vol. Stock Added Vol. of Sample Expected Drug 
Concentration (mg l-1) 
Expected 
Concentration (µgl-1)
   
Control 1 1.9420 0.0010 0.8004 0.0023 2.3050
Control 2 1.9420 0.0011 0.7992 0.0026 2.6242
DK BOF 1.9420 0.0009 0.8004 0.0022 2.2322
ST BOF 1.9420 0.0009 0.8003 0.0022 2.1839
ZVFe 1.9420 0.0010 0.8000 0.0023 2.3061
BDS 1.9420 0.0010 0.8006 0.0025 2.4742
















Table A8.3 Calculation of initial naproxen spiked concentration (expected concentration) in 
preliminary reaction vessel.  This concentration is used as Co in percent removal calculations. 
 
Reaction flask Mass Naproxen in stock 
(mg) 




   
Control 1 1.9760 0.0010 0.8004 0.0023 2.3453
Control 2 1.9760 0.0011 0.7992 0.0027 2.6701
DK BOF 1.9760 0.0009 0.8004 0.0023 2.2713
ST BOF 1.9760 0.0009 0.8003 0.0022 2.2221
ZVFe 1.9760 0.0010 0.8000 0.0023 2.3465
BDS 1.9760 0.0010 0.8006 0.0025 2.5175




Table A8.4 Calculation of initial ibuprofen spiked concentration (expected concentration) in preliminary 
reaction vessel.  This concentration is used as Co  in percent removal calculations. 
 
Reaction flask Mass Ibuprofen in stock 
(mg) 




   
Control 1 2.0010 0.0010 0.8004 0.0024 2.3750
Control 2 2.0010 0.0011 0.7992 0.0027 2.7039
DK BOF 2.0010 0.0009 0.8004 0.0023 2.3000
ST BOF 2.0010 0.0009 0.8003 0.0023 2.2503
ZVFe 2.0010 0.0010 0.8000 0.0024 2.3762
BDS 2.0010 0.0010 0.8006 0.0025 2.5493
WC 2.0010 0.0010 0.8005 0.0025 2.5247
 
 
Table A8.5 Calculation of initial caffeine spiked concentration (expected concentration) in 
preliminary reaction vessel.  This concentration is used as Co in percent removal calculations. 
 
Reaction flask Mass Caffeine in stock 
(mg)  




   
Control 1 1.9700 0.0010 0.8004 0.0023 2.3382
Control 2 1.9700 0.0011 0.7992 0.0027 2.6620
DK BOF 1.9700 0.0009 0.8004 0.0023 2.2644
ST BOF 1.9700 0.0009 0.8003 0.0022 2.2154
ZVFe 1.9700 0.0010 0.8000 0.0023 2.3393
BDS 1.9700 0.0010 0.8006 0.0025 2.5098












Appendix IX: Percent Removal Calculations with respect to concentration 
 
Percent removal was calculated using equation (1).  
 
% Removal = (1- Cf/ Co)*100 (1)  
 
Where Cf is the final PhAC concentration in the treated effluent and Co is the initial PhAC 
concentration.   Co is defined as the average control concentration for the Final batch 
experiements; and defined by the known spiked concentration as calculated in the tables in 
appendix VIII.  Calculations for preliminary batches, where Co is defined as the spiked PhAC 
concentration, were futher defined by equation 2, 
 
 Rm = Rcc – Rcm   (2) 
 
Where Rm = total percent removal by media, and Rcm and Rcc are the calculated percent 
removals of the media and the controls respectively, as calculated by equation one.  This 
second equation is applied so that percent removals include only that removal due to the 































Appendix X: Calculation of Moisture Content for Sediment Back Extractions and Mass 
of PhAC sorbed to Solid 
 
Table A10. Table of measured and calculated quantities used in the computation of moisture 
content and solid-phase sorbed PhACs.  This calculation of sorbed PhACs contributes to mass 
balance calculations in Appendix XI. 
 































Unit  g g g g % g g µgl-1 ug µgg-1 g ug 
CBZ ST-BOF 100.08 10.55 8.24 21.90 51.00 39.83 0.36 0.04 0.00 100.09 0.09
CBZ Borden Sand 100.10 7.59 5.86 22.79 52.00 40.15 0.23 0.02 0.00 103.18 0.06
CBZ Wood Chips 100.05 5.58 0.87 84.41 14.00 2.18 0.04 0.00 0.00 15.05 0.03
CBZ ZVFe 100.52 14.71 11.76 20.05 52.00 41.57 0.04 0.00 0.00 100.03 0.01
      
CAFF ST-BOF 100.08 10.55 8.24 21.90 51.00 39.83 0.05 0.01 0.00 100.09 0.01
CAFF Borden Sand 100.10 7.59 5.86 22.79 52.00 40.15 0.23 0.02 0.00 103.18 0.06
CAFF Wood Chips 100.05 5.58 0.87 84.41 14.00 2.18 0.26 0.03 0.01 15.05 0.18
CAFF ZVFe 100.52 14.71 11.76 20.05 52.00 41.57 0.03 0.00 0.00 100.03 0.01
      
IBU ST-BOF 100.08 10.55 8.24 21.90 51.00 39.83 0.41 0.04 0.00 100.09 0.10
IBU Borden Sand 100.10 7.59 5.86 22.79 52.00 40.15 0.20 0.02 0.00 103.18 0.05
IBU Wood Chips 100.05 5.58 0.87 84.41 14.00 2.18 0.45 0.05 0.02 15.05 0.31
IBU ZVFe 100.52 14.71 11.76 20.05 52.00 41.57 0.18 0.02 0.00 100.03 0.04
      
NPX ST-BOF 100.08 10.55 8.24 21.90 51.00 39.83 0.36 0.04 0.00 100.09 0.09
NPX Borden Sand 100.10 7.59 5.86 22.79 52.00 40.15 0.12 0.01 0.00 103.18 0.03
NPX Wood Chips 100.05 5.58 0.87 84.41 14.00 2.18 0.29 0.03 0.01 15.05 0.20
NPX ZVFe 100.52 14.71 11.76 20.05 52.00 41.57 0.07 0.01 0.00 100.03 0.02
      
GEM ST-BOF 100.08 10.55 8.24 21.90 51.00 39.83 0.35 0.04 0.00 100.09 0.09
GEM Borden Sand 100.10 7.59 5.86 22.79 52.00 40.15 0.10 0.01 0.00 103.18 0.03
GEM Wood Chips 100.05 5.58 0.87 84.41 14.00 2.18 0.20 0.02 0.01 15.05 0.14

















Appendix XI: Mass Balance Calculations of Recovered PhACs 
  
Table A11.  Measured and calculated quantities indicating the calculation of distribution of 
recovered PhAC between solid and solution phases. 
 


























  ug/L L ug Ug/L ug % % %
CBZ ST-BOF 2.17 0.80 1.74 2.24 1.80 5.03 96.75 -1.78
CBZ Borden Sand 2.00 0.80 1.60 2.54 2.04 2.92 78.68 18.40
CBZ Wood Chips 0.98 0.80 0.78 2.52 2.01 1.51 38.94 59.55
CBZ ZVFe 0.27 0.80 0.21 2.37 1.90 0.56 11.23 88.21
    
CAFF ST-BOF 0.11 0.80 0.09 2.22 1.80 0.77 4.77 94.46
CAFF Borden Sand 0.91 0.80 0.73 2.51 2.04 2.85 35.88 61.27
CAFF Wood Chips 0.73 0.80 0.59 2.49 2.01 8.84 29.04 62.12
CAFF ZVFe 0.14 0.80 0.11 2.34 1.90 0.38 5.83 93.79
    
IBU ST-BOF 1.73 0.80 1.39 2.25 1.80 5.72 77.31 16.98
IBU Borden Sand 1.20 0.80 0.96 2.55 2.04 2.56 47.21 50.24
IBU Wood Chips 2.20 0.80 1.76 2.52 2.01 15.51 87.41 -2.91
IBU ZVFe 0.53 0.80 0.42 2.38 1.90 2.27 22.16 75.56
    
NPX ST-BOF 1.99 0.80 1.59 2.22 1.80 5.04 88.68 6.28
NPX Borden Sand 0.89 0.80 0.71 2.52 2.04 1.48 34.93 63.59
NPX Wood Chips 0.97 0.80 0.77 2.49 2.01 9.79 38.38 51.83
NPX ZVFe 0.23 0.80 0.19 2.35 1.90 0.92 9.79 89.29
    
GEM ST-BOF 1.29 0.80 1.03 2.18 1.80 4.92 57.51 37.57
GEM Borden Sand 1.28 0.80 1.03 2.47 2.04 1.29 62.94 35.77
GEM Wood Chips 0.97 0.80 0.77 2.45 2.01 6.77 47.94 45.28



















Appendix XII: Paired T-test Results for Treatments 
 
Table A12.  Table of paired t-test results for all media investigated.  Paired T-test were 
calculated between control samples and treated samples to verify the statistical significance 
on any change in concentration. The significance level , alpha, was set at 5% (α = 0.05). If the 
probability of attaining a statistically similar value (p) is less than alpha, then one rejects the 
null hypothesis that the results are statistically similar and the results cannot be ascribed to 
chance alone; thus the difference in results between the compared sample sets are described as 






Z70:Z30 Z50:A50 AC100% BOF  BDS Wood 
Chips 
Carbamazepine 
        
T value 3.455 10.158 13.417 13.350 12.649 -1.651 0.936 8.982
P value 0.006 0.000 0.000 0.000 0.000 0.130 0.371 0.000
Degrees of freedom 10.000 18.000 18.000 18.000 17.000 10.000 10.000 10.000
p value< or > alpha less less less less less greater greater less
Caffeine 
  
T value 4.372 10.401 12.659 12.636 2.523 5.178 7.665 2.7181
P value 0.001 0.000 0.000 0.000 0.021 0.000 0.000 0.0187
Degrees of freedom 10.000 18.000 18.000 18.000 18.000 11.000 11.000 12.0000
p value< or > alpha less less less less less less less less
Gemfibrozil 
  
T value 2.059 8.333 10.899 10.898 10.899 1.631 1.361 2.580
P value 0.066 0.000 0.000 0.000 0.000 0.129 0.199 0.024
Degrees of freedom 10.000 11.000 11.000 11.000 11.000 12.000 12.000 12.000
p value< or > alpha greater less less less less greater greater less
Naproxen 
  
T value -0.399 7.659 10.724 10.742 10.721 -3.552 1.039 2.052
P value 0.698 0.000 0.000 0.000 0.000 0.004 0.319 0.063
Degrees of freedom 10.000 11.000 11.000 11.000 11.000 12.000 12.000 12.000
p value< or > alpha greater less less less less less greater greater
Ibuprofen 
  
T value 2.467 6.779 10.976 10.954 10.972 -2.398 0.982 -4.202
P value 0.039 0.000 0.000 0.000 0.000 0.034 0.346 0.001
Degrees of freedom 8.000 11.000 11.000 11.000 11.000 12.000 12.000 12.000












Appendix XIII: Confidence Intervals for Controls 
   
Table A13. Confidence Intervals for Controls:  
 
 Control (Final Batch) Control (Preliminary 1) Control (Preliminary 2) 
 Avg.  S.D. C.I.  n Avg.  S.D. C.I.  n Avg.  S.D. C.I.  n 
CAFF 4.394 0.270 0.125 18 2.403 0.035 0.020 12 2.402 0.031 0.017 12 
GEM 2.278 0.103 0.067 18 2.455 0.390 0.230 11 2.703 0.405 0.220 13 
NPX 2.348 0.157 0.092 18 1.084 0.243 0.143 11 2.058 0.352 0.199 12 
IBU 1.250 0.030 0.018 18 0.939 0.136 0.080 11 1.815 0.199 0.139 13 
 







































Appendix XIV: MINTEQA2 Speciated and Unspeciated Charge differences and 
Mineral  
            Saturation Indices  
 
 
Table A14. The following table depicts the results of geochemical modeling with the mass-
transfer code MINTEQA2.  Saturation indices calculation by MINTEQA2 were employed to 
determine potential mineral phases controlling aqueous geochemistry in the reaction vessels.   
Saturation indices of zero value indicate equilibrium with respect to the mineral phase; while 
values greater than 0 indicate supersaturation and values less than zero indicate 
undersaturation.  
 




10 4.681 5.862 0.5201 8.179   
Speciated charge 
difference 












Aragonite -0.064 -0.439 -0.357 -0.384 -0.338 Becomes less 
saturated 
Undersaturation
Calcite 0.081 -0.295 -0.212 -0.239 -0.194 Becomes less 
saturated 
Undersaturation
Ferrihydrite 0.542 1.699 0.581 1.432 0.353 Becomes less 
saturated 
Supersaturation
Boehmite 0.243 0.702 0.573 1.682 0.47 Becomes more 
saturated 
Supersaturation
Gibbsite 0.737 1.197 1.067 2.177 0.964 Becomes more 
saturated 
Supersaturation
Disapore 1.965 2.425 2.295 3.405 2.192 Constant Supersaturation
Lepidocrocite 4.062 5.219 4.101 4.952 3.873 Constant Supersaturation
Magnesium-
Ferrite 
4.894 6.971 4.748 5.601 4.055 Constant Supersaturation
Maghemite 4.48 6.794 4.559 6.26 4.101 Constant Supersaturation
Fe(OH)2.7Cl3 5.18 6.421 5.279 6.1 4.997 Constant Supersaturation
Goethite 6.361 7.519 6.401 7.251 6.172 Constant Supersaturation
Mixed Carbite 8.912 7.962 8.365 6.038 6.826 Becomes less 
saturated 
Supersaturation
Magnetite 10.467 15.511 13.147 14.969 11.312 Constant Supersaturation
Hematite 14.721 17.036 14.8 16.501 14.342 Constant Supersaturation
























9.08 13.19 0.2901 1.9 7.4   








Change  Final State 
Octacaphospha
te 
0.976 -0.934 -2.334 -3.439 -2.658 Becomes less 
saturated 
Undersaturation 
Hausmannite 3.667 1.193 -4.214 0.601 -0.285 Becomes less 
saturated 
Undersaturation 
Magnesite -0.295 -0.174 -0.305 -0.458 -0.22 Constant Undersaturation 
Bixbyite 3.223 1.206 -4.231 0.403 -0.081 Becomes less 
saturated 
Undersaturation 
Mangnitite 1.582 0.573 -2.145 0.171 -0.07 Becomes less 
saturated 
Undersaturation 
Aragonite 0.975 0.512 0.065 -0.255 -0.011 Becomes less 
saturated 
Undersaturation 
Calcite 1.12 0.657 0.21 -0.11 0.134 Becomes less 
saturated 
Supersaturation 
Ferrihydrite 1.127 1.053 -1.198 -0.148 0.319 Becomes less 
saturated 
Supersaturation 
Dolomite 1.407 1.065 0.487 0.014 0.496 Becomes less 
saturated 
Supersaturation 





0.897 0.503 0.354 0.51 0.577 Becomes less 
saturated 
Supersaturation 
Lepidocrocite 4.647 4.573 2.322 3.372 3.839 Becomes less 
saturated 
Supersaturation 
Maghemite 5.65 5.502 1 3.101 4.034 Becomes less 
saturated 
Supersaturation 
Fe(OH)2.7Cl3 5.335 5.223 2.932 3.98 4.512 Becomes less saturated Supersaturation 
Goethite 6.946 6.872 4.621 5.672 6.138 Constant Supersaturation 
Magnesium 
Ferrite 
9.299 9.209 4.807 6.818 7.588 Becomes less 
saturated 
Supersaturation 
Magnetite 11.408 11.737 7.732 8.747 9.986 Becomes less 
saturated 
Supersaturation 
Hematite 15.892 15.743 11.241 13.342 14.275 Constant Supersaturation 
Mixed Carbite 20.817 19.568 17.213 14.555 16.621 Becomes less 
saturated 
Supersaturation 






















4.721 9.661 1.663 5.486 5.024   











Change Final State 
Iron Hydroxide 0.72 0.26 -3.607 -15.548 -12.445 Becomes less 
saturated 
Undersaturation 





3.005 2.883 -1.327 -12.427 -8.823 Becomes less 
saturated 
Undersaturation 
Ferrihydrite 0.454 0.445 -1.469 -7.26 -6.215 Becomes less 
saturated 
Undersaturation 
Lepidocrocite 3.974 3.965 2.051 -3.74 -2.695 Becomes less 
saturated 
Undersaturation 
Rhodocrocite -0.889 -1.205 -1.602 -2.157 -1.734 Becomes less 
saturated 
Undersaturation 
Fe(OH)2.7Cl3 5.467 5.485 3.633 -2.231 -1.405 Becomes less saturated Undersaturation 
Siderite (D) 0.152 -0.265 -0.473 -1.531 -1.349 Becomes less 
saturated 
Undersaturation 
Siderite (C) 0.606 0.189 -0.019 -1.077 -0.895 Becomes less 
saturated 
Undersaturation 
Goethite 6.274 6.265 4.35 -1.441 -0.396 Becomes less 
saturated 
Undersaturation 
Hematite 14.546 14.528 10.699 -0.883 1.207 Becomes less 
saturated 
Supersaturation 
Magnetite 16.956 16.495 12.628 0.687 3.79 Becomes less 
saturated 
Supersaturation 































16.27 13.96 18.48 0.7604 80.13   











Change  Final State 
Jarosite 0.463 -15.422 -29.336 -23.091 -28.265 Become less 
Saturated 
Undersaturation 





12.389 2.349 -13.273 -3.357 -6.133 Become less 
Saturated 
Undersaturation 





-0.27 -1.305 -4.376 -0.959 -3.441 Become less 
Saturated 
Undersaturation 
Dolomite -0.644 -0.944 -5.026 -1.617 -3.297 Become less 
Saturated 
Undersaturation 










0.49 -0.545 -3.616 -0.199 -2.681 Become less 
Saturated 
Undersaturation 
Aragonite -0.038 -1.073 -2.851 -0.821 -1.903 Become less 
Saturated 
Undersaturation 
Lepidocrocite 7.269 1.893 -4.105 -0.631 -1.89 Become less 
Saturated 
Undersaturation 
Calcite 0.107 -0.928 -2.706 -0.676 -1.758 Become less 
Saturated 
Undersaturation 
Rhodochrosite 0.218 -0.765 -1.532 -0.17 -0.952 Become less 
Saturated 
Undersaturation 
Fe(OH)2.7Cl3 8.335 2.975 -2.612 0.442 -0.927 Become less Saturated Undersaturation 
Siderite(D) 1.122 0.631 0.012 1.404 -0.531 Become less 
Saturated 
Undersaturation 
Wustite 0.668 0.175 -1.807 1.163 -0.311 Become less 
Saturated 
Undersaturation 
Siderite(C) 1.576 1.085 0.466 1.858 -0.077 Become less 
Saturated 
Undersaturation 
Goethite 9.568 4.193 -1.806 1.668 0.409 Become less 
Saturated 
Supersaturation 
Hematite 21.135 10.384 -1.613 5.336 2.817 Become less 
Saturated 
Supersaturation 
Mixed Carbite 17.247 12.875 -4.294 12.419 4.997 Become less 
Saturated 
Supersaturation 
Magnetite 25.527 14.26 0.324 10.253 6.14 Become less 
Saturated 
Supersaturation 























5.409 7.951 7.721 5.381 14.32   











Change  Final State 
Lepidocrocite 0.309 -3.399 -3.614 -3.928 -2.123 Become less 
saturated 
Undersaturation
Calcite -1.492 -1.997 -2.085 -3.182 -2.093 Become less 
saturated 
Undersaturation
Fe(OH)2.7Cl3 1.824 -1.937 -2.181 -2.5 -1.008 Become less saturated Undersaturation
Siderite (D) -1.174 -0.379 -0.319 -0.931 -0.557 Become more 
saturated 
Undersaturation
Goethite 2.608 -1.1 -1.314 -1.628 0.176 Become less 
saturated 
Supersaturation
Mixed Carbite 1.034 -0.914 -0.667 -8.665 0.303 Become less 
saturated 
Supersaturation
Hematite 7.215 -0.202 -0.63 -1.258 2.351 Become less 
saturated 
Supersaturation
Magnetite 8.042 1.664 1.432 0.621 5.759 Become less 
saturated 
Supersaturation




































5.409 7.951 7.721 5.381 14.32   











Change  Final State 
Lepidocrocite 0.309 -3.399 -3.614 -3.928 -2.123 Become less 
saturated 
Undersaturation
Calcite -1.492 -1.997 -2.085 -3.182 -2.093 Become less 
saturated 
Undersaturation
Fe(OH)2.7Cl3 1.824 -1.937 -2.181 -2.5 -1.008 Become less 
saturated 
Undersaturation




Goethite 2.608 -1.1 -1.314 -1.628 0.176 Become less 
saturated 
Supersaturation
Mixed Carbite 1.034 -0.914 -0.667 -8.665 0.303 Become less 
saturated 
Supersaturation
Hematite 7.215 -0.202 -0.63 -1.258 2.351 Become less 
saturated 
Supersaturation
Magnetite 8.042 1.664 1.432 0.621 5.759 Become less 
saturated 
Supersaturation



























46.76 28.54 35.29   
Speciated charge 
difference 
92.75 88.09 93.16   
      
NAME Sat. Index Sat. Index Sat. Index Change Final State 
Portlandite -1.95 -1.596 -0.738 Becomes more 
saturated 
Undersaturation 
Cerargyrite -0.089 0.24 -0.561 Becomes less 
saturated 
Undersaturation 
Todorokite -0.903 -3.406 -0.481 Becomes more 
saturated 
Undersaturation 
Pyrocrocite -0.351 -0.353 -0.215 Becomes more 
saturated 
Undersaturation 
Magnesite 0.504  0.025 Becomes less 
saturated 
Supersaturated 





0.49 0.87 0.384 Becomes less 
saturated 
Supersaturated 
Fe(OH)2.7Cl3 0.461 0.567 0.634 Becomes more saturated Supersaturated 
Huntite 1.423 0.662 0.741 Becomes less 
saturated 
Supersaturated 
Nsutite 1.092 0.618 1.052 Constant Supersaturated 
Lepidocrocite 1.058 1.103 1.261 Becomes more 
saturated 
Supersaturated 
Artinite 2.204 1.216 1.705 Becomes less 
saturated 
Supersaturated 
Magnetite 1.69 2.061 2.385 Becomes more 
saturated 
Supersaturated 
Brucite 2.468 1.9 2.447 Constant Supersaturated 
Aragonite 2.385 2.886 3.139 Becomes more 
saturated 
Supersaturated 
Calcite 2.529 3.03 3.284 Becomes more 
saturated 
Supersaturated 
Goethite 3.358 3.403 3.56 Constant Supersaturated 
Dolomite 3.615 3.696 3.891 Constant Supersaturated 
Manganite 4.143 3.905 4.192 Constant Supersaturated 
Gold Metal 5.723 6.085 5.434 Constant Supersaturated 
Magnesium 
Ferrite 
7.205 6.728 7.59 Constant Supersaturated 
Bixbyite 8.346 7.87 8.443 Constant Supersaturated 
Hematite 8.714 8.804 9.119 Constant Supersaturated 
Hausmannite 12.4 11.923 12.634 Constant Supersaturated 
Mixed Carbite 27.154 29.41 30.525 Constant Supersaturated 













24.35 9.7 10.23 37.37   
Speciated charge 
difference 
25.51 10.21 9.697 4.107   
       
NAME Sat. Index Sat. Index Sat. Index Sat. Index Change  Final State 
Manganite -0.701 -1.347 -3.397 -4.074 Becomes less 
saturated 
Undersaturation  
Dolomite -0.367 -0.998 -2.109 -2.108 Becomes less 
saturated 
Undersaturation  
Aragonite 0.71 0.267 -0.421 -0.563 Saturated to 
unsaturated 
Undersaturation  
Calcite 0.855 0.411 -0.276 -0.418 Saturated to 
unsaturated 
Undersaturation  










-10.084 -7.465 -4.535 1.04 Unsaturated to 
Saturated 
Supersaturation 
Ferrihydrate -0.317 -0.284 0.869 1.648 Unsaturated to 
Saturated 
Supersaturation 
Iron Hydroxide -7.114 -6.329 -1.751 1.997 Unsaturated to 
Saturated 
Supersaturation 
Boehmite -0.093 0.37 0.811 2.209 Unsaturated to 
Saturated 
Supersaturation 
Gibbsite (C) 0.401 0.865 1.306 2.703 Becomes more 
saturated 
Supersaturation 
Hercynite -6.343 -4.697 -1.543 3.443 Becomes more 
saturated 
Supersaturation 
Disapore 1.629 2.093 2.534 3.931 Becomes more 
saturated 
Supersaturation 
Lepidocrocite 3.203 3.236 4.389 5.168 Becomes more 
saturated 
Supersaturation 
Fe(OH)2.7Cl3 3.688 3.895 5.253 6.036 Becomes more saturated Supersaturation 





3.597 3.315 4.859 6.988 Becomes more 
saturated 
Supersaturation 
Goethite 5.503 5.536 6.689 7.467 Becomes more 
saturated 
Supersaturation 
Mixed Carbite 15.599 12.698 8.592 9.158 Becomes less 
saturated 
Supersaturation 
Hematite 13.004 13.07 15.376 16.934 Becomes more 
saturated 
Supersaturation 
Magnetite 9.121 9.906 14.484 18.232 Becomes more 
saturated 
Supersaturation 












Woodchips Time 1 Time 2 Time 4 Time 10   
Unspeciated charge 
difference 
97.82 98.11 97.81 96.81   
Speciated charge 
difference 
98.75 98.71 97.87 96.32   





4.354 4.117 -2.499 -1.826 Becomes less 
saturated  
Undersaturation 





-1.213 -0.882 0.196 -0.165 Becomes more 
saturated 
Undersaturation 
Brushite 0.646 0.522 0.397 0.564 Constant Supersaturation 
Octaphosphate 3.088 2.216 0.42 0.622 Becomes less 
saturated  
Supersaturation 
Monetite 0.978 0.853 0.728 0.896 Constant Supersaturation 
Whitlockite 3.322 2.575 0.903 0.938 Becomes less 
saturated  
Supersaturation 
Alumnite -6.348 -5.089 1.013 1.025 Becomes more 
saturated 
Supersaturation 
Maghemite 5.209 5.269 0.037 1.054 Becomes less 
saturated  
Supersaturation 
Zinc Phosphate 0.221 1.341 -3.091 1.08 Becomes more 
saturated 
Supersaturation 
Boehmite 1.002 1.333 2.41 2.05 Becomes more 
saturated 
Supersaturation 





-4.362 -2.832 3.323 2.52 Becomes more 
saturated 
Supersaturation 
Gibsite (C) 1.496 1.827 2.904 2.544 Becomes more 
saturated 
Supersaturation 
Strengite 3.018 3.422 2.103 3.078 Constant Supersaturation 
Fe(OH)2.7Cl3 5.32 5.35 2.97 3.586 Becomes less saturated  Supersaturation 
Disapore 2.724 3.055 4.132 3.772 Becomes more 
saturated 
Supersaturation 





4.673 4.874 4.714 4.818 Constant Supersaturation 
Varscite 2.63 3.335 5.709 5.816 Becomes more 
saturated 
Supersaturation 
Magnetite 13.022 13.737 6.978 7.835 Becomes less 
saturated  
Supersaturation 
Hematite 15.45 15.511 10.279 11.296 Becomes less 
saturated  
Supersaturation 

















42.02 10.11 2.752 12.84   
Speciated charge 
difference 
49.25 14.77 9.326 13.57   









Change Final State  










-0.737 -0.566 -0.336 -1.57 Becomes less 
saturated 
Undersaturation 
Aragonite -1.121 -0.983 -1.24 0.232 Becomes more 
saturated 
Supersaturation  
Calcite -0.976 -0.838 -1.095 0.377 Becomes more 
saturated 
Supersaturation  
Boehmite 1.477 1.648 1.878 0.644 Becomes less 
saturated 
Supersaturation  
Gibbsite (C) 1.971 2.142 2.372 1.139 Becomes less 
saturated 
Supersaturation  
Disapore 3.199 3.37 3.6 2.367 Becomes less 
saturated 
Supersaturation  



































16.65 21 11.56   
Speciated charge 
difference 
17.41 22.64 11.98   
      
NAME Sat. Index Sat. Index Sat. Index Change Final State 
Manganite -0.532 0.315 -1.104 Becomes less 
saturated 
Undersaturation 
Aragonite 0.685 0.921 0.332 Becomes less 
saturated 
Supersaturation  
Calcite 0.829 1.066 0.477 Becomes less 
saturated 
Supersaturation  
Ferrihydrite 0.901 0.743 0.694 Becomes less 
saturated 
Supersaturation  
Lepidocrocite 4.421 4.263 4.214 Constant Supersaturation  
Maghemite 5.198 4.883 4.785 Constant Supersaturation  
Magnesium 
ferrite 
3.654 4.273 4.886 Becomes more 
saturated 
Supersaturation  
Goethite 6.72  6.514 Constant Supersaturation  
Mixed Carbite 9.023 11.727 10.481 Becomes more 
saturated 
Supersaturation  
Magnetite 11.355 11.365 10.853 Constant Supersaturation  
Hematite 15.439 15.124 15.026 Constant Supersaturation  
Pyrolusite 56.045 56.411 55.356 Constant Supersaturation  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
